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ABSTRACT 
 
LOW TEMPERATURE EFFECTS ON THE TRANSCRIPTOME OF YERSINIA PESTIS AND 
ITS TRANSMISSIBILITY BY OROPSYLLA MONTANA FLEAS 
 
 
Yersinia pestis, the causative agent of plague, is primarily a rodent-associated, flea-borne 
zoonosis.  Transmission to humans is mediated most commonly by the flea vector, Oropsylla 
montana, and occurs predominantly in the Southwestern United States.  In these studies, we 
hypothesized that Y. pestis-infected O. montana fleas held at temperatures as low as 6ºC could 
serve as reservoirs of the plague bacillus during the winter months in temperate regions with 
endemic plague foci.  With few exceptions, previous studies showed O. montana to be an 
inefficient vector at transmitting Y. pestis at 22-23C particularly when such fleas were fed on 
susceptible hosts more than a few days after ingesting an infectious blood meal.  We examined 
whether holding fleas at sub-ambient temperatures (for purposes of these studies, ambient 
temperature is defined as 23C) affected the transmissibility of Y. pestis by this vector.  Colony-
reared O. montana fleas were given an infectious blood meal containing a virulent Y. pestis strain 
(CO96-3188), and potentially infected fleas were maintained at different temperatures (6ºC, 
10C, 15C, or 23ºC).  Transmission efficiencies were tested by allowing groups of ~15 
infectious fleas to feed on each of seven naïve CD-1 mice on days 1-4, 7, 10, 14, 17, and 21, 28, 
35, and 42 post infection (p.i.).  Fleas held at 6ºC, 10C and 15C were able to effectively 
transmit at every time point p.i.  The percentage of transmission to naïve mice by fleas 
maintained at low temperatures was higher than for fleas maintained at 23ºC and indicates that 
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O. montana fleas efficiently transmit Y. pestis at low temperatures.  Moreover, bacterial loads of 
flea cohorts maintained at temperatures of 6ºC, 10ºC and 15ºC were statistically higher than fleas 
maintained at 23ºC.  In addition, whole transcriptomes of Y. pestis bacteria grown at 6ºC, 10C, 
15C and 23ºC were analyzed to assess differential gene expression at each temperature to 
identify genes which may contribute to an increase in virulence or survivability of the plague 
pathogen at the lower temperatures when compared to ambient temperature.  This is the first 
comprehensive study to demonstrate efficient transmission of Y. pestis by O. montana fleas 
maintained at temperatures as low as 6ºC.  Our findings further contribute to the understanding 
of plague ecology in temperate climates by providing support for the hypothesis that Y. pestis is 
able to overwinter within the flea gut and potentially cause infection during the following 
transmission season.  The findings also might hold implications for explaining the focality of 
plague in tropical regions where plague occurs in cooler environments, primarily located at 
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YERSINIA PESTIS TRANSMISSION AND DISEASE 
1.1. Historical Background and Yersinia pestis Pandemics 
 Plague has caused three large pandemics which were recorded in 541, 1347, and 1855 
(Perry and Fetherston 1997).  Plague is caused by the bacterium Ye sinia pestis and is further 
subdivided into four biovars, which historically are based on their abilities to reduce nitrate and 
ferment glycerol: Antiqua (glycerol positive, and nitrate positive), Mediaevalis (glycerol 
positive, and nitrate negative), Orientalis (glycerol negative, and nitrate positive), and Microtus 
(glycerol positive, and nitrate negative) (Zhou, Han et al. 2004).  Researchers hypothesized that 
each biovar, excluding microtus, has caused a specific pandemic based on their geographic 
location, as well as on historical records that indicated the geographic origin of the pandemics 
(Drancourt, Roux et al. 2004).  Each pandemic caused devastating mortality of people and 
animals across nations and continents, resulting in more than 200,000 million deaths throughout 
plague history (Frith 2012).  In the human plague pandemics, the primary form of disease was 
the bubonic form.  After the bacteria migrates to the bloodstream, the pathogen quickly 
disseminates throughout the body leading to hemorrhaging and necrosis of the skin followed by 
septicemic plague infection that resulted in shock and death.  If the bacterium spread from the 
blood to the lungs, pneumonic plague ensued, resulting in a highly fatal form of the disease and 
potential of direct transmission from human to human (Frith, 2012).  The primary flea vectors for 
transmission from the rats to humans during the pandemics were primarily the Oriental rat flea, 
Xenopsylla cheopis, and the Northern or Eastern rat flea, Nosopsyllus fasciatus; in addition, the 
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human flea, Pulex irritans, and the dog and cat fleas, Ctenocephalides canis and felis played a 
role as secondary vectors.  The plague pandemics successfully spread over long distances 
because infected fleas were carried on rats as well as humans that traveled along the trade routes 
at sea and overland.  Also, the rats carrying Y. pestis-infected fleas infested grains and rice, trade 
merchandise and clothing, which further contributed to the successful spread of plague (Frith, 
2012).   
The first pandemic, known as the Justinian plague, which was named after Justinian I, the 
Roman emperor of the Byzantine Empire at that time, dates to A.D. 541-544, and began in 
Pelusium, Eqypt, and was caused by the Antiqua biovar of Y. pestis.  The first great pandemic 
recorded people suffering from the characteristic bubonic and septicemic plague infections 
(Frith, 2012).  The epidemic began in Ethiopia and quickly spread to Pelusium, Eqypt in 540, 
and moved west to Alexandria and east to Gaza, Jerusalem, and Antioch.  In 541, ships carrying 
rats with Y. pestis-infected fleas resulted in the spread of plague along sea trading routes to both 
sides of the Mediterranean and arrived in Constantinople (current day Istanbul) (Frith, 2012).  
Once plague reached Constantinople, the pandemic reached its peak in the spring of 542 with 
5,000-10,000 deaths per day occurring in the city and eventually killing over a third of the city’s 
population (Frith, 2012).  The vast quantities of bodies falling victim to plague, were too 
numerous to bury and were stacked high in the city’s churches and city wall towers.  From 54β-
546, plague rapidly spread through Asia, Africa, and Europe, killing nearly 100 million people.  
This pandemic led to a permanent change to the social makeup of the Western world, resulting in 
the demise of Justinian’s reign and disruption of food production leading to an eight year famine 
(Frith, 2012).  This social and economic disruption led to the end of the Roman rule and the 
formation of medieval Europe.  Over the next 200 years, plague outbreaks occurred throughout 
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Europe and the Middle East and intermittent cycles in Europe occurred into the middle of the 8th 
century and plague did not re-emerge as a major epidemic until the 14th century.  During the 
Justinian pandemic, death rates were as high as 15-40%, resulting in population losses reaching 
up to 50-60% between 541 to 700 A.D (Perry and Fetherston 1997). 
During 1330 to 1346, plague spread from the steppes of Central Asia westward along the 
trade routes before successfully making its way to Sicily; therefore, starting what was known as 
the second pandemic covering much of the “known world” (Wagner, Keim et al. 2014).  In 1347, 
plague was brought to the Crimea from Asia by the Tartar armies of Khan Janibeg, who was 
responsible for the siege of Kaffa, which was a Genoese trading town on the shores of the Black 
Sea.  However, the siege was unsuccessful, and in an attempt of revenge, the bodies of plague 
victims were catapulted over the walls of Kaffa.  Panic stricken Genoese traders fled 
Constantinople and crossed the Mediterranean to Messina, Sicily where the second great 
pandemic of Europe began (Frith, 2012).  The Black Death of 1347 was the first major European 
outbreak of plague and marked the second great plague pandemic which occurred between the 
14th to 18th centuries (Frith, 2012).  The first major epidemic of the Black Death pandemic 
resulted in devastating effects killing 17-28 million European deaths and a 30 to 40% 
depopulation.  People died so rapidly that proper burials and cremations did not occur, and 
corpses were thrown into large pits and decaying bodies lay in homes and in the streets (Perry 
and Fetherston 1997).  The epidemic cycles of Y. pestis biovar Medievalis, were unruly and 
persistently occurred in 2-5 year cycles from 1361-1480.  During the Black Death and 
subsequent epidemics, the importance of medical education and practices were impending.  The 
only remedies were inhalation of aromatic vapors from herbs and flowers such as rose, theriaca, 
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aloe, thyme and camphor; however, a shortage of doctors occurred leading to fake doctors selling 
useless adornments that claimed a magical cure (Frith, 2012).   
The pandemic led to great social and economic devastation and many whole families and 
villages would be completely obliterated by the disease.  Crops were not being harvested and 
traveling and trade came to a halt.  The normal upper and lower class divisions of people blurred 
leading to the emergence of a new middle class.  Many new policies were beginning to be 
developed and introduction of clinical research, public health regulations, enforcement of these 
regulations, and development of hospitals to treat and isolate patients were on the rise (Wagner, 
Keim et al. 2014).  These new measures are thought to play a role in the decline of the first and 
second pandemics, as well as potential theories of climate change, rodent populations, public 
health awareness and the life cycle of Y. pestis may have played a role in the decrease of disease 
incidence.  Between 1347-1350, the Black Death killed 25 million people, which was one quarter 
of the population in Europe, and 25 million people in Asia and Africa (Perry and Fetherston 
1997).  Paris, Venice and Florence had higher mortality rates in which more than half of the 
population succumbed to plague infection.  In 1361, a second plague epidemic spread through 
Europe killing another 10-20% of the population, and the Europe population did not recover to 
the pre-pandemic levels until the 16th century (Perry and Fetherston 1997).  In 1374, another 
Black Death epidemic re-emerged in Europe and new public health strategies were employed.  
Public health procedures were initiated including quarantining infected individuals from healthy 
individuals, as well as preventing ships with known disease from landing at port.  Doctors, who 
cared for sick individuals wore peculiar outfits to protect themselves from acquiring plague 
infection, which consisted of leather or oil cloth robes protecting their bodies from head to toe, 
leggings, gloves, hood, a wide brimmed hat which denoted their medical profession, and a beak-
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like mask that had glass eyes and two breathing holes filled with aromatic herbs and flowers to 
ward off the evil.  Doctors treated plague patients by trying to avoid contact and taking their 
pulse using a stick as well as issuing prescriptions for aromatic herbs inhalations by passing them 
through the door, and lancing buboes using knives which were several feet in length (Perry and 
Fetherston 1997, Drancourt, Roux et al. 2004, Gage and Kosoy 2005, Frith 2012).  Plague 
continued to re-emerge causing small epidemics throughout the world.  In 1665-1666, a large 
pneumonic plague outbreak occurred in Europe and England and reached a peak in 1665 when 
7,000 victims were dying of plague infections each week in London.  The epidemic resulted in 
the loss of 100,000 people in London’s population and the subsequent Great Fire of London in 
1666 likely led to the end of the epidemic which resulted in the rebuilding of timber and homes 
with brick and tile which disturbed the normal habitat for the rats and led to an overall reduction 
in infected fleas which, were in close vicinity of humans (Frith, 2012).   
 Lastly, the Chinese province of Yunnan in 1855, began what is known as the third plague 
pandemic.  Once in Yunnan, plague quickly spread along the tin and opium routes before 
reaching the capital of K’umming in 1866, the Gulf of the Tonkin in 1867, and the Kwangtung 
province port of Pakhoi in 1882 (Frith, 2012).  Y  pestis biovar Orientalis is thought to be 
responsible for the rapid spread of the disease throughout the southern coast of China.  Plague 
reached ports on every continent from the successful transportation of infected rats which 
traveled the international trade routes on steamships (Frith, 2012).  Hong Kong and Canton were 
soon affected by 1894 and advancing further to Bombay by 1898.  During the Hong Kong 
epidemic which began in June 1894, two scientists, Alexandre Yersin and Shibasaburo Kitasato 
each declared the isolation of the plague organism.  Kitasato was initially credited with the 
identification and isolation of the plague organism; however, the bacillus Yersin isolated, 
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correctly fit the description of Y. pestis, and Yersin further cured a plague patient in 1896 using 
antiserum he developed against the organism.  Kitasato’s description was different than Yersin’s, 
and later speculated that his organism was potentially contaminated with pneumococcus which 
led to the difference in description.  Yersin further discovered the link between plague and rats.  
Scientists Masanori Ogata, and Paul Louis Simond were each credited with identifying a 
correlation with fleas in plague transmission, which, they each discovered in 1897 during the 
Indian epidemic (Simond 1898, Perry and Fetherston 1997, Frith 2012).    
 With the discovery of the plague organism and better understanding of the important 
correlations with rats and fleas, many scientists began advancing studies trying to find a vaccine 
as well as determining efficacies of antibiotics.  Animal models were used and the epidemiology 
and pathology of the disease were being investigated.  The nomenclature for Y. pestis has 
changed throughout the years and was previously named Bacterium pestis up until 1900, when it
was then named Bacillus pestis until 1923, followed by Pasteurella pestis and finally Yersinia 
pestis in 1970. 
 
1.2. Y. pestis General Characteristics and Etiology 
The genus Yersinia consists of 19 nomen species and is a member of the family 
Enterobacteriaceae (Duan, Liang et al. 2014).  There are three species pathogenic to humans: Y. 
enterocolitica, Y. pseudotuberculosis, and Y. pestis, and one species pathogenic to fish: Y. 
ruckeri.  Y. enterocolitica, and Y. pseudotuberculosis typically cause self-limiting food-borne 
infections, but not all strains are pathogenic to humans (Jaafar, Chettri et al. 2015).  Y. ruckeri is 
responsible for causing enteric redmouth disease (ERM) in salmonid and trout species of fish 
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(Furones, Gilpin et al. 1993).  The species causng the most acute disease in humans is Y. pestis, 
which is the etiologic agent of plague.   
Plague is primarily a flea-borne zoonotic disease of rodents and their associated fleas.  Y. 
pestis is a Gram-negative, non-motile, non-spore forming coccobacillus, measuring 0.5 to 0.8 µm 
in diameter and 1 to γ µm long and exhibits bipolar staining with Giemsa, Wright’s, or Wayson 
staining.  Optimal growth conditions for Y. pestis are at 28-30°C on blood agar or MacConkey 
agar, but is capable of growth ranging from 4-40°C.  Bacterial colonies will appear as gray-white 
to slightly yellow opaque raised, irregular “fried egg” morphology, as well as, as having the 
appearance of a “hammered copper” shiny surface.  Y. pestis’ optimal pH range for growth is 
between 7.2-7.6, but the organism is capable of surviving and tolerating pH extremes as low as 5 
and as high as 9.6 (Brubaker 1969, Poland and Barnes 1979, Holt, Krieg et al. 1994, Poland, 
Quan et al. 1994, Perry and Fetherston 1997).  The cell wall of Yersinia spp., exhibits a typical 
Gram-negative lipopolysaccharide (LPS) and lipid bilayer composition similar to that found in 
members of the family Enterobacteriaceae.  The LPS structures of Y. pseudotuberculosis and Y. 
entercolitica are smooth forms, confer a smooth phenotype and are comprised of a complete 
lipid A-oligosaccharide core-O antigen polysaccharide, whereas as Y. pe tis LPS displays Lipid 
A and core components but lacks extended O-group side chains and is characterized as having a 
rough phenotype.  At temperatures above 33°C, Y. pestis synthesizes a carbohydrate-protein 
envelope known as the fraction 1 (F1) or capsular antigen, but does not retain a true capsule.  Y. 
pestis is a lactose nonfermenter, and is urease and indole negative (Riedel 2005).  The nutritional 
requirements for this organism vary contingent on the environment and temperature in which this 
bacterium is residing; however, Y. pestis must be grown in the presence of L-isoleucine, L-
valine, L-methionine, L-phenylalanine, and glycine.  Additionally, at 37°C, this pathogen has 
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nutritional requirements for biotin, thiamine, pantothenate, and glutamic acid.  Y. pestis is a 
facultative anaerobe which lacks detectable adenine deaminase, aspartase, glucose 6-phosphate 
dehydrogenase, ornithine decarboxylase, and urease activities, but successfully demonstrates 
utilization of a constitutive glyoxylate bypass and unregulated L-serine deaminase expression to 
permit salvage of tetrahydrofolic acid (Brubaker 1969, Holt, Krieg et al. 1994, Perry and 
Fetherston 1997).  Growth of Y. pestis is slow at 28°C, with a 1.25 hour generation time, and 24-
48 hours is needed for colony formation on enriched media (Poland, Quan et al. 1994, Perry and 
Fetherston 1997).   
 Y. pestis is a genetically homogeneous organism considering its wide range of hosts and 
vectors.  Y. pestis has only one serotype, one phage type, and four biovars.  The four Y. pestis 
biovars are Antiqua, Orientalis, Mediavalis, and Microtus.  Each biovar is based on restriction 
fragment length polymorphisms of the locations of the IS100 insertion element, and each biotype 
exhibits different physiological or biochemical requirements based on the conversion of nitrate to 
nitrite as well as the fermentation of glycerol.  The biotype Antiqua, which is believed to be 
responsible for the first pandemic (Wagner, Keim et al. 2014), is positive for the conversion of 
nitrate to nitrite and glycerol fermentation.  Orientalis strains, which are responsible for the third 
pandemic, can convert nitrate to nitrite, but unsuccessfully ferment glycerol.  Biovar 
mediaevalis, implicated in the second pandemic, can successfully ferment glycerol, but is 
incapable of converting nitrate to nitrite.  Lastly, the Microtus biovar, which has not caused any 
pandemics and further was found to be avirulent in humans and guinea pigs but virulent in mice, 
can successfully ferment glycerol, but is unsuccessful in converting nitrate to nitrite (Zhou, Han 
et al. 2004).   Each Y. pestis biovar displays equal virulence (excluding Microtus), and all cause 
the same disease manifestations in humans and animals (Brubaker 1969, Poland and Barnes 
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1979, Perry and Fetherston 1997).  More recently, studies have discovered new ribotypes, which 
is a molecular technique used to differentiate bacteria based on unique DNA sequences, of the 
biovar Orientalis, which have undergone chromosomal rearrangements.  These new ribotypes of 
biovar Orientalis have been isolated in Madagascar, Vietnam and India.  It is still unclear 
whether these new ribotypes have acquired any selective advantages in a new environment 
(Ramalingaswami and Colleagues 1995, Riedel 2005). 
 In the laboratory, fully virulent strains of Y. pestis are processed and contained in 
biosafety level-3 (BSL-3) laboratories and can be manipulated safely using standard 
microbiological methods.  When working with fully virulent cultures and specimens, researchers 
should process samples in class II space A2 or higher biosafety cabinets (BSC), as well as wear 
appropriate personal protective equipment (PPE), because of the risk of generating aerosols 
when working with high concentrations of this pathogen or when working with specific 
antibiotic resistant strains (Perry and Fetherston 1997). 
 
1.3. Plague as a Bioterrorism Agent 
Y. pestis is considered a Tier 1 select agent, and is ranked as a high priority agent that 
poses a potential risk to our national security for reasons such as the pathogen’s capability to be 
easily disseminated and transmitted person-to-person, a high mortality rate, and if used in a case 
of intentional bioterrorism, it would cause public hysteria and possible collapse of the public 
health infrastructure (DHHS 2012, Service 2012).  The use of Y. pestis as a bioweapon would 
result in significant devastation, aside from the severe threat to public health and safety, leading 
to mass causalities and greatly disrupting our economy and critical infrastructure (DHHS 2012). 
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 Plague was first documented as being used as a biological warfare (BW) agent in 1346 
during the siege of Kaffa, which is now known as Feodosia in Crimea, when the Tartars threw 
plague-infected corpses into the city causing an epidemic which contributed to the surrender of 
the city (Horn 2003).  In 1940, Y. pestis was used as a biological weapon during World War II 
when Japanese airplanes flew over Chushien, Chekiang Province, China, as well as another 
identified chinesse city and released rice and wheat contaminated with Y. pestis-infected fleas.  
These two attacks resulted in plague successfully infecting and killing 121 people (Barras and 
Greub 2014). 
Since Y. pestis is considered a Tier 1 select agent, treatment for plague is required to be 
stockpiled in case of bioterrorism or biowarfare attacks.   Y. pestis successfully fits the specific 
criteria must be met in order for an organism to be considered an important select agent.  For an 
organism to be considered a Tier 1 select agent, it must meet the following criteria: (1) the 
organism must be capable of dissemination by aerosol to produce an inhalational form of the 
disease (2) the organisms can be rendered stable in both liquid and dry forms within the aerosols 
and can successfully remain viable for long enough periods to cause disease (3) the majority of 
the population has never been exposed; therefore no natural immunity to infection would exist 
(4) high morbidity and mortality (5) person-to-person transmission can occur, and lastly, (6) the 
diseases produced are difficult to diagnose and treat, because signs and symptoms mimic many 
other common diseases (Schatzmayr and Barth 2013).  Plague has been one of the most 
devastating epidemic diseases known to mankind, and with the presence and availability of 
plague around the world, the capacity for mass production, aerosol dissemination, high fatality 
rate of pneumonic plague, and the potential for rapid secondary spread, thus establishes plague as 
an ideal organism for the potential use as a biological weapon (Riedel 2005). 
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1.4. Y. pestis Evolution from Y. pseudotuberculosis 
Y. pestis recently evolved from Y. pseudotuberculosis, a food and water-borne enteric 
bacterium, within the last 1500-20,000 years.  Chromosomal DNA from the two species exhibit a 
very high degree of relatedness as established by DNA-DNA hybridization and identical 16S 
rRNA genes (Achtman, Zurth et al. 1999, Chain, Carniel et al. 2004, Hinnebusch 2005).  These 
two Yersinia species share a conserved chromosome with ~97% nucleotide identity and ~75% 
shared protein coding genes (Chain, Carniel et al. 2004).  Since these two species cause vastly 
different diseases, have different host preferences, and transmission routes, but have such similar 
genomes, this evolutionary relationship presents an intriguing area of study to better understand 
the molecular determinants responsible for the difference in disease severity, signs and 
symptoms.  Reservoirs of Y. pseudotuberculosis include dogs, cats, cattle, horses, rabbits, deer 
turkey, and many more animals) soil, plants, insects and amoeba.  Y. pseudotuberculosis 
infection typically occurs after ingesting contaminated food or water, in which the pathogen then 
colonizes the gastrointestinal tract.  First, Y. pseudotuberculosis colonizes the Peyer’s patches of 
the small intestine before disseminating to the liver and spleen.  Human infection is characterized 
by gastroenteritis and self-limiting mesenteric lymphadenitis and diarrhea.  The disease is 
usually self-limiting, but in immunocompromised individuals, this pathogen can be severe and 
sometimes fatal.  Y. pseudotuberculosis is capable of surviving long periods outside of a 
mammalian host in soil, water or within amoeba.  Y. pseudotuberculosis can also survive on 
varied nutrients and can retain metabolic capabilities, which have been lost in Y. pestis 
(Lambrecht, Bare et al. 2013, Martinez-Chavarria and Vadyvaloo 2015, Santos-Montanez, 
Benavides-Montano et al. 2015).  In Y. pestis, most infections are acquired from either the bite of 
an infected flea, contact with infected tissues, or inhalation of respiratory droplets or aerosols.  
12 
 
After fleas feed on a highly bacteremic host, they obtain Y. pestis from the blood where the 
pathogen multiplies in the flea proventriculus and midgut eventually causing an occlusion in 
some flea species.  This blockage will impede ingestion of a fresh bloodmeal and the bacteria 
will get regurgitated into the bite site transmitting the pathogen to the host.  After the flea bites a 
mammalian host, Y. pestis colonizes the dermis of the host and will then come into contact with 
macrophages.  The macrophages are permissive to the survival and replication of the pathogen, 
and Y. pestis rapidly migrates to the regional lymph node inflammation and formation of a bubo 
(Sebbane, Gardner et al. 2005, Gonzalez, Lane et al. 2015).  Next, hematogenous spread to the 
spleen and liver occurs, leading to a septicemic infection and possible spread to the lungs leading 
to secondary pneumonic plague.   
The evolution of Y. pestis consisted of horizontal gene transfer and acquisition of two 
specific plasmids, pPCP and pMT1, and the new function of the hms chromosomal genes (Chain, 
Carniel et al. 2004, Hinnebusch 2005).  For Y. pestis to evolve and be capable of surviving 
within the unique lifestyle inhabiting the flea gut as well as mammalian hosts, gene acquisition 
was essential for adaptation and survival.  In addition to the 70 kb virulence plasmid, pCD1, 
which is found in all pathogenic Yersinia spp., Y. pestis acquired two unique plasmids that 
encode a variety of virulence factors.  First, the 9.5 kb virulence plasmid, pPCP1, encodes the 
plasminogen activator pla, and is a putative invasin that is essential for virulence subcutaneously.  
Lastly, the 100-110 kb plasmid, pMT1, encoding murine toxin Ymt, is essential for bacterial 
colonization in the flea gut, and the F1 capsular antigen which is necessary for transmission and 
survival of plague (Parkhill, Wren et al. 2001).  The F1 capsular protein is expressed at 
mammalian temperatures (37°C) and not at flea temperatures (>26°C), and is thought to play a 
role in evasion of phagocytosis by the host immune system (Du, Rosqvist et al. 2002).  The 
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acquisition of the chromosomal hms genes are important in synthesis of extracellular matrix, 
which is required for biofilm formation within the flea (Jackson and Burrows 1956, Moore and 
Brubaker 1975, Lucier and Brubaker 1992, Perry and Fetherston 1997, Achtman, Zurth et al. 
1999, Hinnebusch 2005).  The high relatedness among Y. pestis and Y. psuedotuberculosis led to 
the proposal of each being subspecies, but has since been rejected by medical microbiologists 
because Y. pestis causes a fatal bubonic flea-borne infection, and Y. psuedotuberculosis is caused 
by a fecal-oral route of transmission, and rarely leading to death.  Virulence differences between 
the two species is still unclear, but the acquisition of these two plasmids by Y. pestis is thought to 
play a role in the increased virulence capabilities (Brubaker 1991, Achtman, Zurth et al. 1999).  
More recently, one study proposed that regulatory RNA’s, which are produced in coordination to 
produce distinct factors, are necessary for host adaptation and virulence in response to different 
environments; therefore, leading to distinct pathogenicity between Y. pestis and Y. 
pseudotuberculosis (Martinez-Chavarria and Vadyvaloo 2015). 
 Atypical Y. pestis Pestoides strains have been isolated in Central Asia which differ from 
wild-type Y. pestis by their ability to ferment rhamnose and melibiose, as well as lacking the 
small plasmid encoding the plasminogen activator (pla) and pesticin, and variants of the 
virulence plasmid pMT1.  These atypical strains are thought to be a derived strain from the most 
ancient lineage of Y. pestis, and differences in the strains are a result of strain specific 
rearrangements, insertions, deletions, single nucleotide polymorphisms, and a unique distribution 
of insertion sequences (Garcia, Chain et al. 2007). 
 The dramatic pathogenic difference between Y. pestis and Y. pseudotuberculosis has 
increased interest in elucidating the exact factors responsible for the differences in virulence and 
pathogenesis (Martinez-Chavarria and Vadyvaloo 2015).  Cornelis et al, discovered a shared 
14 
 
virulence factor, the Yop-Ysc Type three secretion system (T3SS), which is a plasmid-encoded 
virulence factor and shared among the two species encoding proteins necessary for the 
injectosome structure required to deliver Yop effector proteins into the cytosol of the host cells.  
The T3SS, is required for infection to enable the bacteria to subvert host immune function 
(Cornelis 2002, Martinez-Chavarria and Vadyvaloo 2015).  Whole genome studies have been 
performed to examine differences between the two species at the DNA level based on 
phylogenetics and determined that genomic rearrangements occur, including gene loss and 
acquisition occurs in Y. pestis isolates more frequently than its predecessor, Y. 
pseudotuberculosis (Achtman, Zurth et al. 1999, Morelli, Song et al. 2010, Martinez-Chavarria 
and Vadyvaloo 2015).  To better understand differences in gene expression between the two 
species, transcriptional studies must be performed.  To date, very few comparative 
transcriptional studies have been performed in order to determine the transcriptional regulatory 
differences between Y. pestis and Y. pseudotuberculosis which would increase insight on the 
regulatory networks and virulence evolution of each pathogen (Heroven and Dersch 2006, Zhan, 
Han et al. 2008, Martinez-Chavarria and Vadyvaloo 2015).   
 
1.5. Y. pestis Life Cycle  
 Plague exists in nature in enzootic or maintenance cycles between wild rodents and their 
associated fleas.  Over 90% of human plague infections are caused by the bite of an infected flea.  
Yersinia pestis has the ability to cause disease in fleas, rodents and humans.  The primary carriers 
of the pathogen are the Oriental rat flea, Xenopsylla cheopis, and infected rodents.  X. cheopis 
was first reported responsible for parasitizing rats during the 19th century and in Egypt which 
caused the spread of plague because of the fleas on the rats carried on cargo ships (Gratz 1999).  
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In the United States, the primary carriers of the pathogen are the California ground squirrel/rock 
squirrel flea, Oropsylla montana.  Other fleas and rodents, as well as lagomorphs have also been 
shown to play a role in plague outbreaks.  Evidence of Y. pestis in the Artiodactyla, Carnivora, 
Hyracoidea, Insectivora, Marsupialia, and Primate families have been identified, indicating 
almost all mammals are capable of acquiring Y. pestis infection; however, birds, reptiles and 
amphibians are thought to be resistant to Y. pestis infection.  Indirect roles in the spread of 
plague could be the result of mammals and birds which prey on plague hosts; therefore enabling 
movement of Y. pestis-infected fleas’ between areas (Gage and Kosoy 2005).  Male and female 
fleas blood feed on rodents and can successfully ingest the pathogen and later can transmit 
disease to naïve hosts.   Plague has two cycles for transmission, the sylvatic cycle, which is also 
known as the pre-human cycle that occurs in wild rodents and fleas.  This cycle continues in the 
wild rodents until a rodent die-off occurs or the fleas find a new food source, such as domestic 
rats or rodents.  Once a domestic rodent or animal is bitten by a flea and becomes infected, the 
urban or demic transmission cycle begins.  This is when humans are most at risk, and infected 
fleas can then bite humans and successfully transmit disease (Gage, Lance et al. 1992).  Plague, 
is thought to be constitutively transmitted between partially resistant rodent hosts and their fleas 
in enzootic or maintenance cycles.  Occasionally, changes in the environments such as those 
related to climate, an increase in the abundance of fleas, and/or increase in susceptible rodent 
hosts can lead to a plague epizootic.  Epizootics are characterized by large rodent die-offs and 
the infected fleas begin seeking alternative hosts, and this is when humans have the highest risk 
for acquiring plague infection.  Understanding the factors that results in plague epizootics is 
important in order to decrease the chance of human infections.  More recently, the trophic 
cascade hypothesis has been suggested, indicating a correlation between increased precipitation, 
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that allows for greater plant growth leading to more rodent food which increases the host 
populations, resulting in a greater risk of an epizootic occurring (Gage and Kosoy 2005).  Other 
models looking at precipitation and temperature correlations have been developed and found that 
increased precipitation leads to increased host and flea populations; therefore increasing the 
probability of acquiring plague infection.  However, temperatures above >32.5C, decrease the 
risk of acquiring plague infections and flea survival decreases.  Studies have suggested that 
higher temperatures unfavorably affects bacterial blockage in the fleas, and leads to decreased 
risks of an epizootic occurring (Cavanaugh 1971, Enscore, Biggerstaff et al. 2002, Gage and 
Kosoy 2005).  Many other factors play a role in the likelihood of a plague epizootic occurring, 
such as heterogeneity in Y. pestis strains, diversity of rodent populations, host immune status, 
genetic makeup of hosts, species of the flea vector, mechanism of transmission, mutations in 
bacterium or host immune cells, and interactions of Y. pestis with other pathogens (Pollitzer and 
Meyer 1961, Gage and Kosoy 2005, Gage, Burkot et al. 2008).  Currently, it is still unclear 
where Y. pestis is maintained in between epizootics or during the inter-epizootic periods.   
In rare instances, humans have become infected through contact of infected rodents or 
animals.  Human to human transmission can also occur if the bacterium is aerosolized by 
coughing or sneezing of a pneumonically infected individual or by direct physical contact of an 
infected person or animal.  Indirect contact, such as by touching contaminated soil; although 
highly unlikely, can be a source of infection.  It has also been documented that consuming raw or 
undercooked meat (camel or goats) can be a source of plague transmission to humans (Leslie, 
Whitehouse et al. 2011).  The human body louse, Pediculous humanus corporis, has also been 
shown to transmit Y. pestis, but clearly is not a significant vector for plague transmission 
(Ayyadurai, Flaudrops et al. 2010). 
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1.6. Y. pestis Reservoirs 
 
1.6.1 Mammalian Hosts: 
 
 The natural vertebrate reservoir of Y. pestis is thought to be the rodent host.  Over 203 
different rodent species or subspecies are reported as being naturally infected with plague.  Also 
playing a role as a reservoir, are the lagomorphs, in which 14 different species have been shown 
to be naturally infected with Y. pestis (Gage and Kosoy 2005).  Many variables factor into the 
ability of a small mammal serving as a plague reservoir.  For instance, the mammals must be 
capable of being infected with Y. pestis and circulating the pathogen at high enough bacterial 
levels in their blood to successfully infect feeding fleas to successfully continue the plague 
transmission cycle.  In rare cases, some rodent hosts will become highly bacteremic and succumb 
to infection; but in most cases, the rodents remain somewhat resistant to the pathogen and never 
develop severe plague illness (Gage and Kosoy 2005).  Important rodent hosts are typically 
densely parasitized by one or more important flea vectors; increasing the potential of disease 
spread.  Rodents living in burrows containing large numbers of fleas, results in intimate 
interactions allowing plague pathogen to successfully cycle among the rodent and flea 
populations (Poland and Barnes 1979, Nelson, Madon et al. 1986, Pavlov, Mokrievich et al. 
1996, Gage and Kosoy 2005).  Many factors will determine rodent susceptiblility to plague 
infection.  Differences among rodents species, such as genetic differences within individuals or 
populations, age, breeding status, immune and physiological status, and the season of the year all 
play a role in host susceptibility to plague infection (Gage and Kosoy 2005, Krasnov, Shenbrot et 
al. 2006, Hubbart, Jachowski et al. 2011).  It is thought that rodent populations contain a mixture 
of hosts which are resistant to infection and a subset that are more susceptible to infection.  Other 
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studies have speculated that some rodents may act as chronic carriers of Y. pestis, and 
successfully maintain infection between transmission seasons or epizootics (Williams, Harrison 
et al. 1975, Williams and Cavanaugh 1983, Gage and Kosoy 2005).  Other studies have 
speculated that susceptible rodents become infected before they hibernate in the winter months, 
and successfully maintain infection until they reawake in the spring months (Pollitzer and Meyer 
1961, Gage and Kosoy 2005).  Plague infection and differences in host responses will lead to 
different outcomes depending on the rodent species infected, for example, plague infection in 
gerbils, marmots, deer mice, and California voles, are highly variable and infection may go 
unnoticed, whereas plague infection in highly susceptible hosts such as the black-tailed prairie 
dogs, will result in devastatation of the entire colony during an epizootic (Kartman 1963, Poland 
and Barnes 1979, Poland, Quan et al. 1994, Gage, Ostfeld et al. 1995, Gage and Kosoy 2005).  
The true number of rodent species that may be important accidental reservoirs of plague is 
unknown.  Plague animal hosts are typically classified as either enzootic or maintenance hosts or 
as epizootic or amplification hosts.  In the maintenance hosts these rodents are considered to be 
somewhat resistant to plague infection and epizootics are not commonly observed.  In contrast to 
the effects when Y. pestis is introduced into a more susceptible rodent colony, or when rodent 
colonies or individuals overlap from two different populations or species, it results in an 
epizootic in the more susceptible colony.  Classification of plague reservoirs is difficult with the 
large number of rodents, lagomorphs and other small mammals that are considered as occasional 
or common hosts of plague.  Reservoir hosts are primarily characterized based on their 
susceptibility of plague infection, and this is difficult because susceptibility among the same 
species or within a single geographic location can be highly variable in susceptibility to plague 
infection.  In addition, the virulence of the Y. pestis strain and the possibility of that strain 
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changing over time, could be factors affecting the appearance of epizootics.  Most natural plague 
foci have been successful for years, therefore indicating that the natural reservoir populations 
must be somewhat resistant to plague infection or be able to survive infection, which has been 
seen in some species where the pathogen is capable of circulating with little observable host 
mortality (Baltazard 1960, Gage, Ostfeld et al. 1995, Gage and Kosoy 2005). 
 
1.6.2 Other Potential Reservoirs: 
Speculation about potential Y. pestis reservoirs has been deliberated for almost a century.  
One major unknown in the plague cycle is how it persists during inter-epizootic periods or the 
time between major epizootics or die-offs.  Many studies have looked into other potential plague 
reservoirs such as, soil, long-term persistence in fleas, hibernating hosts, or survival within 
amoeba, in soil nematodes, or flea feces (Hirst 1953, Pollitzer 1954, Baltazard, Karimi et al. 
1963, Mollaret 1963, Darby, Hsu et al. 2002, Gage and Kosoy 2005, Drancourt, Houhamdi et al. 
2006, Bazanova, Nikitin et al. 2007, Bizanov and Dobrokhotova 2007, Eisen, Petersen et al. 
2008, Boegler, Graham et al. 2012, Jones, Vetter et al. 2013, Williams, Schotthoefer et al. 2013).  
After many years of investigating the epidemiology and ecology of Y. pestis, much is still 
unknown about the strategies the pathogen uses to survive in its natural cycle. 
 
1.7. Y. pestis and Fleas 
In the insect order, Siphonaptera, ~2,500 species and subspecies of fleas exist, 
comprising 220 genera and 15 families.  Around 80 flea species, which are associated with ~200 
species of wild rodents have been found to be infected with Y. pestis (Pollitzer 1954, Lewin, 
Hertwig et al. 1998).  Fleas are small wingless bloodsucking insects that feed on warm-blooded 
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animals.  Flea bodies are small (1/16"), hard, polished, and covered with many hairs and short 
spines directed backward.  The compressed bodies of the fleas, which are flattened side to side 
effectively allows them to easily maneuver through the hair on their hosts’ bodies.  An adult flea 
contains mouthparts consisting of stylets, which are used to pierce the skin of the host animal for 
sucking blood from the host (Gage, Maupin et al. 1997).  Flea legs are long and adapted for 
jumping to aid in facilitation of host acquisition.  The fleas jumping aptitude along with their 
laterally compressed bodies, well-developed sense organs, and haematophagous routine all 
contribute to the ability to successfully transmit Y. pestis (Gage, Maupin et al. 1997).  Flea 
transmission efficiencies greatly varies among the different flea species, and some fleas which 
are capable of consuming an infectious bloodmeal are unsuccessful in being able to transmit the 
pathogen (Wheeler and Douglas 1945, Burroughs 1947).  Approximately, 250 flea species have 
been reported as possessing naturally occurring Y. pestis infections; however, only a small 
number of these fleas are considered to be efficient vectors for transmitting Y. pestis.  For a flea 
to be an efficient vector, they must consume a blood meal from a bacteremic host, live long 
enough for the bacteria to multiply to sufficient numbers to guarantee transmission, and 
successfully transmit Y. pestis to a susceptible host at concentrations adequate to cause infection 
(Gratz 1999, Eisen, Bearden et al. 2006, Eisen, Borchert et al. 2008, Eisen, Eisen et al. 2009).  
Adult fleas are obligate blood-feeding ectoparasites and most live in close association with their 
hosts.  Blood meal storage, digestion, and adsorption all occur in a simple, non-
compartmentalized midgut, which is composed of a single layer of columnar epithelial cells and 
basement membrane.  A valve, known as the proventriculus, is found at the base of the 
esophagus, and guards the entrance to the midgut and is important in the transmission 
mechanism.  The proventriculus of the flea is composed of densely packed rows of inward-
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directing spines that are coated with a layer of cuticle.  When a flea feeds, the proventricular 
valve opens and closes by means of muscles contracting in unison with three sets of pump 
muscles which are located in the flea’s head to force the blood into the midgut and to prevent 
backflow (Hinnebusch 2005).  Digestion of the blood meal begins a few hours after ingested and 
occurs by hemolysis and complete liquefaction of the blood components, and digestion is fully 
completed within a few days (Hinnebusch 2005).  When a flea feeds on a bacteremic host, Y. 
pestis enters the flea midgut as individual planktonic cells and resides in the digestive tract; and 
once Y. pestis reaches the midgut, the bacteria do not adhere or invade the midgut epithelium 
(Engelthaler and Gage 2000, Lorange, Race et al. 2005).  Persistence or maintenance of infection 
within the flea midgut depends on the ability of Y. pestis to form aggregates or clumps of 
bacteria.  The bacterial aggregates will form within the first few days after infection and continue 
multiplying during the first week.  The harsh biochemical and physiological environment of the 
flea digestive tract is still uncertain; however, the digestive milieu of the flea midgut is thought 
to be a hostile environment and few pathogens are found to persist in fleas.  The only known 
flea-borne pathogens include Bartonella henselae, which causes cat-scratch fever and bacillary 
angiomatosis, Rickettsia typhi and Rickettsia felis.  Francisella tularensis is also thought to be 
transmitted occasionally by fleas through mechanical means (contaminated mouthparts); but the 
importance of fleas as vectors for transmission of this pathogen is still unclear.  Lastly, 
myxomatosis, a pox virus in rabbits has been attributed to transmission by fleas; although this is 
thought to be more of a mechanical transmission mechanism (Bahmanyar and Cavanaugh 1976, 
Beard 1988, Beard, Butler et al. 1990, Chomel, Jay et al. 1994). 
The flea gut physiology and associated environmental conditions in the digestive tract 
have been reported as having a pH of 6 to 7, but other parameters such as osmotic pressure and 
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redox potential are still unknown (Wigglesworth 1984).  Insect gut epithelium secretes a variety 
of digestive enzymes such as trypsin, chymotrypsin, amino- and carboxypeptidases, cathepsins, 
lysozymes, glycosidases, and lipases (Fehlbaum, Bulet et al. 1994, Meister, Braun et al. 1994).  
The flea innate immune response to Y. pestis infection has not been characterized, but may 
resemble the immune responses of other insects such as ticks or mosquitoes.  Once Y. pestis is in 
the flea midgut, it has been shown to be resistant to flea midgut cationic antimicrobial peptides, 
specifically at lower growth temperatures (Bengoechea, Brandenburg et al. 1998, Reddin, 
Easterbrook et al. 1998, Anisimov, Dentovskaya et al. 2005).  When fleas feed on mammalian 
hosts; the blood is primarily comprised of proteins and lipids.  The lipids serve as the major 
energy source for hematophagous arthropods. 
 In 1914, Bacot and Martin first described mechanism of Y. pestis transmission by fleas, 
after these authors observed masses of Y. pestis filling the lumen of the proventriculus and 
obstructed blood flow; leading to flea starvation and the flea repeatedly attempting to feed, 
dislodging and flushing the mass of bacteria into the bite site, resulting in the successful 
transmission of Y. pestis to the mammalian host (Bacot and Martin 1914, Bacot and Martin 
1914).  In 1915, Bacot later amended the transmission mechanism, and proposed that fleas with 
only partial bacterial obstructions in their proventriculus were more efficient transmitters (Bacot 
1915).  These partially blocked fleas are still capable of pumping blood into the midgut, but 
some blood and Y. pestis is still able to back flow into the mammalian host.  This change in the 
mechanism was important, because some highly efficient vectors of plague transmission do not 
readily form a blockage in the proventriculus but can become partially blocked (Burroughs 1947, 
Pollitzer 1954, Pollitzer 1954).  Biological transmission, which requires Y. pestis colonization in 
the flea midgut, was thought initially to be the only reliable mechanism or early-phase 
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transmission; however, other studies have found evidence of mechanical transmission in which 
high levels of bacteria are found to survive on the flea mouthparts between feedings allowing for 
successfully transmission to the mammalian host (Burroughs 1947, Eisen, Bearden et al. 2006). 
 Not all flea species are efficient in successfully transmitting Y. pestis.  Flea gut structure 
and environment is very important in bacterial growth.  The flea digestive tract mainly contains 
the esophagus, proventriculus, midgut and hindgut (Hindson, McBride et al. 2005, Hinnebusch 
2005).  The flea midgut, which contains a layer of epithelial cells that cover the interior surface, 
is the main location where the flea digests and absorbs the blood meal.  The proventriculus, the 
pear shaped valve linking the midgut and esophagus, contains packed inward-directing spines 
lying on the interior, which aid in digestion of the blood meal where the spines coated in cuticle 
are capable of lysing the blood cells.  During blood meal digestion, the proventriculus is tightly 
closed in order to prevent any blood meal from leaking out of the midgut (Hindson, McBride et 
al. 2005, Hinnebusch 2005).  In order to be an efficient and competent plague vector, the flea 
must be able to ingest the plague organism with its blood meal, and survive long enough for the 
pathogen to multiply and be transfered to an animal or human host in concentrations high enough 
to cause an infection.  In the United States, at least 28 flea species have been identified as plague 
vectors, but when vector competence has been investigated experimentally, the vector 
competence of the fleas was found to differ immensely (Eisen, Eisen et al. 2009).  Flea species 
found to be inefficient plague vectors were the cat flea (C. felis) and the human flea (Pulex 
irritans) (Laudisoit and Beaucournu 2007, Laudisoit, Leirs et al. 2007).  One study indicated that 
fleas in which the bacterium can successfully form a blockage are more efficient plague 
transmitters (Mury, Paskewitz et al. 2004).  Interestingly, O. montana, the flea responsible for 
the majority of plague infections in the United States, rarely becomes blocked by Y. pestis; 
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whereas the most important plague vector worldwide, X. cheopis, is a very efficient plague 
vector capable of forming bacterial blockages in the flea proventriculus, and has been implicated 
in earlier plague pandemics (Eisen, Eisen et al. 2009, Eisen and Gage 2009). 
 
1.8. Oropsylla montana 
O. montana, is the primary plague vector in the United States, and is found west of the 
Rocky Mountains in the United States and Mexico (Hubbard, 1968).  More specifically, this 
vector is located in the Pacific Coastal region, the Rocky Mountain region and the four corners 
region (Colorado, Utah, New Mexico, and Arizona) of the United States (Traub 1972).  This flea 
most commonly parasitizes ground squirrels in the genus Spermophilus, such as the California 
ground squirrel, Spermophilus beecheui and the rock squirrel, S. variegatus (Traub 1972).  O. 
montana primarily lives in the nests of ground squirrels located in a non-urban setting, and is 
rarely found feeding on other rodents (Beard, Maupin et al. 1992, Beard, Rose et al. 1992).  
Rodent nests inhabited by these fleas are composed of twigs and leaves, and occasionally cotton 
or upholstery stuffing (Beard, Maupin et al. 1992, Beard, Rose et al. 1992).  O. montana has 
been found to be most abundant on ground squirrels at temperature which are lower than 
18.44°C (Lang, 1996).  The hosts of this flea vector may become infected with plague from the 
flea after hibernation and after returning to burrows (Lang, 1996).  O. montana fleas are 
nidicolous parasites, which will get on the host and immediately feed and then quickly get off.  
The flea’s capability to quickly get on and off the host is enhanced by the flea’s specialized 
jumping machinery. (Roberts, Leavitt et al. 1986).  
 Studies by Eskey and Haas, Wheeler and Douglas, and Burroughs, found O. montana to 
be a poor vector in the transmission of Y. pestis (Eskey 1938, Eskey and Haas 1940, Wheeler and 
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Douglas 1945, Burroughs 1947, Wheeler, Suyemoto et al. 1956).  Their studies found only 20% 
of fleas would become infected with Y. pestis when feeding on diseased hosts, and only 10% of 
the fleas were capable of transmitting the pathogen to naïve guinea pigs.  More recently, studies 
have found O. montana to be a highly competent plague vector, which can become infectious 
almost immediately after consuming an infected bloodmeal.  These difference may have been 
contributed to differences in the flea colonies used in the studies in addition to differences in  
laboratory methods and procedures which may have resulted in the observed outcomes (Eisen, 
Bearden et al. 2006).  Furthermore, this vector is capable of becoming infected with Y. pestis, 
and remaining infected and transmitting to naïve mice out to day 21 days post infection 
(Williams, Schotthoefer et al. 2013). 
 
1.9. Flea (Insect) Immunity 
 Insects protect themselves from invading pathogens by possessing a functional innate 
immune system.  The insect innate immune system is a fast acting and transient system 
comprised of organs composed of different types of cells, as well as numerous amounts of cells, 
which circulate freely in the hemolymph (Vilmos and Kurucz 1998, Lemaitre and Hoffmann 
2007).  Insect innate immunity contains three different mechanisms of defense, which include 
the columnar epithelial cells and peristalsis of the gut, which acts as a physical barrier against 
colonization.  Next, are the humoral immune barriers, which include osmotic stress, digestive 
enzymes, lysozymes and two inducible components: the production of antimicrobial peptides 
(AMP) and the secretion of reactive oxygen species (ROS) and nitric oxide in the gut.  Lastly, is 
the cellular immune system, which consists of phagocytosis, nodule formation, encapsulation, 
and melanization in the hemocoel (Lemaitre and Hoffmann 2007). 
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When an insect vector ingests pathogenic bacteria, pattern-recognition molecules will 
interact with the pathogen-associated molecules, (e.g. lipopolysaccharides in gram-negative 
bacteria; teichoic acids in gram-positive bacteria) and will result in stimulation and initiation of 
the insects’ immune responses (Mury, Paskewitz et al. β004).  To date, multiple pattern-
recognition proteins in insects have been identified: beta-1,3-Glucan-recognition protein/gram-
negative-bacteria-binding protein, C-type lectin, hemolin and peptidoglycan-recognition protein, 
which is primarily synthesized in the fat body and hemocytes.  Once the insect pathogen 
recognition receptors (PRRs) recognizes the pathogen associated molecular pattersn (PAMPs) of 
the invading pathogen, the humoral and cellular insect responses are triggered (Meister, Braun et 
al. 1994, Meister, Lemaitre et al. 1997).   
Another important insect immune component are antimicrobial peptides (AMPs), which 
play an important role in protection and are found widespread in plants, insects and vertebrate 
hosts.  An individual insect is capable of producing 10-15 AMPs, each having a different 
antimicrobial target (Meister, Braun et al. 1994, Meister, Lemaitre et al. 1997).  AMPs are 
typically less than 10kD, hydrophobic, and recognize the acidic phospholipids on the membrane 
of bacteria or other pathogens.   Insects express antimicrobial peptides in the hemolymph as early 
as 2 hours after septic injury (Meister, Braun et al. 1994, Meister, Lemaitre et al. 1997).  Five 
different families of AMP are found in Drosophila: cecropin, defensin, drosocin, diptericin and 
attacin, plus two additional antifungal peptides, drosomycin and metchnikowin (Butler, Bate et 
al. 1999).  In a study examining the transcriptome of the salivary glands of the flea vector, X. 
cheopis, an AMP family defensin gene was identified (Wang, Bian et al. 2015).  AMP 
expression is regulated by way of two signaling pathways the Toll and immune deficiency (Imd) 
pathways, which control the transcription factor nuclear factor kappa B (NF-κB) homologs 
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(Silverman and Paquette 2008).  After consuming blood meals, mosquitoes and the blood 
sucking fly Stomoxyscalcitrans, were found to secrete antimicrobial peptides to the gut lumen 
(Dimopoulos, Richman et al. 1997, Lehane 1997, Lehane, Wu et al. 1997).  An immune reaction 
site for Drosophila, as well as the Tsetse flies is the proventriculus, which showed increased 
levels of antimicrobial peptides, nitric oxide, and reactive oxygen species when compared to that 
of the midgut; however, it is still unknown if this occurs in fleas (Tzou, Ohresser et al. 2000, 
Hao, Kasumba et al. 2003, Hao, Liu et al. 2003).  Y. pestis localizes in the flea digestive gut and 
does not enter the hemocoel or salivary glands, and unlike other haematophagous insects, fleas 
do not form a chitinous peritrophic membrane around the bloodmeal (Hinnebusch, Perry et al. 
1996).  Evidence suggests that most Y. pestis flea interactions occur in the flea digestive gut, 
specifically the midgut, which has a pH around 6-7; however, much is still unknown about the 
flea gut environment (Wigglesworth 1984).  In studies examining yeast and E. coli oral infected 
Drosophila identified dual oxidase enzymes, which are capable of producing reactive oxygen 
species (ROS) and catalases that can remove excess ROS were found to be consecutively 
induced (Won JL, 2005).  In insects, the gut Imd/AMP immune response is required to fight 
bacteria that are resistant to ROS, but not to combat organisms which are ROS-sensitive (Won, 
Im et al. 2005).  Production of ROS by insects is considered their first-line defense, which 
protects the epithelial cells from high numbers of bacteria, followed by the secondary Imd 
response, which becomes activated when the initial response unsuccessfully clears the infection.  
ROS are natural byproducts of normal oxygen metabolism but also produced by enzymes such as 
NADPH oxidase in phagocytes, as well as dual oxidases in epithelial cells.  Known ROS include 
superoxide anion, hydroxyl radicals, and hydrogen peroxide, and these also can be converted to 
compounds with even higher antimicrobial activities, such as hypochlorous acid and 
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hypothiocyanite by peroxidase enzymes in mammals (Carlsson, Herrmann et al. 1984, Carlsson, 
Hofling et al. 1984, Weiss, Belisle et al. 1989, Weiss, Post et al. 1989).  An important 
requirement for insect protection against microbes is the production of ROS, as well as the 
ability of the host cells to produce enzymes necessary for removing any excess ROS, such as 
superoxide dismutase (SOD) and catalase, in order to protect themselves from damaging host 
tissues (Carlsson, Herrmann et al. 1984, Carlsson, Höfling et al. 1984).  It has been found that 
antioxidants, such as N-acetyl-cysteine, ascorbic acid and uric acid can be used to successfully 
reduce the oxidative stress in the insect midgut; but results in enhanced pathogen growth 
(Macleod, Darby et al. 2007, MacLeod, Maudlin et al. 2007).  Much is still unknown about the 
production of ROS in the flea vector, but many studies have highlighted the importance of ROS 
in other insects and their role on pathogen survival within insect vectors. 
 
1.10. Y. pestis Transmission Mechanisms 
  Studies have been performed for years trying to establish the role of fleas in plague 
transmission.  If was first suggested in 1897 that fleas could potentially transmit Y. pes is 
(Simond 1898, Pollitzer 1954, Pollitzer 1954, Pollitzer and Meyer 1961, Gage and Kosoy 2005).  
This led to further studies and the theory of the proventriculus blocked model mechanism of 
transmission, which was first described by Bacot and Martin in 1914 (Bacot and Martin 1914, 
Bacot and Martin 1914).  This model of biological transmission was proposed to be the dominant 
paradigm for flea-borne plague transmission and suggested that after fleas consume a host blood 
meal containing Y. pestis, the pathogen multiplies and begins colonizing in the flea midgut.  This 
bacterial aggregation will then spread to the flea proventriculus, and further block any 
subsequent blood meals from flowing into the midgut.  This blockage can form is a little as five 
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days after consumption, but typically occurs after 13-21 days (Mury, Paskewitz et al. 2004).  Y. 
pestis blockage in the flea requires formation of a bacterial biofilm, which is defined as a dense 
association of bacteria cells coated with an extracellular matrix, often attached to a surface 
(Jarrett, Sebbane et al. 2004).  Y. pestis only produces biofilm at flea temperatures ranging from 
21-28°C, and biofilm is not produced at mammalian temperatures (37°C) (Jones, Lilliard et al. 
1999).  When a bacterial blockage occurs, the flea will have no fresh blood in the midgut, and 
begin to starve, and consequently they repeatedly attempt to feed.  During the repeated attempts 
to acquire a fresh blood meal, the blockage prevents the blood from entering the flea midgut and 
the flea esophagus becomes distended with blood, the blood meal will partially return back to the 
biting site of the hosts; potentially dislodging bacteria from the blockage and transmitting plague 
to the host (Bacot and Martin 1914, Bacot and Martin 1914).  This model of transmission, was 
later revised by Bacot when he determined that fleas which were only partially blocked by a 
bacterial aggregation were more effective transmitters.  Fleas were capable of surviving longer 
since the partial blockage allowed for part of the blood meal to pass the proventriculus and reach 
the midgut where it could be further digested.  However, regurgitation of Y. pestis was still 
possible from the pumping of the flea proventriculus during feeding (Bacot 1915).  This revised 
transmission model provided an explanation to better explain why some flea species are good 
transmitters of plague, but are incapable of becoming completely blocked by bacterial biofilm.  
Another potential mechanism of plague transmission is a mechanical transmission route in which 
flea mouthparts could become contaminated with viable Y. pestis after feeding on an infected 
host.  After the flea goes on to take a subsequent blood meal from a new host, the bacteria; which 
have survived on the mouthparts, would be transferred into the new bite site, transmitting plague 
to the host (Hinnebusch 2005).  Recent studies have further investigated the partial-blocked flea 
30 
 
transmission mechanism and found that the flea vector O. montana can successfully transmit 
plague during the early-phase time points; which are the days before Y. pestis forms even a 
partial bacterial blockage in the flea (Eisen, Bearden et al. 2006).  This study suggested a 
different model of biological transmission in which a proventricular blockage is not necessary 
(Eisen, Bearden et al. 2006).  This mode of transmission has also been observed in several other 
flea species including the Oriental rat flea, X. cheopis, prairie dog flea, O. hirsuta, prairie dog 
flea, O. tuberculata cynomuris, cat flea, Ctenocephalides felis, mouse flea, Aetheca wagneri 
(Eisen, Bearden et al. 2006, Eisen, Borchert et al. 2008, Eisen, Holmes et al. 2008, Wilder, Eisen 
et al. 2008, Wilder, Eisen et al. 2008).  This early-phase transmission mechanism has also been 
suggested as being the mechanism used by fleas during rapidly spreading Y. pestis epizootics 
(Eisen, Bearden et al. 2006). During the early-phase period, Y. pestis colonizes in the flea gut, 
where the pathogen successfully survives and multiplies for subsequent transmission.  To date, 
multiple transmission factors and virulence factors of Y. pestis have been identified; however, it 
is still unknown if any flea factors contribute to the success of this transmission mechanism.  
Further identification of these potential factors would give additional insight on the exact 
mechanism of bacterial survival and transmission within the flea. 
 
1.11. Y. pestis Transmissioin Factors 
 
Transmission factors of Y. pestis are genes important for survival within the flea and 
subsequent transmission to a mammalian host.  Survival of Y. pestis in the flea midgut depends 
on the plasmid encoded, Yersinia murin toxin (Ymt), which has phospholipase D (PLD) activity.  
In early studies, Ymt was discovered to be toxic to mice and rats by causing vascular collapse 
leading to death and was categorized as a virulence factor (Schar 1956, Schar and Meyer 1956).  
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Ymt is an important for pathogen survival in the flea midgut during digestion of the blood meal, 
but the agent and mechanism by which the PLD protects the bacterium is still unknown 
(Hinnebusch, Rudolph et al. 2002).  Transmission of Y. pestis by fleas is unique since 
transmission occurs by regurgitation from the digestive tract; whereas many other arthropod-
borne pathogens are transmitted through the vector saliva after dissemination to the salivary 
glands.  Y. pestis infection in the proventriculus of the flea, greatly depends on the ability of Y. 
pestis to form a biofilm on the surface on of the proventricular spines (Darby, Hsu et al. 2002, 
Jarrett, Sebbane et al. 2004).  Once the bacterial biofilm begins to grow and multiply, blockage 
formation occurs and makes possible obstruction of normal blood feeding.  If complete blockage 
of the proventriculus ensues, then the flea will eventually starve to death after tenaciously 
attempting to feed on a mammalian host, while dislodging bacteria into the host and leading to 
potential transmission.  The Y. pestis temperature dependent hmsHFRS genes are required for 
biofilm synthesis and formation of the polysaccharide extracellular matrix (ECM) (Bacot 1915, 
Hinnebusch, Perry et al. 1996).  After ingestion of a Y. pestis-infected blood meal by a flea 
vector, the temperature shift (37°C to ~26°C) is detected by the pathogen and triggers Y. pesti to 
begin gene regulation for survival and adaptation inside of the vector (Perry and Fetherston 
1997).  Y. pestis biofilm formation in the flea involves a complex, multistage process which 
involves synthesis and transport of the biofilm ECM, which is regulated by the bacterial second 
messenger c-di-GMP (Hengge 2009).  The intracellular levels of c-di-GMP depend on the 
opposing activities of GGDEF-domain diguanylate cyclase (DCG) enzymes that synthesize c-di-
GMP and EAL-domain phosphodiesterase (PDE) enzymes that degrade it.  Two functional DGC 
genes found in Y. pestis are hmsT and y3730, and one functional PDE gene, hmsP (Bobrov, 
Kirillina et al. 2011, Sun, Koumoutsi et al. 2011).  The Y. pestis pla gene, encoding the 
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plasminogen activator (Pla), is located on the 9.5-kb plasmid known as pPCP1 (Sodeinde and 
Goguen 1988, Sodeinde, Sample et al. 1988, Hinnebusch 2005).  This gene encodes a surface 
protease, which has been shown to result in increased Y. pestis dissemination and tissue invasion 
(Korhonen, Kosonen et al. 2004).  Pla has been deemed essential as a transmission factor for 
flea-borne spread of Y. pestis, and shown to greatly increase bacterial dissemination following 
subcutaneous injection, a mode of inoculation which mimicked the flea-borne transmission route 
of infection (Sodeinde, Subrahmanyam et al. 1992, Hinnebusch 2005).  Other bacterial 
adaptations occurring inside of the flea gut are genes involved in the uptake and catabolism of 
dipeptides, oligopeptides, and the L-glutamate group of amino acids.  However, genes for hexose 
carbohydrate uptake, glycolysis, and fermentation are under-expressed in the flea environment.  
Y. pestis relies primarily on oligopeptides and select amino acids as its major carbon and energy 
source during persistent infection within the flea midgut.  The Y. pestis PhoP-PhoQ gene 
regulatory system has also been found to be upregulated when inside the flea midgut, resulting in 
LPS modification and other outer membrane components further confering protection against 
cationic antimicrobial peptides (Vadyvaloo, Jarrett et al. 2010). 
 
 
1.12. Y. pestis Virulence and Pathogenesis 
 
 Y. pestis pathogenesis involves complex sets of virulence genes which enable this 
pathogen to evade the host immune system and aid in disease progression.  Many of these 
virulence genes are tightly regulated and expression of virulence components is largely 
dependent on the organism’s response to the environment in which it is residing (flea or 
mammalian host).  Many of the virulence genes among the pathogenic Yersinia spp. are 
conserved, however, a number of the enteropathogenic Y rsinia virulence genes are 
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dysfunctional in the Y. pestis lineage through mutations or insertion sequence interruptions.  In 
mammalian hosts, pathogen-associated molecular patterns (PAMPs) are highly conserved 
molecular structures which are specific to microbes and allows the host innate immune system 
the ability to identify between self and pathogenic cells by using pattern recognition receptors 
(PRRs) (Elvin and Williamson 2000, Li and Yang 2008).  Different PRR’s will react to specific 
PAMP’s and activate immune cells to directly induce expression of a variety of genes involved 
in innate and adaptive immunity designed to fight off foreign invaders.  Once the host PRR’s 
have activated the complement pathway of the innate immune system, this elicits the induction 
of specific cytokines such as interleukin-1  (IL-1 ), IL-6, tumor necrosis factor (TNF).  
Production of chemokines increases to induce the inflammatory response, which starts 
recruitment of host neutrophils to the site of infection as well as initiating activation of 
macrophage cells to begin killing the pathogen.  Y. pestis evades killing by the host innate 
immune system by being introduced directly into the primary host barrier through the bite of an 
infected flea, where the pathogen then encounters phagocytic host cells such as 
polymorphonuclear leukocytes (PMNs), neutrophils, dendritic cells and macrophages (Li and 
Yang 2008).  It is possible that the majority of the plague bacilli may be killed by neutrophils; 
however, Y. pestis is a facultative intracellular pathogen and is capable of successfully infecting 
and surviving within the phagolysosomes of macrophages.  Y. pestis is thought to use specific 
host surface associated molecules such as CCR5 molecules in order to recognize macrophages 
and upon entrance into these cells, the bacterium begins to proliferate and produce multiple 
virulence factors.  This is followed by release of Y. pestis into the extracellular compartment, 
where it then disseminates systemically while exhibiting phagocytosis resistance (Elvin and 
Williamson 2000, Li and Yang 2008).   
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When Y. pestis replicates inside the macrophage, the F1 capsular antigen is expressed and 
forms capsule-like structure around the bacterial cell.  This capsule is an essential virulence 
factor and confers resistance to phagocytosis by macrophages and neutrophils by inhibiting 
receptor binding that would normally allow phagocytic cells to engulf the bacterial cells.  Also 
induced in Y. pestis while residing in the acidic environment of the phagolysosome of the 
macrophages, is PsaA (pH 6 antigen), which encodes a fimbrial structure that eliminates 
interactions of the bacterial cells with macrophages and prevents further recognition and 
destruction by the host immune system (Huang, Chu et al. 2002, Makoveichuk, Cherepanov et 
al. 2003, Huang and Lindler 2004). 
One important PRR hosts use to detect pathogens is Toll-like receptor 4 (TLR4), which 
recognizes the LPS in the outer membrane of Gram-negative bacteria.  The recognition of LPS 
by the host, allows for a swift response to infection, as well as inducing host immune signaling; 
however, in order for the bacterial LPS to trigger a signficant immune response, the LPS 
component lipid A fatty acid acyl side chains need to range from 12 to 14 carbons in length.  
Since Y. pestis displays rough-type (R) LPS, which lacks O-antigen, Y. pestis is capable of 
altering expression of LPS components resulting in modification of LPS structure in response to 
host-specific environments.  Temperature shifts are largely responsible for the different LPS 
structures and Lipid A variations of Y. pestis, which also are regulated by the PhoP-PhoQ system 
(Prior, Hitchen et al. 2001, Rebeil, Ernst et al. 2006, Knirel, Dentovskaya et al. 2007).  More 
specifically, when Y. pestis is inside the flea gut at 21-26°C, the pathogen forms a typical hexa-
acylated Lipid A, which if introduced into a mammalian host can activate immune signaling and 
specific cytokines such as TNF-, IL-1, IL-6, and IL-8.  However, once a temperature change in 
the environment is detected, and the bacteria enter a mammalian host, Y. pe tis forms a tetra-
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acylated Lipid A, which is found to be non-stimulatory to the host pathogen recognition 
receptors, TLR4, TLR2 and TLR9, and allows the pathogen to successfully prevent the induction 
of the inflammation responses by the signaling pathways induced by hexa-acylated Lipid-A-
containing LPS (Montminy, Khan et al. 2006, Telepnev, Klimpel et al. 2009).  Changes in the 
LPS of Y. pestis not only prevent activation of the innate immune response, such as activation of 
macrophages and secretion of proinflammatory cytokines, but also prevents the activation and 
maturation of dendritic cells (DCs) which are required for successful induction of the host’s 
adaptive immune system (Dziarski 2006, Dziarski and Gupta 2006, Montminy, Khan et al. 2006, 
Rebeil, Ernst et al. 2006).  To survive and replicate successfully in blood for transmission 
between the flea and mammalian host, Y. pestis possesses serum resistance to host complement-
mediated lysis.  Y. pestis is resistant to complement at temperatures typical for the bodies of both 
flea (26°C) and mammals (37°C).  However, in other pathogenic Yersinia spp., Y. 
pseudotuberculosis and Y. entercolitica are only resistant to complement at 37°C and this 
function is found to be mediated by YadA, Ail and LPS.  Since Y. pestis does not express YadA, 
the LPS of Y. pestis is thought to play a role in serum resistance because of elevated amounts of 
N-acetylglucosamine (Anisimov, Dentovskaya et al. 2005). 
In the pathogenic Yersiniae, one hallmark feature is the ability of the organism to 
scavenge iron from its host using the siderophore called yersiniabactin (Ybt).  The 
chromosomally located ybt genes are clustered on a high-pathogenicity island (HPI) located in 
the 102 kb pigmentation or pgm locus.  Also located within the pgm region of Y. pestis is the hms 
locus which is responsible for bacterial biofilm formation and flea proventricular blockage.  Y. 
pestis biofilm formation is involved in maintenance of infection in the flea, however, its 
necessity for efficient transmission of the pathogen from the flea vector to mammalian hosts has 
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been subject of much debate (Fetherston and Perry 1994, Parkhill, Wren et al. 2001, Vetter, 
Eisen et al. 2010).  
 In the three human pathogenic Yersinia spp., (Y. entercolitica, Y. pseudotuberculosis, and 
Y. pestis), resides the pCD1 virulence plasmid, which carries the low calcium response (LCR) 
regulon genes, components of the Yersinia T3SS, and associated effector proteins known as 
Yersinia outer proteins (Yops) (Shao 2008).  The V-antigen or LcrV is a multifunctional protein 
that works in coordination with the T3SS, and is involved in formation of the tip complex of the 
T3SS needle as well as activation and secretion of translocation effector proteins by binding to 
the negative regulator LcrG and works in conjunction with YopB and YopD for successful 
delivery of Yops into eukaryotic cells.  LcrV also plays a role in cell-to-cell adhesion by 
becoming exposed externally on bacterial cell surfaces allowing easy adhesion to mammalian 
cells (Lawton, Erdman et al. 1963, Cornelis and Wolf-Watz 1997, Pettersson, van der Biezen et 
al. 1999, Pettersson, Holmström et al. 1999).  Once LcrV is secreted into the extracellular milieu, 
it usurps TLR2 and CD14 resulting in the release of IL-10 by host immune cells and subsequent 
suppression of the production of certain cytokines such as TNF-α and IFN-  (Sing, Roggenkamp 
et al. 2002, Sing, Rost et al. 2002, Sodhi, Sharma et al. 2004, Sodhi, Sharma et al. 2005).  The 
T3SS is important in host immune evasion, by formation of a needlelike structure on the surface 
of the pathogenic Yersinia spp., which then interacts with host target immune cells, such as 
macrophages, dendritic cells, and neutrophils, and quickly enables injection of six different Yop 
proteins which interfere with phagocytosis and other innate host cell responses as well as the 
adaptive inflammatory cascade leading to target cell apoptosis.  Yop proteins (YopH, YopT, 
YopE, and YopO) are involved in preventing phagocytosis by macrophages and neutrophils by 
interfering with host cell actin regulation by Rho GTPases.  YopH has also been linked to 
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suppressing the production of reactive oxygen intermediates by macrophages and 
polymononuclear cells (PMNs) (Green, Hartland et al. 1995). 
 More recently, virulence factor SurA, or survival protein A, which is a chaperone protein 
involved in the biogenesis of outer membrane proteins (OMPs) was found to be necessary in the 
virulence and invasion of Y. pestis.  SurA exhibits peptidyl-prolyl isomerase (PPIase) activity, 
making it part of the parvulin group of PPIases.  SurA was found to play a significant role in 
infection and intracellular replication in epithelial cells, as well as persistence in an in vivo
infection model (Lazar and Kolter 1996, Rouviere and Gross 1996, Southern, Scott et al. 2016). 
 
1.13. Y. pestis Geographical Distribution and Incidence 
  Plague has a worldwide distribution and is found on every continent except Australia 
and Antartica, and has caused epidemics in Africa, Asia, Europe, and South America.  The 
World Health Organization (WHO) predicts between 1000-2000 reported plague cases each year, 
but the true number of cases is likely much higher (Biggins and Kosoy 2001).  According to the 
WHO, Brazil, Democratic Republic of the Congo, Madagascar, Myanmar, Peru, United States of 
America, and Vietnam have reported plague cases every year for the last 44 years (WHO, 2004).  
Plague mortality rates, specifically in developing countries, are hard to predict because some 
cases are never correctly diagnosed or reported; however, the WHO cites mortality rates to be 
around 8-10%, but studies suggest rates are much higher in plague endemic regions (WHO, 
2004).  In the United States between 1900 and 2012, 1006 confirmed or probable human plague 
cases occurred with over 80% presenting in bubonic form (Kugeler, Staples et al. 2015).  Human 
plague cases in the U.S. between 1950-2012, ranged from 1-17 cases per year, and usually 
average ~7 cases per year.  Plague infections occur in people of all ages, and have infected 
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humans as young as infants, and individuals as old as 96 years old; however, 50% of plague 
cases have been found to infect people ages 12–45 years old.  Plague occurs in both men and 
women, with a slightly more frequent occurrence in men than women, which is thought to be 
attributed to increased outdoor activities that put the men at a slightly higher risk of acquiring 
infection.  With successful use of antibiotics to treat human plague infections, the overall number 
of human plague deaths has decreased greatly from what was observed between 1900-1941, 
which was the pre-antibiotic era.  During the pre-antibiotic era, mortality among plague infected 
individuals in the United State was 66%; whereas with the use of antibiotics, the mortality rate 
was greatly reduced and by 1990-2010 the overall mortality rate decreased to 11%.  Even with 
antibiotic treatment, plague infected individuals are still at risk of dying from the disease; 
although the chances are lower for people with the bubonic form of the disease compared to the 
septicemic or pneumonic plague forms.  The actual plague mortality rate in developing countries 
is difficult to assess because relatively few cases are reliably diagnosed and reported to health 
authorities (CDC 1995, CDC 1997, CDC 1999). 
Worldwide plague distributions are impacted by certain landscapes and climatic 
conditions for which Y. pestis is able to establish itself successfully.  In the 1900s, Y. pestis was 
introduced into the United States at the Port of San Francisco, California by urban rats that 
spread the disease to the sylvatic rodent hosts.  Despite improved sanitation methods which 
decreased human plague cases, the pathogen was able to spread and establish itself east to the 
100th meridian (Eisen and Gage, 2011; (Eskey and Haas 1940, Adjemian, Bustos et al. 2007, 
Adjemian, Foley et al. 2007, Morelli, Song et al. 2010).  Within the western United States, 
plague has established itself in enzootic cycles, which are randomly distributed (Eisen and Gage 
2012).  Many studies have examined numerous variables to determine the ecological niches of 
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plague and identify areas that may have potentially higher risks for human exposures or potential 
infection within the plague-endemic regions.   
Studies have focused on landscape, vegetation, and climate variables that could either 
inhibit or aid in the persistence and survival of Y. pestis and have been focused in the African 
and North American regions (Collinge, Simirskii et al. 2005, Davis, Klassovskiy et al. 2007, 
Eisen, Enscore et al. 2007, Eisen, Lowell et al. 2007, Nakazawa, Williams et al. 2007, 
Neerinckx, Peterson et al. 2008, Eisen, Griffith et al. 2010).  In sub-Saharan Africa, plague foci 
were positively correlated with elevation above 1300 meters, evaporation potential and 
transpiration by plants, mean daily temperature range and annual rainfall, making the ecological 
landscape of sub-Saharan Africa a prime location for Y. pestis transmission (Neerinckx, Peterson 
et al. 2008).  Key plague risk predictors in Uganda and Tanzania were related to elevation and 
vegetation when focusing on local spatial scales.  In Eastern Tanzania, plague was found to be 
located at areas at higher elevation (1200-2000 m) and areas in which seasonal vegetation 
changes (Neerinckx, Peterson et al. 2008).  Interestingly, in northwestern Uganda, the risk of 
plague was increased in areas of higher elevation (>1300 m) than areas of elevations below 1300 
m with less vegetation and increased moisture (Eisen, Griffith et al. 2010).  Studies focusing on 
plague in the four corners region of the United States, found human risk of plague exposure 
increased in areas which were at 2300 m in elevation, and had specific vegetation types such as 
pinon-juniper or Ponderosa pine, in areas with higher moisture (Eisen, Enscore et al. 2007, 
Eisen, Lowell et al. 2007, Eisen, Reynolds et al. 2007, Eisen, Wilder et al. 2007).  Plague 
distributions and endemic areas are directly correlated with temperature and rainfall patterns.  
Over 95% of the worldwide distribution of plague cases are reported in areas in which the 
average temperatures exceed 13°C, and most plague outbreaks are in regions where the 
40 
 
temperature ranges from 24°C to 27°C.  Plague epidemics are found to diminish when the 
temperature is above 27°C.  Plague epizootics are found to occur sporadically among the known 
plague foci and the important contributors of plague epizootics are still poorly understood. 
(Davis 1953, Davis 1953, Cavanaugh and Marshall 1972, Cavanaugh and Williams 1980, Gage 
and Kosoy 2005, Gage, Burkot et al. 2008).  In plague enzootic regions in the western United 
States and Kazakhstan, quantitative models were used to determine that an increase in moisture 
levels prior to a transmission season are conducive for epizootic activity; however, elevated 
temperatures during the transmission season caused a decrease in epizootic activity (Parmenter, 
Yadav et al. 1999, Enscore, Biggerstaff et al. 2002, Stapp, Antolin et al. 2004, Stenseth, Samia et 
al. 2006, Stapp, Salkeld et al. 2008, Brown, Ettestad et al. 2010).  The trophic cascade hypothesis 
was then created suggesting elevated precipitation increases the vegetation, and therefore 
enhances the food sources for the harborage of the small rodent hosts.  The small rodent 
populations will increase and the flea infestations will also rise, leading to a higher probability 
that the contact rates between infectious fleas and susceptible hosts will rise and lead to 
increased probability of a potential epizootic (Parmenter, Yadav et al. 1999, Enscore, Biggerstaff 
et al. 2002, Lorange, Race et al. 2005, Eisen, Eisen et al. 2006, Eisen, Bearden et al. 2006).  
More recently, a study examining areas outside of the normal plague distribution in the United 
States, located Y. pestis in areas east of the known active plague endemic locations.  This study 
examined Orosyslla tuberculata and Oropsylla hirsuta fleas, which were collected from black-
tailed prairie dogs in five national parks east of the known distribution of active plague across the 
northern Great Plains and tested the fleas for the presence of Y. pestis.  Fleas were found to be 
infected with Y. pestis, suggesting that sylvatic plague likely occurs across the range of black-
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tailed prairie dogs and indicates that plague foci in the United States could have a much greater 
distribution than previously believed (Mize and Britten 2016). 
 
1.14. Y. pestis Clinical Disease Features 
Plague infections in humans can present in three main manifestations: bubonic, 
septicemic, and pneumonic forms.  Other more rare forms have also been reported such as 
pharyngeal, meningeal, cellulocutaneous, pestis minor, asymptomatic, and abortive forms 
(Meyer 1942, Pollitzer 1954, Pollitzer 1954, Meyer 1961, Marshall, Ouy et al. 1967, Poland 
1977, Hovette, Burgel et al. 1998, Arbaji, Kharabsheh et al. 2005). 
 The most commonly occurring plague form is bubonic.  Bubonic plague infections occur 
most frequently by the bite of an infected flea or less frequently as a result of handling infected 
animals or their tissues.  When an infected flea bites a human or animal, the bacterium gets 
regurgitated into the bite site.  In humans, the bacteria is then capable of entering the lymphatic 
system which drains interstitial fluid, and Y. pestis then begins replicating in the nearest lymph 
node, and subsequently stimulates sever hemorrhagic inflammation that causes the lymph nodes 
to become inflamed and can increase to the size of an egg.  This enlargement of the lymph node 
is clinically known as a “bubo”, associated with the bubonic plague form.  Buboes are typically 
found in the groin, neck and armpits.  Bubonic plague typically manifests within 2-6 days after 
initial infection with Y. pestis, and patients will also exhibit sudden onset of illness characterized 
by headache, shaking, chills, fever, malaise, and pain in the affected regional lymph node.  
Gangrene can also develop in the extremities, which is where, according to some, the name, 




 Next, septicemic plague occurs when Y. pestis is introduced into the bloodstream, causing 
the signs and symptoms of Gram-negative septic shock.  This form can either be primary or 
secondary to bubonic plague.  The disease is contracted primarily through the bite of an infected 
flea or rodent, but like bubonic plague, it is rarely contracted through an opening in the skin or 
by cough from another infected individual.  After reaching the bloodstream, Y. pestis can 
replicate to very high numbers, causing severe sepsis, and experience symptoms such as, fever, 
chills, weakness, abdominal pain, shock, and bleeding underneath the skin or in other organs.  
Once the pathogen has caused bacteremia, it is then capable of advancing to other organs 
systems, and has the potential of progressing to secondary pneumonic plague, plague meningitis, 
plague endophthalmitis, hepatic or splenic abscessed, or generalized lymphadenopathy.  Prompt 
treatment with antibiotics greatly reduces the mortality rate in patients to 4-15% (Meyer 1950).  
If a patient with septicemic plague is not treated promptly with proper antibiotics, patients can 
die on the same day clinical symptoms appear (Meyer 1950, Butler 1983, Butler 1994, Butler 
2009).  
 Lastly, pneumonic plague, which is the most severe form of the disease, can present as 
either a primary or secondary form of infection.  Primary pneumonic plague occurs when the 
plague bacterium is contained in infectious respiratory droplets or is aerosolized and then inhaled 
into the lungs of a susceptible host.  Secondary pneumonic infections can result from the 
progression of bubonic or septicemic plague infections.  Common symptoms include fever, 
headache, weakness, shortness of breath, chest pain, cough, bloody or watery sputum, confusion, 
cyanosis, shock and death.  The incubation period for pneumonic plague is typically 2-4 days, 
however, in some cases it can be as little as a few hours after initial acquisition of the pathogen.  
Without proper treatment or diagnosis, this infection is 100% fatal within 1-6 days after 
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pathogen acquisition (Hoffman 1980, Ratsitorahina, Chanteau et al. 2000, Ratsitorahina, 
Rabarijaona et al. 2000). 
 
1.15. Y. pestis Diagnosis and Treatments 
For timely diagnosis of human plague infections, the first step is for a health care worker 
to evaluate signs and symptoms.  If a plague infection is suspected, the healthcare provider will 
takes samples of the suspect patient’s blood, sputum, or lymph node aspirate, and each sample 
will be sent to the laboratory to be further evaluated.  Once the laboratory receives the sample, 
preliminary results will be completed in less than two hours; and official laboratory confirmation 
will take around 24 to 48 hours to allow ample time for bacterial growth in culture.  If plague 
infection is suspected in the patient, antibiotic treatment will begin as soon as samples are 
collected (Plague Manual, 1999a). 
Diagnosis of bubonic plague-like symptoms are commonly mistaken for other infections, 
such as staphylococcal or streptococcal lymphadentitis, mononucleosis, cat- cratch fever, tick 
typhus, tularemia and other causes of acute lymphadenopathy.  Depending on the location of the 
enlarged lymph node, or bubo, other diagnoses can be mistakenly made such as appendicitis, 
enterocolitis or an inguinal hernia.  If the intrathoracic lymph nodes are targeted during plague 
infection, severe complications such as severe deep cervical adentitis can occur leading to 
tracheal displacement and obstruction of the patient’s airway.  In people who are exhibiting signs 
of septicemic plague, such as gastrointestinal discomfort, abdominal pain, nausea, vomiting and 
diarrhea, it is common for clinicians to diagnose the illness as non-specific sepsis syndrome or 
Gram-negative sepsis.  Other potential issues making plague diagnostics challenging results are 
related to laboratory protocols, miscoding of automated diagnostic machines, or interpretations 
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by laboratorians.  For example, if Gram stains are prepared either from blood smears or lymph 
node aspirates, improperly decolorized, then the bacterium will appear as a Gram-positive 
diplococcus when examined under the microscope.  Also, automated bacterial identification 
devices may not code for Y. pestis; therefore, resulting in misidentification of the pathogen, often 
as closely related Y. pseudotuberculosis.  Diagnosis of pneumonic plague can also be perplexing 
and the symptoms can be mistaken for pneumococcal, streptococcal, Haemophilus influenzae, 
anthrax, tularemia, Legionella pneumophila, letptospirosis, or hantavirus pulmonary syndrome.  
If lymphadentitis is observed in the the regional lymph nodes in plague-endemic regions, then 
clinicians usually properly suspect plague or tularemia pneumonia infection, which could be a 
secondary infection following infection by a cutaneous route (Plague Manual, 1999a). 
In order for a sample from a plague suspected patient to be considered a laboratory 
positive, the isolation and identification of Y. pestis from the clinical specimens or a rise in 
antibody titers from serum samples must be confirmed.  Routine testing includes specimens for 
smear and culture such as whole blood, aspirates from suspected buboes, pharyngeal swabs, 
sputum samples or tracheal washes from plague suspected pharyngitis or pneumonia, and 
cerebrospinal fluid from patients with suspected meningitis.  Bubo aspirates are collected after an 
injection of 1-2 ml of saline using an 18-22 gauge needle.  Microbiological media used to culture 
media include Brain-heart infusion broth, sheep blood agar, or MacConkey agar.  Each smear is 
examined with Wayson or Giemsa stain and Gram stain, and further evaluated by performing a 
direct fluorescent antibody assay, which is an anti-F1 antibody examination.  Acute phase serum 
samples will be tested for detection of antibodies to Y. pestis for serological confirmation, and 
subsequently, convalescent phase serum samples will be collected at 4-6 weeks post infection for 
further validation.  If the suspected plague patient succumbs to infection, appropriate tissues such 
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as lymph nodes, liver, spleen, lung and bone marrow will be collected for culture, 
immunohistochemical staining, and fluorescent antibody testing and samples are then sent to the 
laboratory either fresh or frozen on dry ice, as well as in the appropriate transport media such as 
Cary-Blair (Plague Manual, 1999a). 
When examining blood collected from Y. pestis infected patients, the white blood cell 
(WBC) counts typically range from 12,000-25,000/µl blood, with a large amount of immature 
polymorphonuclear cells (Butler, Bell et al. 1974).  When bipolar staining is conducted, the 
polymorphonuclear leukocytes and the plague Gram-negative bacilli will be found in the sputum 
of plague infected patients.  Patients infected with pneumonic plague will have X-ray’s which 
exhibit patchy bronchopneumonic infiltrates, as well as, segmented or lobar consolidation of 
bilateral diffuse infiltrates of acute respiratory distress syndrome.  In septicemic plague patients, 
Y. pestis will be identified in the stained peripheral blood smear or buffy-coat smear (Butler, Bell 
et al. 1974).  For diagnosis of plague meningitis, cerebrospinal fluid (CSF) is examined and 
plague infected patients exhibit CSF with increased white blood cell counts with predominance 
of PMN’s.  The characteristic bipolar staining of Y. pestis either by Wayson or Giemsa staining, 
is not unique to this pathogen; therefore, is not an ideal indicator of disease and further tests are 
needed for confirmation of a plague positive sample.  For a confirmed plague positive sample, Y. 
pestis must be successfully isolated from cultures of body fluids and/or tissues (Quan 1987, Chu, 
Katakura et al. 1999, Chu, Park et al. 1999, Chu, Tomita et al. 1999).  In infected patients, the Y. 
pestis organism will be successfully isolated with the collection of three blood samples over a 45 
minute period before treatment begins.  When grown on agar for 48 hours at 28°C, Y. pestis 
appears as greyish-white, translucent colonies which are 1-2 mm in diameter.  After 48-72 hours 
of incubation, Y. pestis colonies are raised and have an irregular hammered copper appearance 
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(Butler, Mahmoud et al. 1977, Chu, Katakura et al. 1999, Chu, Park et al. 1999, Chu, Tomita et 
al. 1999).  Y. pestis culture positives are further confirmed by performing a specific 
bacteriophage lysis assay specific to the F1 capsular antigen.  Automated bacteriological test 
systems can also be used to confirm positive plague colonies; however, misidentification of 
isolates can occur if the systems are improperly programmed (Wilmoth, Chu et al. 1996, 
Tourdjman, Ibraheem et al. 2012). 
If plague colonies are not isolated from culture, Y. pestis infection can be tested for 
evidence of seroconversion events by performing passive hemagluttination assays (PHA) or 
ELISA.  Any titers exhibiting changes of four-fold or greater to the Y. pestis F1 capsular antigen 
indicates a positive sample which has resolved a Y. pestis infection (Butler, Mahmoud et al. 
1977, Chu, Katakura et al. 1999, Chu, Park et al. 1999, Chu, Tomita et al. 1999).  PHA 
specificity of a positive test requires further confirmation by performing the F1 antigen 
hemaggluttination inhibition (PHI) assay which tests for any cross-reactivity (Chu, Katakura et 
al. 1999, Chu, Park et al. 1999, Chu, Tomita et al. 1999).  Most plague patients will seroconvert 
between one and two weeks after the onset of disease; however, a few patients have been found 
to seroconvert five days after the onset of illness.  Seroconversion events in some patients can 
take up to three or more weeks after the onset of disease and in rare cases, some patients do not 
seroconvert (Butler, Mahmoud et al. 1977).  Patients who began early antibiotic treatment, are 
found to have delayed seroconversion.  After seroconversion occurs in the patient, positive 
serological titers will decrease gradually over the next few months or years.  Another assay 
commonly used in early stages of plague infection is the enzyme-linked immunosorbent assay 
(ELISA), which detects IgM and IgG antibodies and can also be used for antigen capture. (Chu, 
Katakura et al. 1999, Chu, Park et al. 1999, Chu, Tomita et al. 1999).   
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Plague infections can be successfully treated with antibiotics; however, it is important to 
begin antibiotic treatment as soon as possible after laboratory specimens are taken.  In patients 
with suspected pneumonic plague infection, antibiotics should be given as soon as possible, 
preferably within 24 hours of the first symptoms.  Specific antimicrobial therapy of plague 
patients is determined by the form and stage of the disease.  Aminoglycosides such as 
streptomycin and gentamicin are most effective against Y. pestis in the pneumonic form of the 
disease (Byrne, Welkos et al. 1998) (Plague Manual, 1999a).  For the treatment of bubonic and 
septicmic plague infections, chloramphenicol is considered the drug of choice; as well as for the 
treatment of invasive Y. pestis which has entered tissue spaces as seen in plague meningitits, 
pleuritis, or endophthalmitis since other drugs are incapable of crossing specific blood brain 
barriers. (Meyer 1950, McCrumb, Mercier et al. 1953, Meyer 1961, Becker, Poland et al. 1987).  
Tetracyclines can be used in treatment of patients with uncomplicated plague infections; as well 
as in adjunct with other antibiotics.  Sulfonamindes have been used in plague infections; 
however, studies have determined that patients treated with this antibiotic results in higher 
mortalities, increased complications, and longer fevers (Butler, Mahmoud et al. 1977, Butler 
1983, Boulanger, Le Maire et al. 1996).  More recently, fluoroquinolones such as ciprofloxacin 
have been used in the treatment of plague infections.  Ciprofloxacin is a bactericidal antibiotic 
with broad spectrum activity against most Gram-negative bacteria and many Gram-positive 
bacteria (Lemaitre, Ricard et al. 2012).  Studies looking at the benefits of combination antibiotic 
therapy for treatment of plague have been shown to be more effective in eradication of Y. pestis
specifically when given ciprofloxacin and gentamicin in combination (Lemaitre, Ricard et al. 
2012).  Penicillins, cephalosporins and macrolides are ineffective in the treatment of plague.  
During plague infections, supportive therapy is often needed to manage plague complications, in 
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addition to dealing with potential Gram-negative sepsis (Wheeler and Bernard 1999).  It is 
important to monitor and manage potential septic shock in plague patients in order to prevent 
multiple organ failure, adult respiratory distress syndrome (ARDS) and disseminated 
intravascular coagulopathy (Plague Manual, 1999a).  For treatment of pregnant women or 
children, gentamicin is the preferred antibiotic for plague infections; however, aminoglycosides 
have been shown to be effective for treatment.  Streptomycin is ototoxic and nephrotoxic to 
fetuses and chloramphenicol has risk of causing “grey baby” syndrome and bone-marrow 
suppression so these classes are avoided in pregnant women and children (Plague Manual, 
1999a).  If any individuals were in close proximity or in contact with infected plague patients, 
exposed to Y. pestis infected fleas, had direct contact with body fluids or tissues of an infected 
mammal, or exposed during a laboratory accident, then prophylactic therapy is recommended 
(CDC 1996).  Preferred antimicrobials for patients potentially exposed to plague include 
tetracyclines, chloramphenicols, or an effective sulfonamide, and in 2012, the U.S. Food and 
Drug Administration (FDA) licensed the use of ciprofloxacin (levofloxacin) to prevent and treat 
pneumonic and septicemic plague.  In areas of suspected plague or the veterinary or hospital 
settings, patient care precautions must be followed and procedures such as proper protective 
equipment (PPE, such as gowns, gloves, masks, goggles, etc) should be worn to protect 
individuals from contracting plague infection (Plague Manual, 1999a). 
Currently, no FDA licensed plague vaccine is available; however, plague vaccines are in 
development but not expected to be commercially available in the immediate future (CDC 1982, 
CDC 1996).  Vaccine developers have focused on two subunits of Y. pestis: LcrV, which is a 
protein at the tip of the type III secretion needles, and F1, which is the fraction 1 capsular antigen 
(Quenee, Berube et al. 2010).  LcrV and F1 are currently the only candidates for plague subunit 
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vaccines.  The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) 
developed the F1-V fusion protein, which tethers the two antigens as a translational hybrid into a 
single molecule (Heath, Anderson et al. 1998).  The fusion protein was designed to enable a one-
protein-manufacturing process, which is considered an advantage over purifying two different 
polypeptides (Heath, Anderson et al. 1998, Williamson 2001).  Worldwide, formalin-killed Y. 
pestis and live attenuated vaccines have been developed, but with some weaknesses.  The live 
attenuated vaccine is highly reactogenic and not licensed for human use.  The killed whole cell 
vaccine, also reactogenic, provides poor protection against pneumonic plague and immunization 
requires multiple follow-up doses of the vaccine.  With such adverse reactions to vaccination, 
these vaccines were only given to individuals which are in close proximity of the bacterium, such 
as laboratorians or veterinarians (CDC 1982, CDC 1996, Titball and Williamson 2004) 
  
1.16. Y. pestis Surveillance and Control 
Plague activity in the United States is often difficult to detect.  The limited evidence of 
plague transmission occurring at most times especially between epizootics.  By contrast, there 
are occasional epizootics that result in highly visible die-offs of certain rodent species and it is 
during these times that the disease can be relatively easy to detect.  In the United States, prairie 
dogs (Cynomys spp.) suffer the most dramatic die-offs with up to 98% dying in plague-affected 
populations (Biggins and Kosoy 2001).  Documenting rodent die-offs is an efficient and low-cost 
way to monitor plague dynamics, however they are often detected only after an epizootic already 
has begun and does not serve as an early warning system.  Monitoring plague exposure, or 
seroprevalence, through active surveillance of other animals that can act as sentinel species is a 
proven method for monitoring plague dynamics but is very expensive, time consuming, resource 
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intensive and difficult to maintain.  The time required for analysis of serum samples also can be 
sufficiently long and the results are of little use by the time thtey are received many weeks to 
months later.  In the United States, animal-based plague surveillance is performed by multiple 
state health departments at the local level, as well as through research universities, the Centers 
for Disease Control and Prevention and the US Department of Agriculture (USDA).  The USDA 
Animal and Plant Health Inspection Wildlife Services’ National Wildlife Disease Program 
(NWDP) also conducts continual plague surveillance in regions with documented plague activity 
in the US, which is primarily restricted to areas west of the 100th meridian (IHR, 2005). 
 
1.16.1 Plague Surveillance: 
 For successful plague prevention and control, a surveillance program must be developed 
to allow for up-to-date information on the incidence and distribution of the pathogen.  A 
surveillance program is beneficial when timely information is obtained from the collection and 
analysis of human animal samples, and the useful interpretion of clinical epidemiological data, 
and epizootiological data on Y. pestis.  A successful surveillance program will contain the same 
information that has been collected over many years, in order to detect any changes that may 
lead to a potential plague outbreak in that area.  Once this long-term information has been 
collected, it will be beneficial in multiple ways such as: prediction of areas in which humans and 
rodent epizootics could potentially occur; identification of the most common zoonotic sources of 
human infection; identify the most important rodent and flea species which could be harboring Y. 
pestis; identification of the hosts and flea vectors which are potential targets for control 
measures; assess the effectiveness of plague prevention and control strategies; identification of 
local ecological factors or human activities which may lead to increased human plague exposure 
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risks; and detection of trends in the epidemiology and epizootology of plague in that specific 
area (Gage, Dennis et al. 1999).  The standardization of surveillance reports is crucial so the 
same information is recorded for each case; resulting in a database that can be combined with 
rodent and flea vector surveillance data to design the optimal prevention and control strategies.  
In reports involving human cases, more information must be collected such as: basic patient 
information, clinical observations and treatment, laboratory results, and results of the 
epidemiological and environmental investigations (Gage, Dennis et al. 1999).   
 
1.16.2 Plague Control: 
 Since Y. pestis is a flea-borne disease of rodents, control measures for this disease is 
based on the ability to control the rodent reservoirs and flea vector populations.  Control 
measures are extremely important during outbreaks when rodent die-off occurs, leading to 
starving fleas questing for new mammalian hosts.  Identifying endemic plague foci is important 
in assessing locations of higher risk of outbreaks.  After the plague foci have been identified, 
information should be gathered such as the seasonality of past outbreaks, the rodent reservoirs, 
and the flea vectors in the area.  Also of importance in these areas is to gather baseline data 
which effect the type of control measures that will be administered if an outbreak did happen to 
occur.  Such baseline information would include: insecticide susceptibility of the flea vectors in 
the area, flea population densities, and rodent host/reservoirs densities.  Gathering this yearly 
baseline information would lead to a successful surveillance system, detecting inclines or 
declines in the numbers of fleas and rodents, in order to identify potential plague epizootics 
before they occur (Gage, Dennis et al. 1999).  Other information of importance would be 
ecological and climate change data of the areas, giving insight on factors that would alter the 
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vegetation leading to an increase or decrease in food sources for the endemic rodent populations 
which directly correlates with flea abundance (Gage, Dennis et al. 1999). 
 Many concepts exist regarding controlling the transmission of the Y. p stis pathogen from 
one reservoir animal to another or from animals to humans.  Most commonly, control of the flea 
vector is believed the most important step to be taken.  Previous studies have concluded, that 
when designing plague control methods, the flea is the primary and initial target in controlling 
plague, and the rodents, which harbors the fleas, is secondary (Gordon, Isaacson et al. 1979).  
When controlling plague after a human plague case, it requires direct attack of the plague foci 
where the infection was acquired; which first requires confirmation of the pathogen presence in 
the area.  Next, isolation of the plague infected patient and any contacts the patient may have 
come into contact with during infection is necessary to prevent additional human infections.   
Lastly, it is important to manage and control plague in the area by use of disinfectants and 
evacuation of people, in addition to killing fleas with insecticides to which the fleas are known to 
be highly susceptible to (Gordon, Isaacson et al. 1979, Gage, Dennis et al. 1999). 
 Many studies have looked into the control of flea vectors by use of insecticides, with the 
main purpose being to reduce the density of the rodent-flea vectors in human populated areas, as 
quickly as possible.  Methods such as applying insecticide dusts to rodent runways or burrows is 
effective in controlling flea vectors, and when rodents cross the paths or enter or exit the 
burrows, they become brushed with the dust, which then gets spread all over their bodies during 
grooming, eventually killing the fleas.  In urgent situations, liquid insecticides can be used for 
control of flea vectors in burrows and homes.  In areas in which commensal rodents are found 
nesting in dwellings or buildings as seen in many tropical regions, insecticide dusts must be 
administered carefully to prevent contaminating foodstuffs, cooking utensils, and other personal 
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items.  Some studies have looked at the use of bait boxes (food bait used as a rodent attractant) as 
well as fipronil tubes that coat the rodent with an insecticide; further killing the fleas that are 
parasitizing the host (Boegler, Atiku et al. 2014). 
 Flea control measures of wild rodent populations can be more difficult then commensal 
rodents, primarily because it is more challenging to locate the rodent burrows and runway and 
the populations are widely dispersed over an area.  Fumigation methods are commonly used to 
control rodents, and this method kills very easy and fast, leading to immediate death of rodents 
and fleas.  More recently, wild rodent fleas have been controlled using other methods such as 
insecticide applications by aircraft, or in and around burrows by power and hand dusters.  Much 
concern about flea insecticide resistance and the environmental concerns of insecticides have 
arisen in the last few decades, leading to an increase in use of bait boxes.  Bait boxes have been 
proven to be very efficient and the rodents carry the insecticide on their fur back to their nests, 
further killing the fleas on their body and in the nests.  The bait boxes successfully kill the fleas, 
significantly reducing flea populations over a widely distributed area; however, this method is 
labor intensive and continual rebaiting and replenishing of the bait dust is a downfall (Kartman 
and Longergan 1955, Gage, Dennis et al. 1999). 
 One important step for designing a successful plague and flea vector control program is 
doing susceptibility tests to determine the best insecticide to use for flea control.  Flea resistance 
to insecticides greatly impedes any plague control program.  Previously, 
Dichlorodiphenyltrichloroethane (DDT) dust was the insecticide of choice, however with recent 
environmental concerns and resistant flea populations, other alternative compounds such as 
organo-phophorus, carbamate, pyrethroid, and insect growth regulator compounds are being used 
effectively for control of flea populations.  More commonly used insecticides include fipronil, 
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imidacloprid, lufenuron, and pyriproxyfen, which all have shown to be effective in flea control 
(IHR, 2005)(Boegler, Atiku et al. 2014).  One huge drawback of using insecticides for vector 
control programs is the high likelihood of vector resistance.  Surveys of the flea species and the 
seasonal population densities should be monitored closely to identify the first signs of resistance 
in the population (Gage, Dennis et al. 1999). 
 When a plague outbreak or an epizootic in the commensal or sylvatic rodent hosts occurs, 
it is also important to control the rodent reservoirs.  Foremost, flea vectors parasitizing the 
rodents must be controlled before controlling the hosts in order to prevent a high number of fleas 
carrying plague questing for new hosts and greatly increasing humans risk of plague infections.  
Once the flea populations have been reduced, control of the rodent reservoirs is carried out.  For 
controlling rodents, acute and chronic rodenticides are used, each with pros and cons.  Acute 
rodenticides, such as arsenic trioxide or Bromethalin, are advantageous because they kill the 
mice quickly, and the user can see the immediate effects.  Next, they are very effective and no 
resistance occurs, in contrast to the anticoagulants in the chronic rodenticides in which resistance 
is a problem.  Some cons of acute rodenticides are they can cause bait shyness, are very 
expensive, high concentrations must be administered and poor selectivity to target species 
leading to other potential animal deaths.  In contrast, chronic rodenticides, such as anticoagulants 
and warfarin, have advantages over acute rodenticides, because they do not cause bait shyness, 
can be administered by a non-expert, are administered at a low concentrations can be used, and 
then are much more affordable.  However, some disadvantages include not seeing bodies of dead 
rodents, non-selective target species, slow acting and possibility of anticoagulant resistance.  
Other rodent control methods include fumigants such as hydrogen cyanide or carbon monoxide.  
Fumigants are successful in killing rodents, as well as their ectoparasites, and can be used to 
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target rodents living in inaccessible areas or buildings, ship or burrow systems.  One 
disadvantage of fumigants is they are very dangerous to the person applying them as well as to 
any people or animals in the area.  One advantage however, is they are very fast acting and very 
efficient.  Fumigants are required to be administered by experienced or well-trained individuals 
(Gage, Dennis et al. 1999). 
 
1.17. Animal Models Used in Plague Research 
 
1.17.1 Invertebrate models for studying transmission factors: 
 Many models to study plague have been developed in order to better understand 
interactions between Y. pestis and its hosts, potential antibiotic resistant strains, potential risk of 
plague as a bioweapon, and the development of plague vaccine candidates and prophylactic 
treatments (Galimand, Guiyoule et al. 1997, Inglesby, Dennis et al. 2000).  Plague researchers 
have used animal models for over 100 years in order to study model insect and human infections.  
These plague models have allowed scientists to study different species and determine the 
progression of plague pathology and the effectiveness of vaccine candidates.  Recently, specific 
models have been developed which allow scientists to study Y. pestis pathogenesis, such as 
interactions between the bacterium and the host cells, transmission from the flea vector, infection 
of the mammalian host, and host immune responses during infection (Lawrenz 2010). 
 Y. pestis is unique because it is the only enteric bacterium that uses an insect vector as its 
primary mode of transmission; therefore, invertebrate models are used to study transmission 
factors which are different than virulence genes which are needed for mammalian disease 
(Hinnebusch, Perry et al. 1996, Paskewitz 1997).  Since the flea is the natural vector for Y. pestis, 
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it is the most logical system to use when studying Y. pestis-vector interactions and transmission.  
Most commonly used in the laboratory setting in the U.S., are the flea vectors X. cheopis and O. 
montana, which are both highly efficient vectors for transmission of Y. pestis to mammalian 
hosts (Hinnebusch 2005, Eisen, Bearden et al. 2006).  For example, this model has been essential 
in studies examining the importance of the Yersinia murine toxin (Ymt) which was first 
described due to its toxicity to mice (Warren and Young 2005).  However, later the ymt g ne was 
shown to be unnecessary during mouse infection since the ymt mutants were still fully virulent 
(Drozdov, Anisimov et al. 1995, Hinnebusch, Perry et al. 1996).  Even though the Ymt gene is 
not necessary as a mammalian virulence factor, it has been found to be essential as a 
transmission factor (Hinnebusch 2005).  Studies by Hinnebusch et al, demonstrated using the 
flea model, that Ymt is required for colonization of the flea midgut, and ymt(−) mutants are 
rapidly cleared from the midgut before the bacteria block the proventriculus (Hinnebusch, 
Rudolph et al. 2002).  Other studies, which have been useful to better understand Y. pestis
transmission, examined the importance of biofilm production in the flea vector (Hinnebusch, 
Perry et al. 1996, Jarrett, Sebbane et al. 2004).  Through use of the flea model, the researchers 
demonstrated that Y. pestis transmission efficiencies depend on factors that are not required for 
pathogenesis in the mammal.  While the flea is the natural insect vector for Y. pestis, the model 
poses some difficulties that may limit its widespread use in Y. pestis studies.  These include a 
requirement for dedicated and specialized facilities to work with fleas, relatively slow growth of 
the insects, and a risk for Y. pestis transmission from flea to human.   
Next, a second invertebrate model that has been used to study Y. pestis-host interactions 
is the nematode Caenorhabditis elegans (Darby, Hsu et al. 2002, Joshua, Karlyshev et al. 2003, 
Darby, Ananth et al. 2005, Bartra, Styer et al. 2008).  Benefits of the C. el gans model is the 
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simplicity of the nematode to maintain and rapid growth, as well as its ability to be easily 
tracked, making this a commonly used model system to study pathogenesis of multiple different 
microorganisms.  C. elegans also has a chitinous cuticle which provides a somewhat similar 
substrate to the chitinous lining of the flea proventriculus (Darby, Hsu et al. 2002, Darby, Ananth 
et al. 2005).  For Y. pestis studies, C. elegans grows at a similar temperature as X. cheopis (20–
23°C), which is beneficial since many of the Y. pestis genes are temperature regulated genes and 
only expressed during flea infection.  Y pestis is also capable of formimg biofilms during C.
elegans infection; which inhibits C. elegans ability to feed and leads to the decreased survival of 
the nematodes (Darby, Hsu et al. 2002, Joshua, Karlyshev et al. 2003).  Mutational analysis 
confirmed that the hms genes were required for both biofilm formation and C. elegans death, and 
subsequent studies found that C. elegans can be used to identify new potential transmission 
factors such as the gmhA gene of Y. pestis which is involved in biofilm formation in C. elegans 
and is required for blockage of the flea proventriculus (Darby, Ananth et al. 2005).  In addition, 
Styer and colleagues demonstrated that Y. pestis can kill C. elegans through a biofilm-
independent mechanism by finding that the Y. pestis KIM5 strain, which lacks the hms locus and 
the ability to make biofilms, colonizes the nematode intestinal tract and causes a lethal infection 
(Styer, Hopkins et al. 2005).  The pCD1 and pPCP1 plasmids were also found to not be required 
for death in C. elegans, indicating that the genes on these plasmids do not contribute to nematode 
colonization or death.  These findings suggest that in addition to a model to identify Y. pestis 
factors important for the insect portion of the Y. pestis lifecycle, C. elegans may also be used to 





1.17.2 Mammalian models to study plague virulence and pathogenesis: 
For plague research, many different animal models have been used to study plague 
pathogenesis including many rodent species as well as non-human primates (NHPs).  However, 
rodent models are the most widely used because of factors such as affordability, small size, and 
availability of facilities to house and perform containment work.  In studies such as those 
involving vaccines or other therapeutics, which require further testing and validation prior to 
FDA approval, NHPs are commonly used as the model system.  Many different models are used 
for plague studies because of the wide range of susceptible hosts to plague infection; however, 
each model has its limitations that could influence a researcher's selection of which system is the 
best plague model to use for the intended study. 
 
1.17.2a Mouse Model: 
 The most widely used animal model for plague research is the mouse model.  Mouse 
genomes are well-characterized allowing for the capability of making different knock-out and 
transgenic mouse strains.  The mouse is highly susceptible to plague infection and equally 
susceptible to different strains of Y. pestis (Butler 1983, Goodin, Nellis et al. 2007).  
Furthermore, the mouse model can be used for pneumonic and intravenous infection models, but 
is unable to be used for bubonic infection in studies using strains of Y. pestis lacking the pgm 
locus (Burrows 1956, Une and Brubaker 1984, Une and Brubaker 1984).  Any Y. pestis strains 
lacking the pgm locus (pgm−) can be handled as a biosafely level-2 (BSL-2) organism and are 
exempt from select agent status.  Conveniently for laboratories which do not have a BSL-3 
space, plague studies using the mouse model can still be performed using pgm(−) strains which 
are attenuated, but unable to be used in transmission studies.  Therefore, it is essential that 
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findings with pgm(−) strains, especially in the context of the host, be confirmed with fully 
virulent Y. pestis to ensure that the host does not react differently to the attenuated strain. 
For models of bubonic plague infection, mice can be infected via subcutaneous (s.c.) or 
intradermal injection.  Disease progression via both routes is similar to transmission from 
infected fleas (Jarrett, Sebbane et al. 2004).  The LD50 during subcutaneous (s.c.) infection in 
this model is less than 10 colony forming units (CFUs) (Cathelyn, Ellison et al. 2007).  After 
inoculation with ∼10β cfu, Y. pestis can be detected in the draining lymph nodes as early as 
β4 hours post infection (Lawrenz 2010).  The bacteria continue to replicate and reach high 
concentrations in these tissues, similar to human plague, but lymphadenopathy may not be seen 
until later stages of infection.  In these models, systemic infection begins 12–β4 hours after 
lymph node colonization and is evident by isolation of bacteria from the spleen at 48 hours post 
infection.  Lung colonization or (secondary pneumonic plague) via systemic spread occurs after 
spleen colonization but is seen prior to the animals succumbing to infection.  Death most 
commonly occurs between γ and 5 days post infection (Cathelyn, Ellison et al. 2007, Lawrenz 
2010). 
For models of pneumonic plague infection, mouse models are typically infected by 
intranasal or aerosol inoculation and results in an infection similar to human pneumonic plague 
(Lathem, Crosby et al. 2005, Agar, Sha et al. 2008).  The LD50 for intranasal infection with Y.
pestis CO92 is approximately 10-fold less than for aerosol inoculation (∼β50 cfu vs. β100 cfu), 
although only approximately 10% of the inoculum reaches the lungs by the intranasal inoculation 
route (Meyer 1950, Lathem, Crosby et al. 2005).  Bacterial numbers in the lungs steadily 
increase between 1 and 7β hours post infection regardless of inoculation method.  Lung 
pathology appears mild at β4 hours but drastically worsens over the course of infection, resulting 
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in large areas of consolidation and inflammation by 7β hours.   As seen in primary human 
pneumonic plague, bacteria disseminate from the lungs of infected mice to colonize the spleen 
by γ6 hours post infection.  Despite spleen colonization, bacteria are not detected in the blood 
until 7β hours after aerosol inoculation, which is β4 hours later than from intranasal infection 
when concentrations were greater than 104 cfu/ml (Agar, Sha et al. 2008, Sha, Agar et al. 2008).  
In both aerosol and intranasal infection, mice typically succumb to pneumonic plague infection 
by 72–96 hours after exposure (Lathem, Crosby et al. 2005, Agar, Sha et al. 2008). 
One finding from use of the mouse pneumonic plague model found that a biphasic 
immune response occurs during plague infection (Lathem, Crosby et al. 2005, Bubeck and Dube 
2007, Agar, Sha et al. 2008).  During the first 48 hours of infection, Y. pestis steadily grows in 
the lungs of infected mice in the apparent absence of recognition by the host immune system.  
Concurrent with systemic spread of the infection, a sudden and strong inflammatory response is 
mounted by the host, which includes induction of proinflammatory cytokines and chemokines 
and infiltration of PMNs into the lungs.  Despite this intense response, Y. p stis continues to 
grow unaltered.  Animal death results from the combination of lung damage and the uncontrolled 
host immune response (Lawlor, Daskaleros et al. 1987, Bubeck and Dube 2007).  These findings 
support the hypothesis that Y. pestis actively modulates the immune response through effectors 
(Yops and LcrV) secreted by the type III secretion system encoded on the pCD1 virulence 
plasmid (Cornelis 1997, Viboud and Bliska 2005).  Interactions between Y. pestis and the 
mammalian immune system are also commonly studied using mouse model systems as well as 
understanding host determinants which may contribute to resistance to Y. pestis infection (Li and 
Yang 2008, Smiley 2008, Smiley 2008, Turner, McAllister et al. 2008).  Potential plague 
therapeutics are also initially tested using mouse models to study pathogenesis.  Numerous 
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potential vaccines, including subunit, live-attenuated, killed, and DNA vaccine candidates, have 
been screened for efficacy in the mouse model, in addition to testing novel therapeutics, such as 
monoclonal antibodies, new antimicrobial compounds, and new adjuvants to augment vaccine 
efficacy (Uddowla, Freytag et al. 2007, Smiley 2008, Smiley 2008, Amemiya, Meyers et al. 
2009, Eisele and Anderson 2009).  One important point to note is the vast difference between 
mouse and human anatomy and physiology making a huge difference in the interpretations of 
therapeutic studies.  When using a mouse model to study human plague, one variance to note is 
the difference among the respiratory tracts of mice and humans.  For instance, mice have 
increased surface area in their nasal passages, and have only a single lobe in their left lung, lack 
bronchioles, are unable to cough in response to mechanical stimulation, and exhibit different 
immune potentials in the lungs (Irwin, Averil et al. 1993, Mizgerd and Skerrett 2008).  
Furthermore, the immune systems of mice are different than that of humans, and results from the 
mouse models studies must be further tested in a more closely related model such and NHPs 
before being administered for human use (Mestas and Hughes 2004). 
 
1.17.2b Guinea pig model: 
Since the early 1900s, guinea pigs have been a commonly used plague animal model and 
still used in many vaccines studies (Qu, Shi et al. 2010).  Guinea pigs are highly susceptible to 
plague infections, (subcutaneous LD50 < 10, aerosol LD50 ∼40,000), and subcutaneous 
infection results in the development of papules at the infection site and lymphadenopathy in the 
draining lymph nodes (Welkos, Davis et al. 1995, Titball and Williamson 2001).  Comparable to 
human plague, guinea pigs will develop septicemic infection and succumb to disease within 14 
days (Pollitzer 1954), however, the pneumonic guinea pig model can differ dramatically from the 
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mouse and NHP models, because aerosol infections which initiate a primary pneumonia in mice 
or NHPs may not cause primary pneumonia in the guinea pigs.  Y. pestis introduced into guinea 
pigs by aerosol inoculation will initially colonize the cervical lymph nodes, indicating that 
infection originates from the upper respiratory tract.  Lung infections can still occur, but is more 
delayed and appears as a secondary pneumonic infection as a result of dissemination through the 
blood (Strong, Banks et al. 1912, Meyer 1961).  Another variance in the guinea pig model is the 
differences in susceptibility to different Y. pestis strains compared to other models, such as 
certain auxotrophic strains, in which the guinea pig models are highly resistant; whereas these 
strains are found to be virulent in mice and NHP’s (Burrows 1960, Burrows and Bacon 1960, 
Burrows 1963, Meyer, Hightower et al. 1974, Meyer, Smith et al. 1974, Oyston, Russell et al. 
1996).  The guinea pig is also resistant to infection by Y. pestis strains lacking the F1 capsule; in 
contrast to being virulent in the mouse model; therefore, testing of attenuated mutants or any 
potential live vaccine candidates which are identified using the guinea pig model will have to be 
further tested using other small animal models before progressing to NHP studies (Burrows and 
Bacon 1958, Welkos, Davis et al. 1995). 
 
1.17.2c Rat Model: 
Throughout history, the rat has been linked to urban plague outbreaks of human 
infections.  Rat genetics are well-characterized making this model very useful for research.  Rats 
are susceptible to Y. pestis infection, but are not commonly used in pathogenesis studies because 
of variability in disease progression during infection.  A previous study found that laboratory and 
wild rats have an increased resistance to Y. pestis infection when compared to other rodent 
models (Chen, Foster et al. 1974).  The lethal does for rats is much higher (1,000 fold higher for 
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subcutaneous infection) when compared to the mouse model.  Recently, the inbred Brown 
Norway strain of Rattus norvegicus has been found to mimic human plague, making this a 
reproducible model to study human plague infections, and disease manifestation in this rat strain 
closely simulates human infection therefore making this model useful in studying interactions in 
the draining lymph nodes during bubonic infection (Sebbane, Gardner et al. 2005).  Disease 
manifestations in the rat model follow the same pattern that is seen in human bubonic plague.  
First, the proximal lymph nodes were infected in the rat, followed by the blood, spleen, and 
lastly, the distal lymph nodes.  The draining lymph node was rapidly colonized by Y. pestis, 
within 6 hours post infection, and extracellular bacteria were visible by β4 hours post infection.  
As plague infection progresses, the bacterial numbers increase leading to lymphadenopathy, 
hemorrhage, necrosis, and other pathologies characteristic of human buboes.  Lastly, the plague 
bacteria spread to the blood causing bacteremia, and disseminate to the spleen; which is typically 
seen in septicemic plague (Sebbane, Gardner et al. 2005). 
The Brown Norway model has more recently been used as a model for pneumonic plague 
infections (Agar, Sha et al. 2009, Agar, Sha et al. 2009, Anderson, Ciletti et al. 2009).  Infections 
were acquired by intranasal inoculation, and the LD50 for Y. pestis CO92 in the rat was 
comparable to that of mice (∼β00 cfu) (Anderson, Ciletti et al. 2009).  Other studies further 
confirmed the intranasal LD50 for aerosol transmission was similar to that of mice 
(∼1.6 × 103 cfu) (Agar, Sha et al. 2009, Agar, Sha et al. 2009).  When rats are subjected to 
intranasal infection, rats appeared healthy until γ6 hours post infection, in which they began to 
demonstrate a hunched posture.  Next, the rats’ condition quickly deteriorated and the animal 
succumbed to infection between 3 and 4 days post infection (Anderson, Ciletti et al. 2009).  
Lung inflammation in rats after aerosol inoculation could be observed by 24 hours; whereas, rats 
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which were infected by intranasal inoculation, or in the pneumonic mouse models, no lung 
inflammation was observed until 36 hours post infection (Lathem, Crosby et al. 2005, Agar, Sha 
et al. 2008).  One unique element of the rat model is the capability of rat-t -rat transmission to 
occur (∼33% transmission rate), which has never been demonstrated in mouse models (Agar, 
Sha et al. 2009, Agar, Sha et al. 2009).  This transmission proposes that the rat may be used to 
model person-to-person transmission of primary pneumonic plague, as well as the examining 
lymph node disease between humans and the rat making this a relevant model to study 
pathogenesis in tissues (Sebbane, Gardner et al. 2005). 
 
1.17.3 Non-human Primates (NHPs) models: 
The most expensive but perhaps most relevant animal models are the non-human 
primates.  Research using NHPs requires specialized facilities and experienced handlers.  
Because of this, limitations on the use of NHP models are imposed when studying Y. pestis 
pathogenesis (Patterson and Carrion 2005).  The close relationship of humans to NHPs makes 
this an extremely important model when studying disease progression and manifestations of Y. 
pestis, as well as testing any potential plague vaccines or therapeutics.  Most commonly used 
NHP species for studying plague are the Rh sus macaques, Chlorocebus aethiops (African green 
monkeys), and the Cynomolgus macaques. 
 
1.17.3a Rhesus macaques model: 
Pneumonic plague infection in the Rhesus macaques is very comparable to human 
infection with a very short incubation period and the first signs of infection are observed within 2 
days after exposure (Speck and Wolochow 1957, Finegold 1968, Finegold 1968, Finegold, 
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Petery et al. 1968, Finegold 1969).  The mean time to death for infected Rhesus macaques is 
approximately 6 days, and animals developed all stages of pneumonia during the course of 
infection.  Although disease progression appears similar to humans, Rhesus monkeys are 
significantly more resistant to plague infection (Ehrenkranz and Meyer 1955, Speck and 
Wolochow 1957).  The LD50 for Y. pestis in the Rhesus model can be as much as 10-fold higher 
for pneumonic infection, and several thousand-fold higher for bubonic infection when compared 
to the infectious doses of other NHP models or human infections.  Furthermore, Rhesus 
macaques have demonstrated a tendency to develop a form of plague referred to as chronic 
pneumonic plague, which is very rarely seen in humans (Ransom and Krueger 1954).  These 
differences in the Rhesus model should be considered when using this model to evaluate 
pathogenesis of plague or new plague therapeutics. 
 
1.17.3b Chlorocebus aethiops (African green monkey) model: 
The African green monkey is highly susceptible to plague infection, unlike the Rhesus 
model.  The LD50 of Y. pestis appears to be slightly lower than the predicted doses for humans 
(~100 cfu), with a LD50 ∼γ00 cfu by aerosol transmission and ∼5–50 cfu by intradermal 
inoculation (Chen, Elberg et al. 1977, Powell, Andrews et al. 2005).  Even with this increased 
susceptibility, disease manifestations and pathology in aerosol infected African green monkeys 
in a similar way to that of human pneumonic plague patients (Layton, Brasel et al. 2011).  Y. 
pestis bacteria grow to high numbers in the lungs, which results in severe pneumonia, and 
dissemination to the blood around β days post infection.  The African green monkeys also 
develop fever at various time points post infection; however, most fever cases were not observed 
until after bacteremia and approximately β4 hours before succumbing to infection.  The mean 
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time to death for aerosol infected African green monkeys is approximately 4 days post exposure 
(Layton, Brasel et al. 2011). 
 
1.17.3c Cynomolgus macaques model: 
The Cynomolgus macaque model has been extensively used in the past for plague 
vaccine and pathogenesis studies.  The Cynomolgus macaque is highly susceptible to aerosolized 
plague with the LD50 ∼γ00 cfu’s and the infected animal manifests clinical signs similar to 
human pneumonic plague, in which animals exhibit a fever as their first clinical symptom 
(Powell, Bishop et al. 1998, Powell, Andrews et al. 2005, Koster, Perlin et al. 2010).  No 
additional clinical symptoms were observed until 24 hours post infection when the macaques 
showed signs of lethargy and anorexia; however, no respiratory distress or coughing were 
observed even though histology showed lung damage.  The pathogen ultimately disseminated 
from the lungs to the liver and spleen through the blood stream (Koster, Perlin et al. 2010). 
The use of NHPs as models for human vaccine efficiency are still the most beneficial; 
however, a better understanding of how protective a human vaccine will be is extremely 
challenging.  For example, multiple studies found that antibody titer directly correlated with 
successful protection; however, other studies have discovered that antibody titer may not 
guarantee successful vaccination and cellular responses should also be analyzed (Smiley 2008, 
Smiley 2008).  In order for a model to successfully predict plague protection, further 
characterization of the NHP plague models, as well as immune responses to vaccines will have to 





1.18. Detection Assays Used for Y. pestis Identification in Animals and Fleas 
 
1.18.1 Rodents and other animal populations: 
 For Y. pestis identification in dead rodents or animal populations during or after die-offs 
or ratfalls, direct immunofluorescence assays, agglutination assays, enzyme-linked 
immuosorbent assays, or isolation of the organism in pure culture are the most commonly used 
detection methods.  The best method for rapid and accurate detection for routine plague 
surveillance is direct immunofluorescence assays.  Some advantages of this assay is its high 
sensitivity and specificity, when used appropriately with the necessary controls and plague-
specific conjugates, and quick turn around time which is usually less than two hours.  This assay 
detects the presence of the Y. pestis F1 capsular antigen.  This assay is a useful tool specifically 
during emergency situations, when results can be relayed to local officials of positive test results 
on the same day as the specimens are received.  Another advantage is Y. pest  can be detected in 
carcasses after the animal has been deceased for long periods from days to even weeks if samples 
are taken from the long bones, such as the femur, of the animal.  The Y. pestis-Fraction-1 specific 
fluorescent antibody conjugates are made by hyperimmunizing rabbits with purified Y. p stis-
Fraction 1 antigen, followed by collection of the high titer antibody from the rabbits, and finally 
conjugation of a fluorescent label.  A conclusive diagnosis of plague in rodents relies primarily 
on isolated Y. pestis from the animal tissues, typically from the liver and spleen, and isolation of 
a Y. pestis isolate takes 48 hours; therefore, this method is a much more time consuming test, 
than the previously described direct immunofluorescence assay.  Animal necropsies of the liver 
and spleen are streaked out on sheep blood agar (SBA) and incubated at 28°C for 48 hours, and 
observed for typical plague morphology.  Colonies exhibiting typical plague morphology on the 
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SBA plates, are further confirmed by performing a specific bacteriophage lysis assay.  This test 
is commonly used to identify bacteria which are grouped or subtyped since the bacteriophages 
are viruses adapted for specific host cells; which in turn helps identify the host strain.  Y. pestis 
cells are sensitive to lysis by temperature-specific bacteriophage; therefore making this assay 
successful in identification and confirmation of positive Y. pestis samples (Plague Manual, 
1999a). 
 
1.18.2 Detection of Y. pestis in fleas: 
 In areas where recent rodent die-offs or rat-falls occur, fleas in the area may be collected 
and tested for presence of the plague pathogen.  Fleas can be collected from rodent burrows by 
burrow swabbing or flagging.  A burrow swab consists of a flexible steel cable or hard rubber 
hose with a piece of white flannel cloth attached to the end.  This cable is used to power the cloth 
down the burrow hole; in which fleas will cling to the cloth.  The cloth is then removed from the 
burrow, and if fleas are attached to the cloth, it will be placed in a plastic bag and transported 
back to the laboratory where the flags (cloths) will be placed in the freezer to kill the fleas.  Each 
dead flea will then be placed individually in an Eppendorf tube, and Heart Infusion Broth (HIB) 
will be added to each tube.  Fleas are then homogenized using a sterile teflon pestle in order to 
disrupt the gut contents where Y. pestis will be present.  Each flea triturate will then be plated on 
SBA plates and incubated at 28°C for 48 hours.  Any colonies with typical plague morphology 
will be further confirmed at Y. pestis by performing the phage lysis assay.  Plague colonies can 
also be grown up in pure culture and passaged through a laboratory mouse for further 
confirmation of the plague pathogen.  At the United States CDC, the standard procedure to 
prepare fleas for inoculation is to grind flea pools in a mortar and pestle and further suspend the 
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ground material in 2 ml of physiological saline.  This suspension will then be used to inoculate 
mice subcutaneously (0.5 ml per mouse).  Mice are then monitored for 21 days for signs of 
infection.  Any sick or dead mice will then be necropsied to collected tissues which will be used 
for bacterial isolation.  Any mice surviving out to day 21 post infection will be euthanized and 
serum tested for presence of Y. pestis infection.  Other methods for Y. pestis detection include 
polymerase chain reaction (PCR), which is highly sensitive and reliable; however, false positives 
and contamination can be an issue (Plague Manual, 1999a). 
 
1.19. Next Generation Sequencing (NGS) for Transcriptomics Analysis 
Next generation sequencing (NGS) is a state of the art technology allowing researchers to 
investigate cellular states, physiology, and gene activity.  NGS has quickly became the method 
of choice for transcriptional profiling experiments.  In contrast to microarray technology, high 
throughput sequencing allows identification of novel transcripts, does not require a sequenced 
genome and avoids background noise associated with fluorescence quantification.  Furthermore, 
unlike hybridization-based detection, RNA-seq allows genome wide analysis of transcription at 
single nucleotide resolution, including identification of alternative splicing events and post-
transcriptional RNA editing events.  NGS is commonly used for whole transcriptome sequencing 
and includes many applications such as simple messenger RNA (mRNA) profiling for discovery 
and analysis of the entire transcriptome, including both coding mRNA and non-coding RNA 
(ncRNA) (e.g., micro RNA, small RNAs) (Martin, Wang et al. 2012).  These applications, as a 
group are termed RNA-seq, and have become popular because of the capability of exposing new 
genetic information that may have been missed by array-based platforms since no prior 
knowledge of the gene sequence is necessary.  A transcriptome is defined as the whole set of 
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RNAs that are transcribed by the genome from a specific tissue or cell type at a specific 
developmental stage or under a certain physiological condition (Willingham, Dike et al. 2006, 
Jacquier 2009).  RNA-seq uses data from millions of short sequence reads, which are aligned to a 
reference genome, and can be used to perform comparative transcriptomics analyses to get a 
global view of the cell’s response to a given environment or stimulus.  RNA-seq was initially 
used for discovery applications such as rare genes, splice junctions, and gene fusions, as well as, 
with novel or poorly studied organisms for which there was no good standard microarrays.  More 
recently, RNA-seq has become more widely available and the overall costs have been 
decreasing.  Specialty applications can also be performed using RNA-seq such as RNA editing 
and allele specific expression since the technology is sequenced based (Qi, Liu et al. 2011, 
Martin, Wang et al. 2012).  While there are a variety of RNA-seq applications and protocols, 
most follow the basic strategy of isolation of total RNA, following removal of the ribosomal 
RNA (rRNA) since rRNA accounts for 95-98% of the transcriptome, and is beneficial to 
eliminate as much of the rRNA as possible prior to sequencing.  Commercially available kits are 
commonly used for ribodepletion, and these work by using oligos which are complementary to 
known rRNA sequences to sequester the ribosomal RNA molecules.  Following removal of 
rRNA, the remaining RNA is fragmented and adaptor sequences are ligated and hybridized to 
each RNA fragment, and first strand cDNA is synthesized.  Next, the cDNA is amplified in order 
to generate the cDNA library.  After the cDNA libraries are constructed, they are used as 
sequencing templates for NGS.  Following sequencing, bioinformatics analysis is performed 
which maps each sequencing read to a reference genome, and further comparative analysis can 
be performed to determine differentially expressed genes (DEGs).  NGS platforms can be used 
for transcriptome profiling, miRNA profiling, DNA-protein interaction studies using chromatin 
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immunoprecipitation (ChIP), and DNA methylation studies (Wang, Gerstein et al. 2009, Wang, 
Feng et al. 2010).   
A significant part of transcriptome research is the bioinformatics analysis.  The 
bioinformatics analyses of these studies involves massive amounts of data, in addition to the 
complexity of the transcriptome.  A typical RNA-seq data analysis typically includes the 
following steps (i) Low-quality sequences produced from library construction or the sequencing 
process are trimmed and removed. (ii) If a reference genome is available, then the millions of 
short reads are mapped to the reference genome, the expression level of each transscript is 
calculated, and then differentially expressed genes (DEGs) across the samples are compared (Li, 
Dong et al. 2013). For studies in which no reference genome is available, de novo transcriptome 
assembly is performed from short RNA-seq reads and then assembled contigs are subjected to 
functional annotation, which requires extensive computer resources (Grabherr, Haas et al. 2011).  
Further specific analysis will be performed to investigate specific questions involved in 
transcriptomics, such as analysis of RNA editing and ncRNAs, discovery of novel transcripts, 
and correlation of transcriptome data to available genomic or epigenetic data (Li, Morgenroth et 
al. 2008, Li, Dong et al. 2013, Zhang, Wang et al. 2014).  RNA-seq technology has created the 
ability to obtain a global view of the transcriptome in normal and pathological processes, or in 
different environmental conditions, which contributes to a greater understanding and novel 
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 Yersinia pestis, the causative agent of plague, is primarily a rodent-associated, flea-borne 
zoonosis maintained in sylvatic foci throughout western North America.  Transmission to 
humans is mediated most commonly by the flea vector, Oropsylla montana, and occurs 
predominantly in the Southwestern United States.  With few exceptions, previous studies showed 
O. montana to be an inefficient vector at transmitting Y. pestis at ambient temperatures, 
particularly when such fleas were fed on susceptible hosts more than a few days after ingesting 
an infectious blood meal.  We examined whether holding fleas at sub-ambient temperatures 
affected the transmissibility of Y. pestis by this vector.  An infectious blood meal containing a 
virulent Y. pestis strain (CO96-3188) was given to colony-reared O. montana fleas.  Potentially 
infected fleas were maintained at different temperatures (6ºC, 10 5C, or 23ºC).  
Transmission efficiencies were tested by allowing up to 15 infectious fleas to feed on each of 
seven naïve CD-1 mice on days 1-4, 7, 10, 14, 17, and 21 post infection (p.i.).  Mice were 
monitored for signs of infection for 21 days after exposure to infectious fleas.  Fleas held at 6ºC, 
10C and 15C were able to effectively transmit at every time point p.i.  The percentage of 
transmission to naïve mice by fleas maintained at low temperatures (46.0% at 6ºC, 71.4% at 
10C, 66.7% at 15C) was higher than for fleas maintained at 23ºC (25.4%) and indicates that O.
montana fleas efficiently transmit Y. pestis at low temperatures.  Moreover, pooled percent per 
flea transmission efficiencies for flea cohorts maintained at temperatures of 10ºC and 15ºC (8.67 
and 7.87 percent, respectively) showed a statistically significant difference in the pooled percent 
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per flea transmission efficiency from fleas maintained at 23ºC (1.94 percent).  This is the first 
comprehensive study to demonstrate efficient transmission of Y. pestis by O. montana fleas 
maintained at temperatures as low as 6ºC.  Our findings further contribute to the understanding 
of plague ecology in temperate climates by providing support for the hypothesis that Y. pestis is 
able to overwinter within the flea gut and potentially cause infection during the following 
transmission season.  The findings also might hold implications for explaining the focality of 
plague in tropical regions. 
 
2.1. Introduction 
Yersinia pestis, a Gram-negative bacterium and agent of plague, is a recently emerged clone 
of Yersinia pseudotuberculosis having evolved within the past 1,500-20,000 years (Achtman, 
Zurth et al. 1999).  The distinct life cycles of these two organisms can likely be explained as a 
function of both genetic loss and the recent acquisition of the unique plasmids pPCP and pMT by 
Y. pestis (Ferber and Brubaker 1981, Chain, Carniel et al. 2004, Chain, Hu et al. 2006).  In 
humans, the enteropathogenic Y. pseudotuberculosis promotes a relatively benign food-borne 
gastrointestinal illness while Y. pestis causes a severe, acute, often fatal disease that has been the 
cause of three historic pandemics including the Black Death which was responsible for millions 
of deaths in 14th century Europe .   
Despite its historical human toll, plague is primarily a flea-borne zoonosis of rodents, though 
nearly all mammals are susceptible to infection with the highly virulent plague bacterium and 
some experience severe disease (Pollitzer 1954, Gage and Kosoy 2005).  Plague is thought to 
persist in nature in enzootic or maintenance cycles involving transmission between rodents and 
their associated fleas (Gage and Kosoy 2005).  Periods of enzootic transmission are characterized 
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by low to virtually undetectable levels of rodent mortality.  Although this might be explained 
simply by low level but sustainable transmission between rodents and their fleas, the actual 
mechanism(s) of persistence of Y. pestis during enzootic or interepizootic periods is still a 
subject of much speculation (Gage and Kosoy 2005, Eisen and Gage 2009).  However, under 
favorable conditions, which are likely to include certain abiotic environmental factors, such as 
those related to climate, as well as the abundances of both fleas and susceptible mammalian hosts 
(amplifying hosts), rapidly spreading epizootics can occur that often have devastating effects on 
local populations of rodents and, occasionally, other wildlife species.  Periods of epizootic 
activity also can pose significantly increased risk for human plague, as infected fleas seek 
alternative hosts (Poland and Barnes 1979, Poland, Quan et al. 1994, Gage, Ostfeld et al. 1995, 
Gage and Kosoy 2005, Eisen and Gage 2009). 
Transmission of Y. pestis typically occurs through the bite of an infectious flea that has fed 
on a heavily bacteremic host.  Subsequent transmission to a naïve host has been reported to be 
dependent on the ability of the plague bacteria to colonize the midgut and proventriculus of the 
flea, eventually forming bacteria-laden masses large enough to occlude the proventricular valve 
separating the foregut from the midgut.  This blockage phenomenon, which was first described 
by Bacot and Martin (Bacot and Martin 1914) in the flea X nopsylla cheopis and quickly became 
the prevailing paradigm for flea-borne transmission of Y. pestis, prevents the flow of blood to the 
midgut resulting in starvation of the flea.  Blocked fleas, though tenacious in their repeated 
attempts to feed, are typically unsuccessful in moving blood past the proventricular blockage.  
Consequently, blood and Y. pestis bacteria are ostensibly flushed back into the bite site thus 
infecting the parasitized host (Gage and Kosoy 2005).  More recently, the molecular mechanisms 
responsible for blockage-dependent transmission of Y. pestis from flea to mammalian host have 
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been elucidated (Hinnebusch, Perry et al. 1996, Perry and Fetherston 1997, Hinnebusch 2005).  
Y. pestis forms a biofilm whose synthesis is temperature-dependent and reliant on the gene 
products of the hms (hemin storage locus) operon involved in the adsorption of exogenous hemin 
or the dye Congo Red and which comprises three gene loci (Perry, Pendrak et al. 1990, 
Hinnebusch, Perry et al. 1996, Perry and Fetherston 1997, Jones, Lilliard et al. 1999, Kirillina, 
Fetherston et al. 2004).  Moreover, regulation of biofilm production occurs post-transcriptionally 
and synthesis of this polymeric -1,6-N-acetyglucosamine-containing extracellular 
polysaccharide matrix appears optimal at ambient temperatures (23-28ºC) and thus conducive to 
the environment of the flea gut (Kirillina, Fetherston et al. 2004, Perry, Bobrov et al. 2004, 
Bobrov, Kirillina et al. 2008, Hinnebusch and Erickson 2008).  Recently, Sun et al. (Sun, 
Koumoutsi et al. 2011) described the differential control of Y. pestis biofilm formation in vitro 
and in the flea gut by the DGCs HmsT and Y3730, respectively, with the latter exhibiting 
significantly greater involvement in blockage formation within the flea, X. cheopis.  While 
biofilm-mediated proventricular blockage has been the prevailing paradigm for flea-borne 
transmission of plague for nearly a century, recent evidence has demonstrated that unblocked 
fleas are also capable of transmitting Y. pestis almost immediately after obtaining an infectious 
bloodmeal, with the time to transmission being largely determined by how soon an infected flea 
will take its next bloodmeal (Eisen, Bearden et al. 2006, Eisen, Wilder et al. 2007, Eisen, 
Borchert et al. 2008, Eisen, Holmes et al. 2008, Wilder, Eisen et al. 2008, Wilder, Eisen et al. 
2008).  This so-called early phase transmission (EPT) model, which focuses on the ability of 
unblocked fleas to transmit for a period of a few days post-infectious feeding (~ 4 days), may be 
a means of explaining the dynamics of rapidly moving plague epizootics (Eisen, Bearden et al. 
2006).  Moreover, EPT can occur in the absence of biofilm formation though biofilm likely is 
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required for long-term maintenance of Y. pestis infection in fleas (Vetter, Eisen et al. 2010 Vetter 
et al., unpublished data).  Further, Schotthoefer et al. (2011b) observed that infectious X. cheopis 
fleas can successfully transmit Y. pestis during EPT at temperatures up to 30ºC, a temperature 
that equals or exceeds what has historically has been reported to result in blockage inhibition, 
low transmission rates, and higher clearance of infection (Kartman 1969, Cavanaugh 1971, 
Hinnebusch, Fischer et al. 1998, Schotthoefer, Bearden et al. 2011). 
The relationship between climate, temperature and plague transmission has been studied for 
decades.  Climatic conditions have been shown to influence the prevalence of plague with 
variations in temperature, relative humidity, vapor pressure deficits, and precipitation as factors 
either favoring epidemic spread of plague or causing its rapid decline with the latter being 
significantly influenced by temperatures that exceed 27-28ºC (Cavanaugh 1971, Cavanaugh and 
Marshall 1972, Montminy, Khan et al. 2006, Pham, Dang et al. 2009).  Similarly, in the 
southwestern US, increased late winter-early spring precipitation (Parmenter, Yadav et al. 1999) 
or time-lagged increases in late winter precipitation correlated positively with increased human 
plague cases, while case declines were significantly impacted by the number of days exceeding 
threshold temperatures of 32 or 35ºC, depending on the area investigated (Enscore, Biggerstaff et 
al. 2002, Gage, Burkot et al. 2008).  While recent studies have demonstrated successful 
transmission of Y. pestis by X. cheopis fleas at temperatures up to 30ºC during the early phase 
(days 1-4 p.i.) (Schotthoefer, Bearden et al. 2011) and late phase periods (days 7-28 p.i.) 
(Rouviere and Gross 1996), X. cheopis-mediated transmission of Y. pestis at low temperatures 
has met with limited success due either to increased mortality of this tropical flea species 
(Rouviere and Gross 1996) or prolonged extrinsic incubation periods (Kartman 1969).  In the 
current study, we report on the successful transmission of Y. pestis by the temperate zone ground 
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squirrel flea O. montana maintained at temperatures as low as 6ºC over a period of 21 days p.i..  
Exposure of fleas to sub-ambient temperatures is not without precedent as ground squirrel 
burrow temperatures reportedly have been measured at 15ºC (Telepnev, Klimpel et al. 2009).  
The implications of low temperature growth, survival, and persistence within the O. montana gut 
as a means of explaining the potential for Y. pestis to persist during the colder winter months and 
remain viable transmitters of the plague bacillus during the subsequent transmission season are 
discussed.  We also discuss the implications of these findings for the potential role of fleas as 
reservoirs of Y. pestis and the maintenance of long-term plague foci in both temperate and 
tropical regions. 
 
2.2. Materials and Methods 
Yersinia pestis growth conditions: 
The bacterial strain used in this study, CO96-3188 (Pgm+, pCD1+, pMT1+, pPCP1+) 
(Engelthaler and Gage 2000), is a fully virulent North American strain of Y. pestis.  Culture 
stocks of CO96-3188 were maintained in heart infusion broth (HIB) supplemented with 10% 
glycerol and stored at -80°C.  For artificial infection of fleas, Y. pestis CO96-3188 was grown in 
HIB and incubated at 28°C overnight for 14-16 h with shaking at 175 rpm. 
Infection of fleas: 
Colony-reared, Oropsylla montana, the California ground squirrel flea, were obtained from 
the Centers for Disease Control and Prevention/Division of Vector-Borne Diseases for artificial 
infection with Y. pestis and for transmission feeds on 6-8 week-old naïve, female Charles River 
(Charles River Laboratories International, Inc., Wilmington, MA) CD-1 outbred mice obtained 
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from the specific pathogen-free mouse colony maintained by the Division of Vector-Borne 
Diseases, Fort Collins, CO. 
The artificial feeding procedure used to feed O. montana fleas an infected bloodmeal was 
performed as previously described (Eisen, Bearden et al. 2006).  Briefly, O. montana male and 
female adult fleas were randomly collected and removed from an established colony and starved 
for 4 days at 23°C.  An overnight culture of CO96-3188 was prepared by inoculating 60 ml of 
HIB with a 0.5 ml aliquot of bacterial glycerol stock and grown as described above.  Bacteria 
were pelleted by centrifugation and resuspended in 40 ml of defibrinated Sprague-Dawley strain 
rat blood (Bioreclamation, Jericho, NY) pre-warmed to 37°C.  Artificial feeders, each containing 
approximately 200 O. montana fleas, were prepared according to Eisen et al. (Eisen, Bearden et 
al. 2006) and fleas were allowed to feed for 1 h through mouse skins taken from euthanized, 
hairless SKH-1 mice (specific pathogen-free mouse colony maintained by the Division of 
Vector-Borne Diseases, Fort Collins, CO) on blood infected with 108-109 CFU ml-1 of Y. pestis 
CO96-3188.  Three independent artificial infections of O. montana fleas were performed for 
each temperature.  Fleas were then examined by light microscopy to determine whether fleas had 
consumed a potentially infectious bloodmeal.  Fed fleas were collected and maintained in 25 cm2 
tissue culture flasks (Corning, Lowell, MA) at their respective treatment temperature (6°C, 10°C, 
15°C, or 23°C) and held in acrylic dessication chambers (Thermo Scientific, Rockford, IL) 
containing beakers of saturated potassium chloride (KCl) solution to maintain relative humidity 
at 80-85%.  Fleas which did not feed on the infected blood were discarded. 
Flea-borne transmission to naïve mice: 
Transmission feeds were performed on days 1-4, 7, 10, 14, 17, and 21 post infection (p.i.) 
using fleas maintained at each temperature to determine the relative efficiencies of transmission 
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of low temperature fleas compared to those maintained at 23ºC.  Capsules were affixed to seven 
6-8 week-old, naïve, specific pathogen free, CD-1, outbred mice (CDC, DVBID mouse colony, 
Fort Collins, CO), and pools of ~15 potentially infectious fleas were allowed to feed for 1 h 
(Eisen, Bearden et al. 2006).  Fleas were then collected, and viewed by light microscopy to 
determine fed status as well as the sex of each flea in the pool.  Fleas were stored individually in 
microcentrifuge tubes and placed at -80°C for later analysis to determine infection prevalence 
and bacterial loads.  Exposed mice were held in individually ventilated cages (Tecniplast, 
Philadelphia, PA) at 27ºC and monitored for signs of infection (e.g. ruffled fur, lethargy, 
hunched posture, slow response to stimuli).  At first sign of illness, mice were euthanized and 
later necropsied to detect Y. pestis infection by performing Y. pestis anti-F1 antigen direct 
fluorescent antibody assays (DFA) on liver and spleen smears.  Positive transmission events 
were confirmed by specific bacteriophage lysis of bacterial colonies isolated from mouse tissues 
(Chu 2000).  Though subjective in nature, monitoring for distinct signs of illness in exposed 
mice correlated well with the presence of Y. pestis organisms in mouse tissues following 
euthanasia and necropsy.  There were no instances in which mice were euthanized and Y. pestis 
bacteria were not recovered.  Time to death or time to euthanasia for individual mice for each 
time point and temperature also was recorded.  Mice showing no signs of infection were held for 
up to 21 days p.i. before being euthanized.  Animal procedures used in this study were approved 
by the Centers for Disease Control and Prevention, Division of Vector-Borne Diseases, 
Institutional Animal Care and Use Committee (Protocol #09-020). 
In Vitro Bacterial Viability Curve: 
A 0.5 mL aliquot of frozen glycerol stock of strain CO96-3188 was used to inoculate 3 ml of 
HIB and grown for 16 h at 28°C and 175 rpm.  Overnight cultures were diluted 1:50 into 15 ml 
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of fresh HIB to achieve a bacterial concentration of ~1 x 107 CFU mL-1.  Cultures were grown 
statically (in the absence of aeration) and maintained at 6°C, 10°C, 15°C, and 23°C.  Cultures 
were inoculated in duplicate for each growth temperature.  Aliquots from each tube were 
obtained at time 0 h and decimally diluted in saline, plated on blood agar containing 6% sheep 
blood (SBA) in duplicate, and incubated at 28°C for 48 h to determine initial bacterial 
concentrations.  Broth cultures were incubated at their appropriate temperature for a total of 5 
days, and aliquots of each culture tube were serially diluted and plated in duplicate on SBA at 
times: 0, 4, 8, 12, 24, 36, 48, 60, 72, 84, 96, 108, and 120 h.  Bacterial colonies were enumerated 
and recorded to determine viable bacteria at each time point and incubation temperature. 
Flea infection prevalence and bacterial loads: 
Fleas were homogenized in 100 µL of HIB + 10% glycerol using sterile Teflon pestles and 
plated on SBA medium to determine infection status.  The number of artificially fed fleas that 
were both infected and uninfected and which fed on naïve mice were used in determining the 
infection prevalence of fleas at each time point and incubation temperature.  Bacterial loads of Y. 
pestis-infected fleas were estimated by decimally diluting individual flea lysates and plating on 
SBA media in duplicate.  Per flea bacterial load estimates were used in calculating the median 
bacterial burden of fleas at each time point and temperature as well as computing the average of 
the log-transformed sum of bacteria within groups of fleas which fed on naïve mice at each time 
point and temperature (average logsum, described below). 
Statistical Analyses: 
Maximum likelihood estimates for percent per flea transmission rates were calculated by 
using the Microsoft Excel Add-In PooledInfRate v. 4.0 (Ransom and Krueger 1954), for each 
time point at each temperature.  Estimates were based on the number of infected fleas that were 
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also determined to have fed on an individual mouse and whether subsequent transmission 
occurred in that mouse.  Pooled percent per flea infection rates were also used to analyze the 
effect of day p.i. as well as temperature on transmission by using a pooled binomial regression 
algorithm in R (binGroup package, the Comprehensive R Archive Network (CRAN), 
http://cran.r-project.org/web/packages/binGroup/index.html). 
Pooled percent per flea transmission rates for each temperature, total mouse transmission 
rates for each temperature, and bacterial viability curve analysis by temperature, time point, and 
bacterial counts were compared using one-way ANOVA.  The average logsum f bacterial CFU 
of infected, fed fleas at each time point were compared between temperatures using one-way 
ANOVA with Dunnett’s post-hoc control test.  Logsum data comprise the log-transformed sum 
of the bacterial loads of all infected fleas that fed on an individual naïve mouse for a particular 
time point and temperature.  Logsum calculations were determined for each group of fleas which 
fed on mice within a cohort (7 mice) for each time point at a particular treatment temperature.  
The bacterial logsum value to which each individual mouse within a cohort was exposed, were 
then averaged to obtain a single logsum value at each time point for all four temperatures.  These 
averaged logsum values were then used in further statistical analyses.  Differences among or 
between groups were considered statistically significant at P < 0.05.  Contingency table analysis 
was also performed to determine differences in transmission efficiencies for each temperature 
and day p.i.  Wilcoxon/Kruskal-Wallis tests (rank sums) were used to establish the significance 
of incubation temperature on i) in vitro bacterial viability, ii) average bacterial logsum data, iii) 
pooled percent per flea transmission rate, iv) mouse infection rate, and v) median flea bacterial 




2.3. Results  
Effects of temperature on flea transmission efficiencies: 
Y. pestis transmission was observed on each challenge day post infection (p.i.) using fleas 
maintained at each of the three low temperatures tested (6°C, 10°C, and 15°C); whereas no 
transmission was observed on day’s γ and 4 p.i. from fleas held at ambient temperature (i.e. 
23°C) (Table 2.1).  With the exception of results for the in vitro bacterial viability curve (see 
below), all references to temperatures and numerical notations for specific temperatures (eg. 
10ºC) refer to the maintenance temperatures of infected fleas and not to temperatures at which 
mice were exposed.  All mice used in this study were held at a constant temperature of 27ºC.  
Percent per flea transmission efficiencies, which estimate the number of infected fleas that were 
also determined to have fed on an individual mouse and whether subsequent transmission 
occurred in that mouse, were highest at 10°C. The lowest percent per flea transmission efficiency 
(1.02%) was exhibited at day 1 p.i. for 10o C, with transmission efficiency for the remaining 
eight time points ranging from 5.55-13.09%, with day 17 p.i. showing the highest observed 
percent per flea transmission efficiency (Table 2.1).  Similarly, percent per flea transmission 
efficiencies were observed at 15°C ranged from 1.12-15.05%, excluding days 10, 14, and 17 
which showed percent per flea transmission efficiency estimated at 100%).  Percent per flea 
transmission efficiencies at 6°C ranged from 0.96-7.52% with successful transmission events 
observed on each challenge day (Table 2.1).  Surprisingly, the lowest overall percent per flea 
transmission efficiencies were observed at 23ºC, the temperature at which most previous 
transmission studies for O. montana  has been performed (Burroughs 1947, Eisen, Bearden et al. 
2006, Eisen, Lowell et al. 2007).  In the current study, percent per flea transmission efficiencies 
ranged from 0.00-3.45%, in which no successful transmission events were observed on days 3 
132 
 
and 4 p.i. (Table 2.1).  Pooled percent per flea transmission rates, incorporating all days p.i., 
were 4.11 (95% CI, 2.83-5.84), 8.67 (95% CI, 6.43-11.65), 7.87 (95% CI, 5.82-10.58), and 1.94 
(95% CI, 1.16-3.09) for 6,°C 10°C, 15°C, and 23°C, respectively.  By pair-wise comparisons, 
significant differences in pooled percent per flea transmission rates were observed between 
temperatures, 6°C and 10°C (P = 0.0170), 10°C and 23°C (P = 0.0022), and 15°C and 23°C (P = 
0.0136) (Figure 2.1).  Pooled binomial logistic regression analysis by temperature incorporating 
simultaneous 95% confidence intervals for each time point also demonstrated significant 
differences between 6°C and 10°C, 10°C and 23°C, and 15°C and 23°C (P < 0.05).  Logistic 
regression analysis by day p.i. showed no significant differences in pooled percent per flea 
transmission rate with the exception of day 1 versus day 14 p.i. (P < 0.05).  Overall, the data 
reflect that pooled percent per flea infection rate was influenced by temperature. (2 = 13.69, 
df=3, P = 0.0034). 
The number of successful transmission events directly correlated with the pooled percent per 
flea transmission rates.  Late phase time points (day’s 7-21 p.i.) showed the highest rates of 
transmission with days 10, 14, and 17 p.i. showing 100% transmission in all seven mice 
challenged at 15ºC (Table 2.1).  Consistent with the 10°C percent per flea transmission 
efficiencies being the highest, the number of total transmission events that occurred at this 
temperature was also found to be the highest with 46 out of the 63 (71.4%) mice exposed 
succumbing to infection by Y. pestis (Table 2.1).  Transmission events for days p.i. 2-21, ranged 
from 57.1-85.7%, with only a single successful transmission occurring on day 1 p.i. for 10ºC 
fleas.  Transmission events at 15°C were also successful at each of the nine time points with the 
fewest number of events observed on day 4 and 100% transmission occurring on days 10, 14, 
and 17 p.i. (Table 2.1).  Transmission rates to naïve mice ranged from 14.3-100% for fleas 
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maintained at this temperature.  For Y. pestis-infected fleas maintained at 6ºC, 46.0% (29 of 63) 
of naïve mice challenged, successfully became infected and died, with each time point having 
successful transmission events (range, 14.3-71.4%).  The lowest number of transmission events 
occurred at 23°C on days 3 and 4 with no successful transmission, and overall, only 25.4% (16 
of 63) of mice exposed to fleas at this temperature resulted in mortal infection by the pathogen 
(range, 0-42.9%) (Figure 2.2).  Flea maintenance temperature was a significant factor in mouse 
mortality (2 = 13.52, df = 3, P = 0.0036).  Similar to pair-wise comparisons for pooled percent 
per flea transmission, statistical significance in the number of successful transmission events 
were found between 6°C vs. 10°C (P = 0.0343), 10°C vs. 23°C (P = 0.0003), and 15°C vs. 23°C 
(P = 0.011) (Figure 2.2).  Moreover, binomial logistic regression analysis revealed flea 
maintenance temperature and day p.i. as significant predictors of the rate of mouse infection.  
Specifically, as day p.i. increased, the probability of a successful transmission event occurring 
also increased (all P values < 0.05). 
Effects of temperature on Y. pestis bacterial loads in fleas: 
Individually homogenized infected fleas maintained at each of the four temperatures which 
fed on exposed naïve mice were quantified to determine infection prevalence and bacterial loads.  
Though more female than male fleas were used in our study, no significant differences were 
found between male and female fleas with regard to feeding rate and infection prevalence and 
thus, sex of the flea was not used as a criterion in our study.  Overall flea infection prevalence for 
each of the four temperatures tested and on each day p.i. ranged from 93.8-100%.  The average 
number of fleas feeding on each of seven mice per time point and temperature (Table 2.1) 
yielded a range of 13.1-15.1 fed fleas per naïve mouse.  No significant differences in the number 
of infected fleas that successfully took a blood meal from naïve mice were shown on any of the 
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challenge days or among temperatures (Table 2.1).  When quantifying bacterial loads for each 
infected, fed flea, a significant difference was found between fleas maintained at 6°C, (2.45 x 106 
median CFU per flea, averaged for each time point), when compared to fleas maintained at 10°C 
(1.03 x 106 median CFU per flea, averaged for each time point) (P = 0.0181), 15°C (5.96 x 105 
median CFU per flea, averaged for each time point) (P = 0.0026) and 23°C (1.61 x 104 median 
CFU per flea, averaged for each time point) (P = 0.0002) (Figure 2.3).  While fleas maintained at 
23°C were found to harbor the lowest median number of bacteria, comparisons to average 
median bacterial loads for 10°C and 15°C were not statistically significant (P = 0.0832 and P = 
0.3159, respectively) (Figure 2.3).  However, our results indicate that temperature is an 
influential factor on median bacterial loads (2 = 23.31, df = 3, P < 0.0001). 
To determine whether the total number of CFU calculated from all fleas within a cohort 
which were infected and fed on an individual naïve mouse, we employed average logsum data as 
a means to evaluate whether or not this parameter was affected by incubation temperature of the 
flea.  Pair-wise comparisons of average logsum CFU per temperature and incorporating all time 
points show that values for fleas maintained at 6°C were significantly higher than those for 10°C 
(P = 0.0231), 15°C (P = 0.0071), and 23°C  (P < 0.0001) (Figure 4).  Moreover, average logsum 
values at 23°C were also significantly less than the determined values for 10°C (P < 0.0001) and 
15°C (P < 0.0001) (Figure 2.4).  Overall, temperature proved to be a significant factor with 
respect to logsum values (2 = 22.06, df = 3, P < 0.0001). 
In vitro  bacterial viability curve: 
Based on observations on in vivo growth of Y. pestis within fleas at 6°C, 10°C, 15°C, and 
23°C, and the patterns revealed in the results for median bacterial loads and logsum values, we 
chose to examine growth and viability of Y. pestis in vitro at the same temperatures.  A five day 
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growth curve analysis measuring bacterial cell viability showed statistically higher peak growth 
at temperatures 10°C and 15°C when compared to 6°C (P = 0.0121 and P = 0.0099, respectively) 
and 23°C (P = 0.0075 and P = 0.0060, respectively) (Figure 2.5).  Static growth (without 
aeration) at 6°C appears to be more linear and approaching stationary phase at the end of the 5 
day sampling period, whereas 23°C had achieved peak growth by 24 h.  Although pair-wise 
comparison of results by temperature indicate that Y. pestis grows more favorably in vitro at 
10°C and 15°C when compared to 6°C and 23°C, a comparison of all temperatures incorporating 
all time points showed no statistical significance in overall growth of Y. pestis (2 = 7.68, df = 3, 
P < 0.0531) (Figure 2.5).  Moreover, in vitro growth at 6°C does not appear to mimic in vivo 
bacterial loads as shown in Figures 3 and 4, however, the comparative trend of higher peak 
growth of Y. pestis at lower temperatures remains consistent when compared to growth at 23°C. 
 
2.4. Discussion 
Historically, it has been shown that increases in the mean monthly ambient temperature 
above 27.5ºC result in declines in epizootic and human plague activity (Pollitzer 1954, Schar 
1956, Cavanaugh 1971, Cavanaugh and Marshall 1972, Enscore, Biggerstaff et al. 2002, Brown, 
Ettestad et al. 2010).  These declines in transmission are thought to be associated with reductions 
in flea blockage or loss of infection (Kartman and Prince 1956, Kartman 1969, Hinnebusch, 
Fischer et al. 1998) however, Schotthoefer et al. (2011), recently demonstrated Y. pestis 
transmission by the flea X. cheopis at temperatures as high as 30ºC during the early phase 
transmission period (days 1-4 p.i.) (Schotthoefer, Bearden et al. 2011), as well as during late 
phase (days 7-28 p.i.) (Rouviere and Gross 1996), suggesting that other factors, such as threshold 
host or flea densities also could be involved.   
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Similar studies have not been performed at low temperatures.  The aim of the current study 
was to examine the effect of low temperature incubation of O. montana (formerly D. montanus) 
fleas on transmission during both early and late phase periods.  Kartman et al. (Kartman 1969) 
demonstrated survival and transmission of X. cheopis at 8.5ºC, however these fleas were held 
until blockage was observed which was beyond the extrinsic incubation period of the fleas held 
in the current study.  We used O. montana, a temperate flea that rarely blocks (Burroughs 1947, 
Engelthaler and Gage 2000), to demonstrate transmission during early and late phase periods at 
sub-ambient temperatures.  Our data clearly demonstrate that efficient flea-borne transmission of 
Y. pestis does occur at low temperature during both early and late phase periods and is 
particularly robust at 10ºC and 15ºC.  Though the data do not provide a specific explanation for 
greater transmission as measured by mouse mortality from infected fleas held at sub-ambient 
temperatures relative to 23ºC, reasons for this may include higher median bacterial loads and 
bacterial logsum values of flea groups held at the lower temperatures that fed on individual mice 
(Figures 3 and 4, respectively).  Though overall transmission events from infected fleas held at 
23ºC was significantly lower than fleas held at 10ºC and 15ºC and differ substantially during 
EPT from data reported by others using O. montana (Eisen, Bearden et al. 2006), our study 
utilized CD-1 outbred mice which may have slightly different susceptibility characteristics.  
Moreover, Eisen et al. (2006) used only female fleas for transmission experiments.  Additionally, 
bacterial load and logsum data were significantly lower at 23º in the current study.  Furthermore, 
EPT studies by Vetter et al. (2010) using O. montana fleas and biofilm biosynthetic mutants also 
showed reduced mouse mortality numbers during these time points including one EPT p.i. time 
point in which no transmission was observed (Vetter, Eisen et al. 2010). 
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Percent per flea transmission efficiency data (Table 2.1 and Figure 2.1), a maximum 
likelihood estimate of transmission by infected fleas that also fed on a naïve mouse, clearly 
indicates the significance of low temperature incubation in promoting flea-borne transmission.  
Pooled percent per flea transmission efficiencies were highest at 10ºC and 15ºC.  Additionally, 
binomial logistic regression analysis also showed an increased probability of flea-borne 
transmission over time particularly at 10ºC and 15ºC.  Schotthoefer et al., demonstrated 
transmission in X. cheopis fleas held at 10ºC up to 14 days p.i. (Rouviere and Gross 1996), 
though these fleas showed much lower survivability than was observed in our study for O. 
montana fleas held at the same temperature at 14 days p.i. (data not shown).  Since ground 
squirrel burrow temperatures of 15ºC have been described previously (Telepnev, Klimpel et al. 
2009), it is possible that temperatures of 10-15ºC represent burrow conditions that are optimal 
for both bacterial growth and transmission potential by O. montana or the fleas of other burrow 
dwelling rodent hosts of plague. 
Changes in lipopolysaccharide (LPS) structure for Y. pestis at lower temperatures may 
provide an alternative explanation to explain enhanced transmission at low temperatures by O. 
montana fleas (Anisimov, Dentovskaya et al. 2005, Han, Zhou et al. 2005, Knirel, Lindner et al. 
2005, Knirel, Lindner et al. 2005).  These changes may be more conducive to survival, growth, 
and transmission potential for Y. pestis within the flea, although Suomalainen et al. (2010) 
recently reported a dramatic reduction in LPS-dependent plasminogen activation by the Pla 
surface protease as a result of temperature-induced (20ºC) changes in the LPS of Y. pestis 
(Suomalainen, Lobo et al. 2010) from which one might conclude that dissemination of Y. pestis 
may be delayed and flea-borne transmission impaired at temperatures even lower than 20ºC.  
However, results of the current study suggest that the reduction in Pla protease activity is only 
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transient as transmission of Y. pestis by O. montana fleas maintained at 10ºC and 15ºC is 
significantly higher than at the other study temperatures and no significant differences were 
observed in mean time to death among transmission events across all temperatures (data not 
shown),  It should also be noted that LPS biosynthesis by an alternative pathway has been 
suggested for Y. pestis grown at 6ºC resulting in a novel LPS structure (Knirel, Lindner et al. 
2005).  It would be of interest to know whether this novel Y. pestis LPS structure interacts with 
the Pla protease or fosters enhanced resistance to antimicrobial factors in the flea gut, although 
very little is known about immunity in fleas. 
Due to significantly greater bacterial growth within the flea gut at lower temperatures 
(Figures 2.3 and 2.4), it may be likely that up-regulation of bacterial factors that contribute to 
growth and survival occurs at sub-ambient temperatures.  Although a direct comparison cannot 
be made due to presumed differences in the growth enviroments of HIB media and the flea 
midgut, it is interesting to note that the in vitro static growth characteristics of Y. pestis at 
different temperatures showed peak growth at lower temperatures similar to the growth kinetic 
patterns observed in vivo.  Conversely, physiological changes within the flea may favor 
maintenance and growth of the plague bacilli.  Moreover, factors that contribute to resistance to 
infection or elimination of Y. pestis within the flea may be down-regulated or altered in function 
at lower temperatures.  In a recent study, genes identified as being involved in the production of 
reactive oxygen species in response to Y. pestis infection in X. cheopis fleas (Collinge, Simirskii 
et al. 2005), may be less active or non-functional at lower temperatures.  Toxic degradation 
products derived from the flea blood meal and from which Y. pestis is thought to be protected via 
expression of ymt, encoding a phospholipase D required for survival of Y. pestis in the flea, may 
be less abundant in fleas maintained at low temperatures thus reducing exposure of Y. pestis to 
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these compounds (Hinnebusch, Fischer et al. 1998).  Moreover, likely induction of the cold 
shock protein stimulon (Han, Zhou et al. 2005) may act as a global regulatory mechanism for 
factors which enhance the growth and survival of Y. pestis within the flea at low temperatures.  
These factors will require further investigation and planned studies involving transcriptomic 
analysis of Y. pestis infected O. montana may reveal additional factors that contribute to 
enhanced growth and survival. 
Increased growth and survivability of Y. pestis in the flea gut at low temperature may 
contribute to the transmissibility of overwintering fleas, particularly in burrow-dwelling fleas 
such as O. montana.  Overwintering of Y. pestis infection in fleas have been previously reported 
for various species of fleas including ground squirrel fleas (Kartman, Quan et al. 1962, 
Baltazard, Karimi et al. 1963, Sing, Roggenkamp et al. 2002, Bazanova, Nikitin et al. 2007, 
Bizanov and Dobrokhotova 2007, Robinson, Telepnev et al. 2009, Anisimov, Dentovskaya et al. 
2010).  O. montana or other fleas overwintering as infectious fleas in burrows may transmit to 
hibernating hosts or hosts in late winter and early spring.  Because low temperature incubation of 
infected fleas enhances the growth of Y. pestis (Figures 2.3 and 2.4), it would be of interest to 
know whether these conditions also promote partial or complete blockage and/or enhanced 
biofilm production within O. montana, a flea that rarely blocks at temperatures and time periods 
used in earlier studies (Burroughs 1947, Engelthaler and Gage 2000).  Additional experiments, 
beyond the scope of the current study, will utilize reporter strains of Y. pestis to localize the 
bacteria within the flea gut.  Biofilm biosynthetic mutants will be used to determine the 
contribution of exopolysaccharide production in the growth and survival of Y. pestis within the 
flea at low temperatures.  The results of the current study have significant implications for the 
utility of fleas as reservoirs for plague from one season to the next as well as the focality of 
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plague in global endemic foci including those in tropical regions that occur at higher elevations 
and experience cooler temperatures.  This is particularly true in the East African countries of 
Uganda and Tanzania where elevated plague risk is associated with vegetation and higher 
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Table 2.1. Transmission efficiency of infected fleas held at different temperatures during 










Average No. fed, 
infected fleas per mouse 






Percent per flea 
transmission 
efficiency (95% CI) 
6 1 100 14.9 (104) 1 (7) 0.96 (0.06-4.76) 
2 98.1 14.7 (105) 4 (7) 4.99 (1.71-12.81) 
3 97.3 15.0 (108) 4 (7) 4.89 (1.68-12.56) 
4 99.0 14.9 (105) 3 (7) 3.38 (0.93-9.60) 
7 96.0 13.1 (106) 3 (7) 3.82 (1.06-10.78) 
10 98.1 14.7 (104) 2 (7) 2.08 (0.39-7.01) 
14 96.9 15.1 (109) 5 (7) 7.28 (2.85-18.37) 
17 99.0 14.7 (105) 2 (7) 2.06 (0.38-6.98) 
21 98.9 14.1 (106) 5 (7) 7.52 (2.94-18.96) 
10 1 95.1 14.0 (105) 1 (7) 1.02 (0.06-5.04) 
2 98.1 15.0 (107) 6 (7) 10.04 (4.43-27.45) 
3 96.3 14.9 (106) 5 (7) 6.95 (2.75-17.23) 
4 100 14.9 (105) 6 (7) 9.97 (4.40-27.37) 
7 100 13.1 (106) 4 (7) 5.11 (1.74-13.21) 
10 98.7 14.4 (104) 4 (7) 8.27 (3.29-20.20) 
14 98.1 14.9 (106) 6 (7) 10.56 (4.81-27.69) 
17 98.1 14.9 (105) 6 (7) 13.09 (5.66-44.93) 
21 96.3 13.3 (97) 6 (7) 12.84 (5.80-34.27) 
15 1 93.8 14.1 (103) 3 (7) 3.70 (1.02-10.53) 
2 99.0 14.9 (105) 2 (7) 2.05 (0.38-6.92) 
3 98.0 14.7 (105) 4 (7) 5.08 (1.73-13.17) 
4 95.1 13.4 (98) 1 (7) 1.12 (0.07-5.51) 
7 99.0 14.7 (99) 5 (7) 7.29 (2.85-18.39) 
10 98.9 14.1 (104) 7 (7) (N/A)a 
14 96.4 15.1 (105) 7 (7) (N/A)a 
17 97.4 14.4 (105) 7 (7) (N/A)a 
21 97.1 13.6 (93) 6 (7) 15.05 (7.70-33.48) 
23 1 99.0 14.4 (98) 2 (7) 2.11 (0.40-7.10) 
2 100 14.7 (104) 1 (7) 0.95 (0.06-4.71) 
3 100 14.9 (106) 0 (7) 0.00 (0.00-2.93) 
4 100 14.4 (102) 0 (7) 0.00 (0.00-2.87) 
7 100 14.3 (102) 3 (7) 3.30 (0.91-9.34) 
10 100 14.1 (101) 3 (7) 3.38 (0.94-9.51) 
14 99.0 14.1 (103) 3 (7) 3.36 (0.93-9.49) 
17 99.0 13.7 (102) 3 (7) 3.45 (0.95-9.85) 
21 98.1 14.0 (103) 1 (7) 0.98 (0.06-4.87) 
aWhen all pools are positive, likelihood methods cannot be calculated.  Likelihood estimates 









Figure 2.1.  A one-way ANOVA analysis comparing pooled percent per flea transmission 
rates by temperature and including all experimental time points (represented by closed 
squares).  Means are indicated by the center horizontal lines within each rhombus and parallel 
lines above and below the means denote the 95% confidence intervals (CI).  The horizontal 
line extending from the Y axis to the right margin of the graph is the mean of response across 
all temperatures.  The mean pooled percent per flea transmission rates were: 6°C (4.11; 95% 
CI, 2.83-5.84), at 10°C (8.67; 95% CI, 6.43-11.65), 15°C (7.87; 95% CI, 5.82-10.58), and 
23°C (1.94; 95% CI, 1.16-3.09). 
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Figure 2.2. Mouse mortality at each temperature and time point 
 
   
  
 
Figure 2.2. Graph showing the number of mice that succumbed to Y. pestis infection, or were 
euthanized and confirmed to be infected by Y. pestis by bacteriophage lysis of culture isolates 
from mouse tissues, for each temperature and day post infection.  The X axis denotes days on 
which naïve mice (7 mice were used for each time point and temperature) were exposed to 
infected fleas (infected fleas were obtained from three independent artificial infections for each 






Figure 2.3. Median CFUs/flea for each temperature and time point 
 
                             
 
 
Figure 2.3. Histogram comparing median Y. pestis CFU per flea (Y axis) for temperatures 6°C, 10°C, 15°C, and 23°C and across all 
experimental time points denoted as days post infection (X axis).  Sets of bars for each day post infection represent the average of 





























Figure 2.4 A one-way ANOVA analysis (left panel) with Dunnett’s post-hoc control test (right panel) comparing the average logsum 
CFU’s (Y axis) of infected, fed fleas maintained at each temperature (X axis) incorporating all time points.  Diamonds not connected 
by the same letter are significantly different.  Means are indicated by the center horizontal lines within each rhombus and parallel lines 
above and below the means denote the 95% confidence intervals (CI).  The horizontal line extending from the Y axis to the right 
margin of the graph is the mean of response across all temperatures.  The Dunnett’s post-hoc control test (right panel) shows a 
significant difference between all three lower temperatures when compared to the control temperature (23°C), which is represented by 
the  bottom circle in the right panel.  
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Figure 2.5. In vitro static growth of Y. pestis CO96-3188 over 5 days at different temperatures. Viable bacterial counts depicted as 
CFU/mL (Y axis) for a period of growth ranging from 0 h to 120 h (X axis) were determined by plating in duplicate from two 
independent experiments.  Error bars for each sampling time point represent the standard deviation of two independent experiments.  
Pair-wise significant differences for mean growth between temperatures and inclusive for all time points were observed between 6ºC 










 Yersinia pestis is a zoonotic disease which cycles between fleas and rodent hosts.  In the 
United States, the majority of human cases are associated with the flea vector, Oropsylla 
montana.  To better understand plague ecology in temperate climates, our study tested the ability 
of infected fleas to live in soil and successfully transmit at temperature’s mimicking rodent 
burrows.  Fleas were fed an infectious Y. pestis bloodmeal, and further divided and maintained at 
one of four temperatures (6ºC, 10C, 15C, or 23ºC) in flasks containing autoclaved prairie dog 
burrow soil.  Flea transmissibility of this pathogen was tested by feeding ~15 fleas weekly in 
capsules placed on seven naïve CD-1 mice.  Fleas held at 6ºC were able to survive and 
effectively transmit out to 42 days p.i., as indicated by 87% overall mortality among mice fed 
upon by these fleas.  Fleas held at 10C and 15C survived out to day 28 p.i. and transmitted Y. 
pestis to mice resulting in >90% overall mouse mortality.  Fleas held at 23ºC, were unable to 
survive past day 11 p.i., therefore, transmission studies could only be conducted on day 7 p.i.  A 
significant difference was found in flea mortality, as well as average bacterial loads between 
fleas held at sub-ambient temperatures when compared to 23ºC (2=0.0012) on day 7 p.i..  Our 
study suggests that plague bacteria might overwinter in the flea gut and persist for weeks to 
months during other seasons in infected fleas living off-host in relatively cool rodent burrows. 
The ability of fleas to transmit Y. pestis to susceptible hosts after many days to weeks of 
incubation below ambient temperatures also demonstrates the potential of these insects to act as a 




The Gram-negative, rodent associated pathogen, Yersinia pestis, causes a zoonotic disease that 
has been implicated in three historic pandemics causing millions of deaths.  Y. pestis is the 
etiologic agent of the disease most commonly known as plague, which is primarily a flea-borne 
disease of rodents.  Plague is thought to persist in nature in enzootic or maintenance cylces 
involving transmission between rodents and their associated fleas (Gage and Kosoy 2005).   
Oropsylla montana, a ground squirrel flea commonly found on California ground squirrels and 
the closely related rock squirrel, is the vector most commonly associated with human plague 
transmission in the United States.  Transmission of plague typically occurs through the bite of an 
infectious flea that has fed on a highly bacteremic host.  Occasionally, epizootic periods or rapid 
spread of plague occurs, causing noticeable rodent die-offs and increasing human risks for 
plague infection from the susceptible rodent hosts succumbing to infection as their starved fleas 
begin questing to find new hosts (Eisen, Wilder et al. 2007).  The potential mechanisms of 
plague maintenance during inter-epizootic periods have been studied extensively but are still 
poorly understood.  Persistence of Y. pestis in soil has been suggested as a possible mechanism 
of interepizootic persistence as well as a potential factor describing plague foci.  Much 
speculation regarding plague reservoirs exists in the literature, including such proposed 
mechanisms as low levels of transmission occurring between enzootic hosts and fleas (Gage and 
Kosoy 2005), survival of Y. pestis in soil (Mollaret 1963, Drancourt, Houhamdi et al. 2006, 
Boegler, Graham et al. 2012) or transmission of Y. pestis by contact of susceptible hosts with 
infected flea feces (Jones, Vetter et al. 2013).  Some support for low level transmission between 
fleas and hosts during interepizootic periods exists, but the question of its importance relative to 
other mechanisms remains uncertain.  Similarly, a report by Drancourt et al. (2006) discovered 
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that Y. pestis could remain viable and fully virulent after 40 weeks in soil suggesting a possible 
reservoir role for survival of Y. pestis in soils but Boegler et al. (2012) succeeded in infecting 
only one mouse out of 104 exposed to Y. pestis-contaminated soil.  Although this finding 
demonstrates that transmission of Y. pestis to rodents through contact with contaminated soils is 
possible, the frequency at which such transmission occurs appears to be very low, making its 
significance uncertain. Survival of Y. pestis in flea feces for many weeks was first documented 
during the last pandemic in India but its significance as a reservoir mechanism has received little 
attention and has been dismissed by some.     
 Environmental conditions such as climate, temperature, and humidity play a pertinent 
role in the viability and transmission of this particular pathogen.  Plague transmission and its 
relationship to climate and temperature (e.g. relative humidity, vapor pressure deficits, 
precipitation, or changes in temperature) has also been studied for decades and found to 
influence plague prevalence in ways which either favored epidemic spread of the pathogen at 
relatively moderate temperatures or significantly decreased its spread when temperatures 
surpassed 27-28ºC.  This relationship has been observed in the plague endemic areas in the 
southwestern United States, in which an increase in late winter-early spring precipitation 
positively correlated with an increase in human plague cases.  In contrast, human plague cases 
decline significantly when temperatures increased above 32-35 ºC for a given time period.  In 
this study, we examined the effects of incubating infected fleas at sub-ambient temperatures, 
which mimic ground squirrel burrow temperatures during the winter months, (e.g. 6 ºC, 10 ºC, 
15 ºC), on their ability to remain viable and successfully transmit Y. pestis to naïve rodent hosts.  
The implications of low temperature growth, survival, and persistence within the O. montana 
midgut could further explain the potential for Y. pestis to persist during the colder winter months 
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and remain viable in order to successfully transmit during the subsequent transmission season.  
Because Y. pestis is pathogenic for its flea vector and could be subject to attack by the fleas 
natural immune system we also measured midgut peroxide levels to provide some estimate of the 
innate immune responses of O. montana.  Finally, we discuss the implications of these findings 
for the potential role of fleas maintained in soil of burrows as a potential reservoir of Y. pestis 
and the maintenance of long-term plague foci in both temperate and tropical regions. 
 
3.2. Materials and Methods 
Yersinia pestis growth conditions: 
The fully virulent Yersinia pestis strain, CO96-3188 (Pgm+, pCD1+, pMT1+, pPCP1+), was 
used for artificial infection of fleas.  Glycerol stocks of CO96-3188 were maintained in heart 
infusion broth (HIB) with 10% glycerol and overnight cultures were grown in HIB and incubated 
at 28°C overnight for 14-16 h with shaking at 180 rpm.   
Infection of fleas: 
Colony-reared, Oropsylla montana fleas were obtained from the Centers for Disease Control 
and Prevention/Division of Vector-Borne Diseases for artificial infection with Y. pestis and for 
transmission trials performed on 6-8 week-old naïve, female Charles River CD-1 outbred mice 
obtained from a specific pathogen-free mouse colony (Charles River Laboratories International, 
Inc., Wilmington, MA). 
The artificial feeding procedure used to feed O. montana fleas an infected bloodmeal was 
previously described (Eisen, Bearden et al. 2006, Williams, Schotthoefer et al. 2013).  Briefly, O. 
montana male and female adult fleas were randomly collected and removed from an established 
colony and starved for 4 days at 23°C.  An overnight culture of CO96-3188 was prepared by 
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inoculating 60 ml of HIB with a 0.5 ml aliquot of bacterial glycerol stock and grown as described 
above.  Bacteria were pelleted by centrifugation and resuspended in 40 ml of defibrinated 
Sprague-Dawley strain rat blood (Bioreclamation, Jericho, NY) pre-warmed to 37°C.  Artificial 
feeders, each containing approximately 75 O. montana fleas, were prepared according to Eisen et 
al (6) and fleas were allowed to feed for 1 h through mouse skins taken from euthanized, hairless 
SKH-1 mice (specific pathogen-free mouse colony maintained by the Division of Vector-Borne 
Diseases, Fort Collins, CO) on blood infected with 108- 9 CFU ml-1 of Y. pestis CO96-3188.  
Fleas were then examined by light microscopy to determine whether fleas had consumed a 
potentially infectious bloodmeal.  Any fleas which did not feed on infected blood were 
discarded.  Fed fleas were collected and maintained in 30 grams of autoclaved prairie dog 
burrow soil (Boegler, Graham et al. 2012) contained in 25 cm2 tissue culture flasks (Corning, 
Lowell, MA) at their respective treatment temperatures (6°C, 10°C, 15°C, or 23°C). Fleas in 
these flasks were held for incubation in acrylic desiccation chambers (Thermo Scientific, 
Rockford, IL) containing beakers of saturated potassium chloride (KCl) solution to maintain 
relative humidity of 80-85%.  The acrylic desiccation chambers containing the fleas were held in 
the dark within temperature controlled incubators and remained untouched until subsequent 
transmission feeds.  
 
Flea-borne transmission to naïve mice: 
Transmission feeds were performed on days 7, 14, 21, 28, 35*, and 42* (*for 6ºC fleas only) 
post infection (p.i.) using fleas maintained at each temperature to determine the relative 
efficiencies of transmission of infected fleas incubated at low temperatures compared to those 
maintained at 23ºC.  Capsules were affixed to seven 6-8 week-old, naïve, specific pathogen free, 
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CD-1, outbred mice (Charles River Laboratory Inc.,), and pools of ~15 potentially infectious 
fleas were allowed to feed for 1 hour.  Fleas were then collected, and viewed by light microscopy 
to determine fed status as well as the sex of each flea in the pool.  Fleas were stored individually 
in microcentrifuge tubes and placed at -80°C for later analysis to determine infection prevalence 
and bacterial loads.  Exposed mice were held in individually ventilated cages (Tecniplast, 
Philadelphia, PA) at 27ºC and monitored for signs of infection (e.g. ruffled fur, lethargy, 
hunched posture, slow response to stimuli).  At first sign of illness, mice were euthanized and 
later necropsied to detect Y. pestis infection by performing Y. pestis anti-F1 antigen direct 
fluorescent antibody assays (DFA) on liver, spleen, or abscess smears.  Positive transmission 
events were confirmed by specific bacteriophage lysis of bacterial colonies isolated from mouse 
tissues.  In one instance the Y. pestis bacterium could not be recovered from a euthanized mouse, 
which showed signs of illness typical of Y. pestis infection on day 42 p.i. at 6 ºC.  Mice showing 
no signs of infection were held up to 21 days p.i. before being euthanized after blood was taken 
by cardiac puncture from the anesthetized mice for serology testing to identify evidence of 
resolved infections using passive hemagglutination and inhibition tests (PHA/HI) for antibodies 
to Y. pestis F1 antigen.  Animal procedures used in this study were approved by the Centers for 
Disease Control and Prevention, Division of Vector-Borne Diseases, Institutional Animal Care 
and Use Committee (Protocol #09-020 and #14-004). 
Flea infection prevalence and bacterial loads: 
Fleas were homogenized in 100 µL of HIB + 10% glycerol using sterile Teflon pestles and 
plated on SBA medium to determine infection status.  The number of artificially fed fleas that 
were both infected and uninfected and which fed on naïve mice were used in determining the 
infection prevalence of fleas at each time point and incubation temperature.  Bacterial loads of Y. 
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pestis-infected fleas were estimated by serially diluting individual flea lysates and plating them 
on SBA media in duplicate.  Per flea bacterial load estimates were used in calculating the median 
bacterial burden of fleas at each time point and temperature within groups of fleas which fed on 
naïve mice at each time point and temperature tested. 
Measurements of Midgut Peroxide Levels: 
O. montana fleas were artificially fed either an infectious CO96-3188 blood meal (1 × 
108Y. pestis CFU/ml), or uninfected rat blood as previously described.  Fed fleas were collected 
and stored at three respective temperatures.  A total of 10 fleas from each temperature and group 
(infected and uninfected fleas) were individually collected on Days 1, 4. 7, and 10 post infection.  
Each flea was homogenized in 100 µl of phosphate buffered saline (PBS).  Peroxide levels in 
each sample was determined using the Pierce Quantitative Peroxide Assay Kit (ThermoFisher, 
Scientific, Wilmington, DE), which is based on oxidation of ferrous to ferric ion in the presence 
of xylenol orange (Jiang et al. 1991).  Samples were read at 595 nm using a plate reader to 
determine the optical densities.  The data were expressed as the average of ten fleas per 
temperature and time point. 
Statistical Analyses: 
Maximum likelihood estimates for percent per flea transmission rates were calculated by 
using the Microsoft Excel Add-In PooledInfRate v. 4.0 (Ransom and Krueger 1954) for each 
time point at each temperature.  Estimates were based on the number of infected fleas that were 
also determined to have fed on an individual mouse and whether subsequent transmission 
occurred in that mouse.  Pooled percent per flea infection rates were also used to analyze the 
effect of day p.i. as well as temperature on transmission by using a pooled binomial regression 
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algorithm in R (binGroup package, the Comprehensive R Archive Network (CRAN), 
http://cran.r-project.org/web/packages/binGroup/index.html). 
Pooled percent per flea transmission rates for each temperature, total mouse transmission 
rates for each temperature, and bacterial counts were compared using one-way ANOVA.  The 
average bacterial CFU of infected, fed fleas at each time point were compared between 
temperatures using one-way ANOVA. CFU data are comprised of the bacterial loads of all 
infected fleas that fed on an individual naïve mouse for a particular time point and temperature. 
CFU calculations were determined for each group of fleas which fed on mice within a cohort (7 
mice) for each time point at a particular treatment temperature.  The bacterial CFU values to 
which each individual mouse within a cohort was exposed, were then averaged to obtain a single 
CFU value at each time point for all four temperatures.  These averaged CFU values were then 
used in further statistical analyses.  Differences among or between groups were considered 
statistically significant at P < 0.05.  Contingency table analysis was also performed to determine 
differences in transmission efficiencies for each temperature and day p.i.  Wilcoxon/Kruskal-
Wallis tests (rank sums) were used to establish the significance of incubation temperature on i) in 
vitro bacterial viability, ii) average bacterial CFU data, iii) pooled percent per flea transmission 
rate, iv) mouse infection rate, and v) median flea bacterial loads.  All statistical comparisons 
were performed using JMP statistical software (SAS Institute, Cary, NC). 
 
3.3. Results  
Low temperature effects on flea transmission efficiencies: 
Transmission efficiencies of Y. pestis infected fleas held in soil and maintained at different 
experimental temperatures (6°C, 10°C, 15°C, and 23°C) showed no significant differences 
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between the control temperature, 23°C, and the three low temperatures tested for common post-
infection time points among all temperatures, nor for common p.i. time points among the sub-
ambient temperatures (Table 3.1).  Fleas held at 6°C were able to survive in soil longer than all 
other temperatures tested and successfully transmitted to naïve mice at each time point tested out 
to day 42 p.i..  Pooled fleas held at 6°C had the greatest number of successful transmission 
events by infected fleas to naïve mice on each study day p.i., with all seven mice exposed on 
day’s 7, 14, and γ5 p.i., expiring from Y. pestis infection (Table 1).  Pooled fleas maintained at 
10°C and 15°C successfully survived and transmitted out to day 28 p.i., with an overall flea 
survival rate slightly higher at 10°C than 15ºC (data not shown).  Pooled fleas maintained at 
10°C, attained a 100% transmission outcome on day’s 7, 14, and β1 p.i., as well as for 6 of the 7 
mice exposed on day 28 p.i..  Pooled fleas held at 15°C also had comparable success in 
transmission to naïve mice from fleas surviving out to day 28 p.i., with 100% successful 
transmission to all 7 mice exposed on day’s 7 and 14 p.i., and 6 out of 7 mice successfully 
obtaining plague infection on days 21 and 28 p.i. (Table 3.1).  Interestingly, infected fleas held at 
the control temperature (23°C), were only able to survive out to day 11 p.i. when stored in soil 
with no maintenance feeds; however, these fleas had a 100% success rate of transmitting to naïve 
mice on Day 7 p.i..  To estimate the number of infected fleas which fed on a naïve mouse and 
resulted in a successful transmission event, percent per flea transmission efficiencies were 
calculated for each temperature and time point.  Percent per flea transmission efficiencies were 
unable to be calculated for 6°C day’s 7, 14, γ5 p.i., 10°C day’s 7, 14, and β1 p.i., 15°C day’s 7 
and 14 p.i. and 23°C day 7 p.i., because all seven mice tested succumb to infection; therefore 
likelihood calculations are not applicable.  The highest percent per flea transmission efficiency 
(10.85%) for all temperatures, occurred in fleas held at 10°C on day 28 p.i..  Fleas maintained at 
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10°C also transmitted to 27 of the 28 mice tested, suggesting that this temperature falls within 
the optimal range for Y. pestis to survive and successfully transmit to naïve mice among the 
temperatures tested.  The next highest percent per flea transmission efficiency transpired with 
fleas maintained at 6°C, which were able to survive and transmit out to day 42 p.i., resulting in 
100% transmission occurring on days 7, 14, and 35 p.i..  Transmission efficiencies for pooled 
fleas held at 6°C ranged from 2.16-10.35% (Table. 3.1).  Fleas held at 15°C survived out to day 
β8 p.i., and 6 out of the 7 mice on day’s β1 p.i. and β8 p.i., successfully acquired Y. pestis 
infection with the highest percent per flea transmission efficiency on day 21 p.i. (9.82%) (Table 
3.1).  Y. pestis transmission was successfully observed for each challenge day post infection at 
each of the three low temperatures tested, whereas, fleas held at the control temperature (23°C) 
were unable to survive beyond 11 days p.i..  Poor survival at this temperature is likely the result 
of increased activity which in the absence of a maintenance blood meal resulted in rapid 
desiccation of these fleas when compared to fleas maintained in soil at the three lower 
temperatures tested.  Overall flea infection prevalence for each of the four temperatures tested 
and on each day p.i. ranged from 85.7-100%.  The average number of fleas feeding on each of 
seven mice per time point and temperature yielded a range of 12.6-15.0 fed fleas per naïve 
mouse (Table 3.1).  No significant differences in the number of infected fleas that successfully 
took a blood meal from naïve mice were found on any of the challenge days or between 
temperatures (Table 3.1).  Bacterial loads of each of the infected, fed fleas were quantified; 
however, a comparison among all four temperatures could only be performed on day 7 p.i., in 
which the average CFU’s per temperature was significantly lower in the fleas stored at 23°C, 
when compared to the three lower maintenance temperatures tested (6°C, 10°C, and 15°C) (χ 
²=0.0112).  When quantifying bacterial loads for each infected, fed flea on all other day’s p.i. 
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across the three low temperatures, the loads remained consistently high with no significant 
differences found between the average CFUs per flea for each time point p.i. at each of the sub-
ambient temperatures.  Our results indicate that temperature is an influential factor on flea 
survival and bacterial loads in the midgut of the flea when comparing ambient and sub-ambient 
temperatures.  The data reported here on flea survival and bacterial loads relative to temperature 
are consistent with results previously reported by Williams et al. (2013). 
Low temperature effects on reactive oxygen species in flea: 
The reactive oxygen species assay identified significantly increased ROS levels in Y. 
pestis-infected fleas on day 10 post infection (p.i.), in fleas maintained at 23°C (P=0.0014), when 
compared to blood fed only fleas on the same day p.i. and temperature (Figure 3.3).  Across the 
three low temperatures and time points, the Y. pestis-infected O. montana fleas maintained at 
6°C, 10°C and 15°C, had no differences in the ROS levels, as well as, no differences were found 
among Y. pestis-infected O. montana fleas when compared to uninfected blood fed O. montana 
fleas on each temperature and time point p.i. (Figure 3.3).   Bacterial loads of the Y. pestis-
infected fleas, showed no significant difference between temperatures or time points (Figure 
3.4).  Our results indicate that ROS may limit Y. pestis colonization of O. montana fleas at 23°C 




Our study suggests that fleas have a potential role as reservoirs of Y. pestis and the 
maintenance of plague foci or central areas in nature.  Our findings also suggest that the 
temperatures encountered by fleas in their environments can significantly affect this reservoir 
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potential and the ability of infected fleas to survive in off-host environments and then transmit Y. 
pestis to susceptible hosts many days to weeks after they become infected and their original host 
has died of plague.  This current study established the ability of Y. pestis-infected O. montana 
fleas to successfully survive in soil and transmit the plague bacterium to naïve mice up to day 42 
p.i. when maintained at 6ºC without maintenance blood meals.  O. montana is a temperate zone 
flea whose primary host is the California ground squirrel or rock squirrel.  These fleas are 
commonly exposed to ground squirrel burrow temperatures reportedly ranging from 10-15ºC 
during winter months (Belovezhets and Nikol’skii, β01β).  The capability of Y. pestis to survive 
and effectively grow at the lower temperatures tested in our study (6 ºC, 10 ºC, 15 ºC), and the 
pathogen’s ability to persist within the midgut of the O. montana flea, suggests this flea and 
perhaps other flea species, could maintain a Y. pestis infection during the colder months and 
emerge as a viable transmitter during the subsequent transmission season.  Indeed, Golov (1928) 
reported that three species of fleas (Ctenophthalmus breviatus, Ceratophyllus tesquorum and 
Neopsylla setosa) could survive for up to 220 days when held at 14-27C and another species 
(Ct. breviatus) survived for 396 days at 0-15C.  Even more significantly, over half of C.
tesquorum altaicus fed on Y. pestis-infected long-tailed susliks (Spermophilus undulatus) 
became infected and maintained their Y. pestis infections from mid-September to mid-June, a 
period of time sufficient to allow overwintering of the bacterium in its flea vectors and 
transmission by these fleas to susceptible susliks during the next transmission season (Bazanova 
and Maevskii 1996).  Other  studies have demonstrated successful transmission of Y. pestis by X. 
cheopis fleas at temperatures up to 30ºC during the early phase (days 1-4 p.i.) and late phase 
periods (days 7-28 p.i.), however,  transmission of Y. pestis by X. cheopis at lower temperatures 
(e.g. 10C ) was unsuccessful perhaps because this semi-tropical and tropical flea species 
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survives poorly at such low temperatures or because of the overwhelming growth of Y. pestis 
observed in these fleas when they are incubated at low temperatures  (Schotthoefer, Bearden et 
al. 2011).   
Despite the many studies that have examined potential Y. pestis reservoirs to explain 
where this organism resides during inter-epizootic periods, the primary mechanism of survival 
and persistence remains uncertain (Gage and Kosoy 2005, Drancourt, Houhamdi et al. 2006).  
Nonetheless, different hypotheses for Y. pestis survival and maintenance have been proposed by 
numerous researchers, including low-level transmission of the pathogen between enzootic hosts 
and their associated fleas, Y. pestis survival in flea feces, prolonged survival of the pathogen, in 
the soil, persistence in infected and partially resistant rodent hosts, encystment in protozoan 
hosts, or within biofilms associated with soil nematodes (Pollitzer and Meyer 1961, Baltazard, 
Bahmanyar et al. 1963, Mollaret 1963, Darby, Hsu et al. 2002, Pushkareva 2003, Gage and 
Kosoy 2005, Drancourt, Houhamdi et al. 2006, Bizanov and Dobrokhotova 2007, Ayyadurai, 
Houhamdi et al. 2008, Eisen and Gage 2008, Boegler, Graham et al. 2012, Jones, Vetter et al. 
2013).  In studies performed by Mollaret et al. (1963) and Ayyadurai et al. (2008), viable Y. 
pestis was reported to be isolated after surviving months in both non-autoclaved and autoclaved 
soil (Mollaret 1963, Ayyadurai, Houhamdi et al. 2008).  In a fatal human case study in 2008, 
Eisen et al, showed the ability of Y. pestis to remain viable in blood-contaminated soil for at least 
3 weeks (Eisen, Petersen et al. 2008).  In another study in which plague infected animals died, Y. 
pestis was reportedly isolated from carcasses after 11 months in rodent burrows (Karimi, 
Baltazard et al. 1963).  Finally, a study which examined the ability of naïve scarified animals to 
successfully obtain plague infection from Y. pestis-infected soil, showed limited success in 
animals becoming infected after exposure to plague infected soil (Boegler, Graham et al. 2012).  
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In our study, we looked at whether the flea midgut can harbor Y. pestis for extended periods and 
act as a reservoir for this pathogen, particularly at low temperatures.  It has been suggested that 
most fleas spend the majority of their time in the host nest or rodent burrow, rather than on the 
host itself (Benton 1980).  The temperatures used in our study are similar to those previously 
reported for rodent burrows in temperate plague foci as well as foci located at higher elevation in 
tropical regions.  Fleas residing in rodent burrows reside in distinctive and stable environments 
protecting the Y. pestis infected flea from extreme temperature fluctuations, swings in relative 
humidity and other conditions that might negatively affect flea survival through desiccation or 
other factors, thus allowing the pathogen to take advantage of these stable conditions to flourish 
within the flea’s midgut and perhaps persist until the flea takes its next blood meal on a 
susceptible host, thus providing the opportunity to initiate new cycles of flea to rodent to flea 
transmission.  Fleas usually are short lived, however several studies have been found them to 
survive off hosts for several months to more than a year in rodent burrows (Kartman, Prince et 
al. 1958, Bazanova and Maevskii 1996, Bazanova, Voronova et al. 2000)(Golov and Ioff, 
1928)(Sharets et al. 1958).  In our study, we found evidence that temperature plays a role in the 
ability of fleas to survive for extended periods.  Our Y. pestis-infected O. montana fleas housed 
at 6ºC were found to harbor higher bacterial loads and remain capable of successful transmission 
to naïve mice out to day 42 p.i..  In infected fleas maintained at 10ºC and 15ºC, the growth, 
survival and transmission of Y. pestis was still higher when compared to fleas incubated at our 
control temperature (23 ºC) (Table 3.1, Figure 3.1 & 3.2).  Many different variables are capable 
of playing a role in the survival of off-host fleas such as the age and sex of the flea, the flea 
species, infection with Y. pestis, or the availability of hosts to obtain a blood meal.  In our study, 
flea survival may have been extended if maintenance feeds were provided to fleas during the 
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study, as was done in Williams et al. (2013), however, we still observed a trend in which our 
lower temperatures, mimicking burrow temperatures, showed an increase in plague growth, as 
well as, increased flea survival and transmission when compared to fleas maintained in soil at 
23ºC.  Y. pestis survival and growth in fleas maintained at 23ºC was significantly lower when 
compared to the infected fleas maintained at our three lower temperatures; indicating 
temperature contributed significantly to Y. pestis survival and growth within fleas, and may play 
a role in the focality of plague in temperate and tropical locations.  The ability of temperature to 
influence the growth and transmission of Y. pestis in fleas is particularly interesting with respect 
to the focality of plague in the tropics where the disease typically does not occur or only briefly 
invades hot lowland areas and is found primarily in high, relatively cool upland areas.    
In this study, we were able to demonstrate the ability of Y. pestis-infected O. montana 
fleas to successfully maintain infection and transmit Y. pestis to naïve rodent hosts out to day 42 
p.i. when maintained at 6 ºC.  Temperature seems to play a huge role in the growth of the 
bacterium within the flea, as well as the transmission efficiencies to mice.  Flea survival at the 
lower temperatures is also significantly higher when compared to fleas held at 23 ºC.  A previous 
study looking at lower temperatures and the effect on flea transmission found a significant 
increase in transmission efficiencies and growth of Y. pestis when infected fleas were maintained 
at temperatures lower than 23ºC (Williams, Schotthoefer et al. 2013).  In order to determine why 
Y. pestis is better able to survive and be transmitted at these lower temperatures inside the flea 
gut, it is likely that further studies must be performed to examine transcriptional changes that are 
occurring in vivo at these lower temperatures but not at 23C.  Studies examining the 
lipopolysaccharide (LPS) of Y. pestis grown at 6ºC found temperature induced changes in this 
molecule which resulted in a rough LPS structure and a lack of expression, of genes which 
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encode the synthesis of the O-antigen, further allowing Y. pestis to avoid the innate immune 
responses once transmitted from the flea to the naïve rodent host (Suomalainen, Lobo et al. 
2010).  This change in the LPS structure may also play a role in the ability of Y. pestis to survive 
at the lower temperatures within the flea gut, a hypothesis that needs to be further investigated.  
With this current study it is known that temperature plays a pertinent role in Y. pestis survival 
and transmission from the flea to rodent host.  To further elucidate how the Y. pestis 
transcriptional regulation is being altered at sub-ambient temperatures inside the flea, other 
studies must be performed to investigate temperature-related differences in gene expression, as 
well as, several global transcriptional regulators which could play major roles in regulating 
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Table 3.1. Transmission efficiency of infected fleas held in soil at different temperatures 




*For 6°C fleas only.  Fleas held at this particular temperature survived out to day 42 p.i.. 
** Fleas held at 23°C in soil with no maintenance feeds were unable to survive out passed 
day 11 p.i.; therefore, transmission feeds were able to be performed at 7 days p.i.. 
aWhen all pools are positive likelihood methods are not applicable.  Likelihood estimates 


















Average no. fed, 
infected fleas per 






Percent per flea 
transmission 
efficiency (95% CI) 
6* 7 99.0 14.4 (102) 7 (7) (N/A)a 
14 96.0 13.6 (99) 7 (7) (N/A)a 
21 98.1 14.4 (101) 6 (7) 10.35 (4.55-28.72) 
28 98.1 14.4 (101) 5 (7) 8.94 (3.48-22.45) 
35 99.0 14.6 (102) 7 (7) (N/A)a 
42 97.8 13.7 (41) 2 (3) 2.16 (0.14-11.83) 
10 7 92.3 13.7 (104) 7 (7) (N/A)a 
14 92.9 13.0 (98) 7 (7) (N/A)a 
21 100 14.9 (104) 7 (7) (N/A)a 
28 100 15.0 (105) 6 (7) 10.85 (4.77-30.29) 
15 7 85.7 12.9 (105) 7 (7) (N/A)a 
14 100 12.9 (104) 7 (7) (N/A)a 
21 100 15.0 (105) 6 (7) 9.82 (4.36-26.35) 
28 99.0 13.4 (94) 6 (7) 7.47 (2.91-18.91) 
23** 7 88.2 12.6 (97) 7 (7) (N/A)a 
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Figure 3.1. Histogram comparing average Y. pestis CFU per flea (Y axis) for temperatures 6°C, 
10°C, 15°C, and 23°C and across all experimental time points denoted as days post infection (X 
axis).  Sets of bars for each day post infection represent the average of the median CFU per 
infected, fed fleas for all temperatures at that time point. A significant difference in bacterial 



































Figure 3.2. Histogram showing the number of mice that succumbed to Y. pestis infection, or 
were euthanized and confirmed to be infected by Y. pestis by bacteriophage lysis of culture 
isolates from mouse tissues, for each temperature and day post infection.  The X axis denotes 
days on which naïve mice (7 mice were used for each time point and temperature) were 
exposed to infected fleas (infected fleas were obtained from three independent artificial 
infections for each temperature) and the Y axis indicates mouse mortality (dead or euthanized 
mice). Each temperature is denoted by a different block color (figure legend above).  No 
significant difference was found in mouse mortality between temperatures on Days 7, 14, 21 






























Figure 3.3. ROS Assay Average OD in Y. pestis-Infected vs. Uninfected O. montana Fleas  
 
 
Figure 3.3. Histogram comparing the reactive oxygen species (ROS) assay of the average Y. pestis OD of fleas (Y axis)  for 
temperatures 6°C, 10°C, 15°C, and 23°C and across all experimental time points denoted as days post infection (X axis).  Sets of bars 
for each day post infection represent the average of the median OD per ten Yp-infected fleas, compared to ten blood fed fleas, for all 
temperatures at that time point.  Temperatures are divided up by color, blue-6°C, purple-10°C, green-15°C, and red - 23°C.  Solid bars 















*(P= 0.0088) * 









Figure 3.4.  Y. pestis-infected ROS fleas average CFU’s/temperature/day post infection (p.i.)  
 
 
Figure 3.4. Histogram comparing average Y. pestis CFU per flea (Y axis) for temperatures 6°C, 10°C, 15°C, and 23°C and across all 
experimental time points denoted as days post infection (X axis).  Sets of bars for each day post infection represent the average of the 
CFU per infected, fed fleas for all temperatures at that time point. Temperatures are divided up by color, blue-6°C, purple-10°C, 





























Comparative Transcriptomics of Yersinia pestis: A Global View of Low Temperature 




Yersinia pestis, the causative agent of plague, is transmitted to mammals by infected 
fleas.  Y. pestis is maintained within a distinct, closed life cycle encountering many changes in 
temperature and environmental conditions.  Flea vectors are thought to optimally persist at 
temperatures between 21C and 26C however, survival of fleas at temperatures as low as 0C, 
as might be encountered in the burrow of a hibernating rodent, have been reported.  After 
transmission of Y. pestis to a mammalian host, the plague bacillus encounters a temperature shift 
to 37C, inducing the expression of many well described Y. pestis virulence factors that confer 
resistance to host innate immunity.  Gene expression in Y. pestis at a range of temperatures 
equivalent to those encountered in seasonally differentiated rodent burrows has never been 
examined.  Identifying genes and factors which may be differentially expressed by Y. pestis at 
sub-ambient temperatures, may lead to new insights into vector-pathogen interaction and the 
virulence and pathogenesis of the plague pathogen.  In this study, we used RNA-seq to compare 
the transcriptomes of Y. pestis grown at three sub-ambient temperatures (6C, 10C and 15C), 
and found that the transcriptional profiles of Y. pestis at lower temperatures (6º, 10º and 15ºC), 
showed distinct gene expression patterns that varied significantly from those encountered at 
23ºC.  The number of differentially expressed genes (DEGs) for Y. pestis at each of the three 
lower temperatures tended to decrease as temperature increased (6ºC>10ºC>15ºC) relative to the 
ambient control temperature, 23ºC.  When Y. pestis is grown at sub-ambient temperatures (6 °C, 
10°C and 15°C) the largest proportion of the differentially expressed genes (DEGs) were 
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metabolic genes involved in the uptake and catabolism of amino acids and carbohydrates, 
resulting in up-regulation of the phosphotransferase system (manXYZ).  The cyclic AMP receptor 
protein (Crp), was up-regulated at 6 °C, possibly regulating the differential expression of 81 
genes at this growth temperature.  The maltose operons, which include malQPT, malEFG, malK, 
malM and malS, was found to be expressed the highest in Y. pestis grown at 6°C, resulting in the 
mal operon genes being up-regulated by more than 2-fold, a statistically significant difference 
based on logβ fold changes (p < 0.05).  At 6°C and 10°C, the LPS core biosynthesis protein 
CoaD was up-regulated.  By contrast, the genes involved in the inner core biosynthesis, waaE, 
waaA and kbl were down-regulated potentially leading to an alternate LPS-type from that 
produced by Y. pestis at 23°C.  Low temperature also played a role in the differential expression 
of Y. pestis outer membrane proteins (OMPs), as well as differential expression of an important 
adhesion and virulence gene, yadB, which was up-regulated at 6ºC and 10ºC, and is required for 
its role in bubonic plague pathogenesis.  Our results suggest that Y. pes is growth at sub-ambient 
temperatures may play an important role in survivability and an expanded role in preparing the 
bacterium for pathogenesis within the mammalian host as has been suggested for Y. pestis during 
its transit through the flea. 
 
4.1. Introduction 
Yersinia pestis is the etiologic agent of plague.  Plague is a rodent associated, flea-borne 
disease and responsible for emaciating human populations as a result of three large pandemics.  
Fleas are thought to acquire Y. pestis by feeding on plague infected mammals.  The bacterium 
multiplies rapidly and forms masses within the flea gut at 26°C.  Once the pathogen has been 
ingested by the flea, Y. pestis must adapt to the temperature shift (26°C), coming from a 
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mammalian host (37°C).  To successfully adapt to changes in temperature, the bacterium must 
also adapt to changes such as nutrient requirements, enzyme activity, caspsule formation (37°C), 
and pigmentation production (Jackson and Burrows 1956, Tengerdy and Hillam 1973, Alonso, 
Hurtrel et al. 1982, Lindler, Klempner et al. 1990, Pendrak and Perry 1991).  In addition, 
differential gene expression at these two temperatures may allow the bacterium to colonize its 
host efficiently, leading to commensalism or pathogenesis.  More recently, studies have shown 
that Y. pestis transmits more efficiently to mammalian hosts and the bacterium replicates to 
higher levels in temperatures lower than 26°C (Williams, Schotthoefer et al. 2013).  A study 
examining temperatures of rodent burrows during the winter months, found that Y. pestis-
infected fleas had significantly higher bacterial loads then fleas maintained at 23°C.  
Furthermore, this study examined Y. pestis-infected fleas maintained at three sub-ambient 
temperatures (6°C, 10°C, and 15°C), and compared them to fleas maintained at 23°C.  
Surprisingly, fleas maintained at the three lower temperatures had higher transmission to rodent 
hosts and the lower the temperature, the better the flea survivability (Williams, Schotthoefer et 
al. 2013).  Other studies in the past years have discovered many temperature-regulated virulence 
determinants (Straley and Perry 1995).  With the completion of the annotated genome of Y. 
pestis CO92, studies comparing different Y. pestis strains, serotypes, and biovars, as well as its 
ancestor Y. pseudotuberculosis by DNA microarray were performed in order to compare 
different strains as well as determine the evolutionary genomic analysis (Parkhill, Wren et al. 
2001).  Subsequently, a study examining the transcriptional regulation of Y. pestis upon the 
increase of growth temperature from 26°C to 37°C in a chemically defined medium was 
performed and found that Y. pestis has the ability to extensively alter gene regulation in each 
environment (Han, Zhou et al. 2004).  At the time, DNA microarray offered a tool for genome-
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wide analysis of gene regulation at the transcriptional level (Kendall, Movahedzadeh et al. 2002).  
Currently, next-generation sequencing (NGS), is the state of the art technology in assessing the 
quantification of transcript levels as well as sequence information.  Since microarray technology 
is limited to the amount of starting RNA, the quantification of transcript levels and the need for 
prior knowledge of sequence information, NGS has become the gold standard in transcriptome 
analysis.  In this study, NGS was used to investigate whole transcriptomes of Y. pestis at lower 
temperatures (6°C, 10°C and 15°C compared to 23°C).  This novel study will assess whether 
rodent burrow hibernation temperatures affect gene regulation, and determine the global 
transcriptional response to low temperature shifts; which could potentially lead to better survival 
or increased virulence.  This data will provide a genome wide profile of gene transcription 
induced by low temperature shifts and will shed light on pathogenicity and host-microbe 
interaction of this deadly pathogen. 
 
4.2. Materials and Methods 
Bacterial strain, growth condition and preparation of bacterial pellet 
 
A fully virulent Yersinia pestis CO96 strain was grown statically in Bacto Heart Infusion broth 
(Difco Laboratories) at 6°C, 10°C, 15°C, or 23°C for 3 days in duplicate, then concentrated by 
centrifugation at 12,000 x g for 10 minutes.  Pellets were stored at -80°C after each culture was 
subjected to RNAlater® stabilizing reagent (Ambion) was added prior to freezing. 
RNA extraction  
 
Bacterial pellets were thawed on ice and homogenized in Lysis/Binding Solutions 
(Ambion).  Each sample was further submitted to mechanical disruption using frozen pestles to 
lyse cells, followed by vortexing of each sample.  The total RNA was isolated using the 
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RNAqueous Kit, according to the manufacturer’s recommendations.  RNA samples were eluted 
with RNase/DNase free water and yields were determined using the NanoDrop 2000 
Spectrophotometer (ThermoFisher, Wilmington, DE).  TURBO DNase was used to treat each 
sample to remove any contaminating genomic (Ambion).   Additionally, the RNA integrity was 
checked on the Agilent Bioanalyzer using the Agilent RNA 6000 Kit (Agilent Technologies, 
Inc., Santa Clara, CA).  Total extracted RNAs preparations were stored at -80°C until further use. 
rRNA depletion 
 
Ribosomal RNA depletion was performed on each Total RNA sample using the 
RiboMinus™ Transcriptome Isolation Kit (Invitrogen), 6 mg of total RNA were loaded and 
treated according to the manufacturer’s recommendations.  Each RiboMinus-depleted sample 
was eluted in RNase/DNase free water and further analyzed using the Agilent Bioanalyzer, 
Agilent RNA 6000 Kit (Agilent Technologies, Inc., Santa Clara, CA).  All depleted RNA 
samples were stored at -80°C prior to further manipulations. 
RNA-seq Library Construction 
 
For RNA-sequencing, rRNA-depleted samples were used for cDNA library preparations 
using the Ion Total RNA-Seq Kit v2 (ThermoFisher, Wilmington, DE).  Briefly, 10-500 ng of 
ribo-depleted RNA was fragmented using RNase III for 4 minutes.   Each fragmented RNA 
sample was purified using the Magnetic Bead Clean-up Module (ThermoFisher Scientific) and 
yield and size distributions of each samples were assessed using the Agilent 2100 Bioanalyzer, 
Agilent RNA 6000 Kit (Agilent Technologies, Inc., Santa Clara, CA).  Fragmented RNA was 
then used to further construct the whole transcriptome library by hybridization and ligation of 
specific primers to each sample (Ion adaptor mix, (ThermoFisher, Wilmington, DE).  Next, 
reverse transcription was performed using 10X SuperScript III Enzyme (ThermFisher Scientific), 
195 
 
on each ligated RNA sample.  The resulting cDNA samples were purified using the Magnetic 
Bead Clean-up Module (ThermoFisher Scientific) and yield and size distributions of each 
samples were assessed using the Agilent 2100 Bioanalyzer, Agilent High Sensitivity DNA Kit 
(Agilent Technologies, Inc.).  The cDNA was further amplified and purified using the Magnetic 
Bead Clean-up Module (ThermoFisher, Wilmington, DE).  ach amplified cDNA sample’s yield 
and size distribution were assessed using the Agilent 2100 Bioanalyzer using the Agilent High 
Sensitivity DNA Kit (Agilent Technologies, Inc., Santa Clara, CA).  Using the Agilent 2100 
Bioanalzyer (Agilent Technologies, Inc.) smear analyses were performed to quantify the 
percentage of DNA that ranges in size from 50-160bp.  Molar concentrations were then 
determined for each cDNA library using the size range from 50-1000 bp.  After the smear 
analyses were performed and if the percentage of DNA in the 50-160 bp range is <50%; then 
determination of the library dilution factor could be completed which is required for template 
preparation.  With less than 50% of the amplified DNA in the correct range, and for template 
preparation using the Ion PGM Template OT2 400 kit, or the Ion Hi-Q OT2 kit, library dilutions 
that give a concentration of 100 pM are required.  (Ion Total RNA-Seq Kit v2 for Whole 
Transcriptome Libraries, (ThermoFisher, Wilmington, DE). 
Ion Torrent Template Preparation and PGM sequencing 
 
Diluted libraries were used as template for an emulsion PCR (emPCR) using reagent 
from either the Ion PGM OT2 400 Template Kit or Ion PGM Hi-Q Template kit (ThermoFisher 
Scientific).  In brief, the DNA fragments were bonded onto spheres Ion Sphere™ particles (ISPs) 
and then amplified using the Ion OneTouch 2 Instrument (ThermoFisher, Wilmington, DE).  
Following the amplification, the emulsion was broken with successive washes using the Ion 
OneTouch ES instrument (ThermoFisher Scientific), and the spheres without template were 
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removed using the Dynabeads® MyOne™ Streptavidin C1 Magnetic Beads (ThermoFisher, 
Wilmington, DE).  Next, the enriched ISP’s which contain only template-positive ISP’s were 
then mixed with Control Ion Sphere Particles (Ion PGM Hi-Q Sequencing Kit (ThermoFisher, 
Wilmington, DE).  Next, sequencing primers were added to the ISP’s mixture and placed in a 
thermocycler for 95°C for 2 minutes and then 37°C for 2 minutes to anneal the primers.  
Sequencing polymerase enzyme was added to the ISP mix and incubated for 5 minutes and room 
temperature.  The resulting mixture was loaded on the Ion γ18™ Chip for sequencing using the 
Ion Torrent Personal Genome Machine™ (PGM) (ThermoFisher, Wilmington, DE). 
Bioinformatic analysis 
 
All RNA-seq fastq data output files collected from the results of Y. pestis at 6°C, 10°C, 
15°C and 23°C were aggregated and sent to the IDCR Bioinformatics Core for downstream 
bioinformatic analysis.  Bioinformatic analyses were performed using Strand NGS software, 
Version 2.1, Build 163982 (Strand Scientific Intelligence, Inc., San Francisco, CA, USA).  To 
begin, the quality control manager and preprocessing of each sample were assessed by removal 
of low quality bases (<Q20), rRNA sequences, adapter sequences, and short reads (<35bp).  
Next, RNA-seq bioinformatics analyses were applied to each sample by aligning the 
trimmed/filtered samples to the proper reference genome, Y. pestis CO92 (RefSeq genome 
NZ_CP009973.1) using the Strand NGS aligner, which uses a proprietary algorithm based on the 
Burrows Wheeler Transform.  This aligner is significant because the aligner algorithm is capable 
of handling both short reads and long reads as well as allowing an arbitrary number of gaps and 
mismatches within the reads (Strand NGS Manual, Version 2.0, San Francisco, CA).   Next, 
DESeq was integrated into the analysis tools for multi-conditional batch processing and used for 
normalization and differential analysis to produce classical statistical analysis (Z-scores and fold 
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changes) (Anders and Huber, 2010).  Pathway and gene ontology analysis were performed and 
enabled comprehensive cross-comparisons of the genomic or proteomic data to identify key 
pathway/GO perturbations and underlying mechanistic regulatory points.  A subset of the 
complete array of genes that map to the analyzed pathways and gene ontology groups are used in 
the analysis.  Strand NGS provided the analyses and modeling results by a secure web-based 
analyses reporting system which will result in two excel files containing log2 fold change values 
and p-values that have been adjusted for multiple testing for each gene that was mapped. 
Quantitative Real-Time PCR (qRT-PCR) Validation 
A quantitative RT-PCR assay was designed to target genes that were both upregulated 
and downregulated in order to ensure the integrity of the PGM sequencing results.  To validate 
our NGS transcriptome results, differentially expressed genes (DEGs) of Y. pestis were selected 
for qRT-PCR analysis from each temperature (6C, 10C and 15C).  Genes that are highly 
downregulated or highly upregulated at the different temperatures were tested and compared to 
NGS fold change values to verify gene expression patterns are credible before subsequent studies 
are conducted.  Briefly, primers were designed for each selected differentially expressed gene 
(DEG).  Primers were designed using Primer Express Software, v3.0 (Applied Biosystems, CA), 
and purchased from the Biotechnology Core Facility Integrated (DSR, Atlanta, GA).  Real-time 
efficiency for each primer set were determined by amplification of a standardized cDNA dilution 
series, and specificity of the amplified PCR products were verified by melting curve analyses.  
Each real-time quantitative PCR reaction was performed using the CFX Connect™ Real-Time 
PCR Detection System (Bio-RAD).  Briefly, RNA was isolated and prepared in duplicate from 
Y. pestis grown at 6°C, 10°C, and 15°C as described above.  To avoid contamination with DNA, 
samples were treated with Turbo DNA-free DNase I (ThermoFisher Scientific, Wilmington, 
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DE).  Next, each RNA sample subjected for qRT-PCR was reverse transcribed to synthesize 
cDNA in 20 μl reactions according to the manufacturer’s protocols using the MultiScribe™ 
Reverse Transcriptase (Applied Biosystems, CA).  A control reaction lacking reverse 
transcriptase was performed for each primer set using total RNA to ensure samples are not 
contaminated with DNA.  Next, cDNAs were used as templates for qPCR using Power SYBR 
Green PCR master mix (PE Applied Biosysthems) and gene-specific primers (0.5 μM).  Next, 
cDNA amplification was performed in β0 μl volumes for each reaction.  Template and no-
template controls were used for each primer set.  All sample results were normalized against the 
expression level of the proS gene, which is constitutively expressed and not found to be 
differentially expressed at different growth temperatures used in this study. All reactions were 
assayed in triplicate, and the average Ct value were used to quantify the relative level of 
expression.  Replicate raw data (threshold cycle number, or Ct) for each sample was averaged 
and then adjusted by comparing to the corresponding averaged Ct for the endogenous control 
gene to correct for any differences in the starting quantity of the material.  Relative quantification 
using comparative Ct analyses were performed using the CFX Manager™ software (Bio-Rad), 
and relative expression levels across samples were performed using the comparative Ct method 
(ΔΔCt) (Livak and Schmittgen 2001).  The qRT-PCR relative expression (fold change) ratios 
were compared to the RNA-seq DESeq fold changes to test for accuracy of the RNA-seq 







4.3. Results  
Transcriptional profile of Y. pestis at sub-ambient temperatures: 
The transcriptional profiles of Y. pestis at low temperatures, mimicking the burrow 
temperatures (6º, 10º and 15ºC) of rodents including those in hibernation, showed very distinct 
transcriptional profiles.  The number of differentially expressed genes (DEGs) for Y. pestis at 
each of the three lower temperatures were compared to the ambient control temperature, 23ºC 
(Figures 1 and 3.).  Among 4,012 genes of Y. pestis CO92, of which 192 are pseudogenes 
(Parkhill, 2011), transcript abundances were the most differentially altered for Y. pestis grown at 
6ºC, in which 1375 genes were either up- or down-regulated.  Out of the 1375 DEGs for Y. pestis 
at 6ºC, 656 (48%) genes were up-regulated and 719 (52%) genes were down-regulated (Figure 
4.1.).  Y. pestis grown at 10º was found to have the second highest number of genes (1218) 
differentially expressed.  Of these 1218 genes showing differential expression, 655 (54%) were 
up-regulated, and 563 (46%) were down-regulated (Figure 4.1).  Y  pestis grown at 15ºC, resulted 
in the fewest number of differentially expressed genes compared to Y. pestis grown at ambient 
temperature.  A total of 968 genes were differentially expressed at 15ºC, of which 442 (46%) 
genes were found to be up-regulated, and 526 (54%) were down-regulated (Figure 4.1.).  Based 
on log2 fold changes (p < 0.05), transcript levels for 465 Y. pestis genes expressed at 6C, 
changed more than 2-fold relative to those expressed at the control temperature of 23C.  Next, 
Y. pestis grown at 10C yielded 409 genes whose transcript levels changed more than 2-fold 
based on log2 fold changes (p < 0.05), and for Y. pestis grown at 15C, only 210 genes were 





Transcriptional control by global regulators: 
Crp: 
 In our study, Y. pestis grown at 6C showed a 3.1-fold up-regulation of the cyclic AMP 
receptor protein (Crp).  Crp is an important transcriptional regulator that plays a role in bacterial 
survival and virulence.  In Y. pestis, Crp controls the expression of at least 214 known bacterial 
genes by a process known as catabolite repression, which typically occurs in response to 
environmental cues by sensing carbon availability (Busby and Ebright 1999, Zhan, Han et al. 
2008).  Of the 214 known Y. pestis genes that are regulated by Crp at mammalian temperatures, 
we identified 81 genes which exhibited up or down gene expression in response to growth at 6C 
(Table 4.1).  In addition, Hfq, which is a small RNA (sRNA) chaperone protein involved in 
posttranscriptional regulation, was found to be up-regulated (2.6-fold) at 6C.  Interestingly, 
neither crp or hfq were found to be up- or down-regulated at 10C or 15C relative to 23C.  
Also regulated by Crp, is the maltose (mal) regulon, which was found to be up-regulated when Y. 
pestis was grown during 6C but not at 10ºC or 15ºC.  The mal operon, which includes malQPT 
and malEFG were up-regulated by more than 2-fold (range, 2.5-3.8), based on log2 fold changes 
(p < 0.05) in Y. pestis at 6C (Table 4.1).  The maltose operon encodes genes important for the 
uptake and metabolism of maltose, as well as enzymes that play a role in the conversion of 
maltose into glucose and glucose α-1- phosphate (Boos, Ferenci et al. 1981, Boos and Shuman 
1998).  The most highly up-regulated genes in Y. pestis grown at 6C (ranging from 4.9-7.2 fold, 
based on log2 fold changes (p < 0.05), were the gal genes, comprising the galactose operon, 
which are known to be regulated by Crp, and recognized as playing a role in cell wall biogenesis, 
and commonly found in the LPS structure of Y. pestis at lower growth temperatures (Table 4.2) 
(Knirel and Anisimov 2012).  As was determined for the mal operon genes, the gal operon was 
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not found to be up-regulated in Y. pestis at 10C or 15C.  The csrA gene encoding a carbon 
storage regulator (CSR) homolog was found to be up-regulated at Y. pestis grown at 6C and 
10C, and is part of the CSR system, necessary for glycogen metabolism and gluconeogenesis 
(Table 4.5).  In addition, Crp-mediated expression of csrA is required for biofilm formation 
independent of glycogen metabolism (Willias, Chauhan et al. 2015).  Other genes found to be 
up-regulated by Crp in response to growth temperatures at 6C, included the deoABCD genes, 
which are important in amino acid metabolism and transport, and the glucose phosphotransferase 
(PTS) system which includes the mannose operon (ma XYZ) and the N-acetylglucosamine 
operon (nagABCE) with fold change ranging from 3.1-15.6 (p < 0.05) (Table 4.1).  Although 
inactive in Y. pestis epidemic strains, the Crp-regulated zwf gene, encoding glucose-6-phosphate 
dehydrogenase, showed increased expression at 6C.  Energy production genes of Y. pestis that 
are known to be regulated by Crp (aceEF, atpI, adhE, epd, focA, pflA, ducA, lpdA, nirB) also 
were significantly up-regulated (2.1-7.4 fold) at 6C, suggesting an increased requirement in 
expression of genes involved in the ATP-proton motive force and oxidative phosphorylation 
pathways of Y. pestis (Table 4.1).  Lipid biosynthesis (fadDH) and transport (lipB) genes, were 
found to be down-regulated by Crp in Y. pestis at 6C.  The universal stress response gene, uspA, 
altered by Crp was also down-regulated (3-fold) in Y. pestis at 6C. 
PhoP: 
The transcriptional regulator gene phoP of the PhoPQ two-component regulatory system 
and the PhoP-regulated mgtC gene were expressed at levels >2-fold higher in Y. pestis grown at 
6C when compared to Y. pestis grown at 10C, but no difference in expression of either gene 
was found between Y. pestis grown at 6C and expression at bacterial growth during 15C and 
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23C (data not shown).  It has been previously determined that PhoP and MgtC are known 
virulence factors necessary for survival of Y. pestis and other Gram-negative bacteria in 
macrophages, as well as for resistance to cationic antimicrobial peptides (CAMPs) of the 
mammalian innate immune response (Vadyvaloo, Jarrett et al. 2010).  The expression of phoQ 
was found to be down-regulated in Y. pestis at sub-ambient temperatures when compared to 
pathogen growth at 23C (data not shown). 
The autoinducer-2 (AI-2) quorum-sensing system: 
The autoinducer-2 (AI-2) quorum-sensing system has been linked to diverse phenotypes 
and regulatory changes in Y. pestis bacteria.  Quorum sensing (QS) is a process of cell-to-cell 
communication that relies upon secretion and detection of chemical signals called autoinducers 
(AIs). Yersinia pestis possesses two conserved QS systems, the AI-1 pathway, which utilizes 
acyl homoserine lactones (AHLs) as signaling molecules, and the LuxS or AI-2 pathway, which 
uses a furanone autoinducer (Bobrov, Bearden et al. 2007).  The AI-2 signaling pathway is 
commonly found in to many bacteria as homologues of the luxS gene.  LuxS has two main 
functions, to generate the major methyl donor S-adenosylmethionine, and to detoxify S-adenosyl-
l-homocysteine to homocysteine and 4,5-dihydroxy-2,3-pentandione (DPD), which yields AI-2 
(Chen, Schauder et al. 2002).  In our study, we found the luxS gene was up-regulated in Y. pestis 
when grown at 6C (2.5 fold) and 10C (2.8 fold).  No change was detected in the luxS gene in Y. 
pestis grown at 15C compared to Y. pestis grown at 23C.  Neither the ypsIR nor the ytbIR gene 
pairs of the two AHL quorum sensing systems in Y. pestis, were found to be up- or down-






The lipopolysaccharide (LPS) of Y. pestis plays a significant role in resistance to host 
complement, antibiotics and and other host defense mechanisms and is considered an important 
virulence factor of Y. pestis.  As in other Enterobacteriacae, LPS is a major component of the 
outer membrane of the Y. pestis cell wall and forms the outer layer of the LPS-phospholipid 
bilayer.  In our study, we found that coaD, which encodes a LPS core biosynthesis protein, was 
up-regulated at 6C and 10C, and waaE, waaA and kbl, which are essential genes for the 
synthesis of the inner core were down-regulated at 6C and 10C, and waaE and kbl were down-
regulated at 15C.  In addition, YPO0415 was found to be up-regulated in Y. pestis grown at 6C, 
10C and 15C and encodes a putative carbohydrate kinase necessary for LPS core synthesis, as 
well as the late stages of lipid A biosynthesis (Table 4.3).  The LPS heptosyltransferase genes 
waaC and waaQ were up-regulated in Y. pestis grown at 15C compared to Y. pestis expression 
at 6C, 10C and 23C (Table 4.3). 
Outer Membrane Proteins (OMPs): 
 Y. pestis is richly endowed with proteins in its outer membrane (OMPs).  Many of the 
OMPs of Y. pestis have been associated with pathogenicity and evasion of the host immune 
response including resistance to complement and antibacterial peptides as well as invasion and 
survival within mammalian cells (Weiser and Gotschlich 1991, Weiser and Gotschlich 1991, 
Prasadarao, Wass et al. 1996, Fu, Belaaouaj et al. 2003, Llobet, March et al. 2009).  In our study, 
we found that Y. pestis grown at 6C had increased gene expression of the transcriptional 
regulators, ompR and ompF, in addition to up-regulation of the outer membrane protein genes 
ompA and ompX and the chaperone-encoding gene ompH.  When the pathogen was grown at 
10C, increased gene expression of the two transcriptional regulatory proteins, mpR, ompF, and 
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ompH were observed.  Y. pestis grown at 6C and 10C showed down-regulation of the outer 
membrane protein C gene, ompC.  When Y. pestis was grown at 15C, no changes in gene 
expression related to OMPs were found in comparison to Y. pestis grown at 23C (Table 4.4). 
Yersinia pestis metabolic adaption to growth at low temperatures: 
The majority of the differentially expressed genes (DEGs) in Y. pestis at lower 
temperatures were those related to metabolism involved in the uptake and catabolism of amino 
acids and carbohydrates (Table 4.5).  In particular, genes involved in transport and catabolism of 
the L-glutamate group of amino acids, arginine (argC), histidine (hutIG).  The degradation of 
these amino acids gives rise to L-glutamate and the TCA cycle intermediates succinate, formate, 
and α-ketoglutarate.   Additionally, the ABC-transport gene metN, involved in methionine uptake 
was up-regulated in Y. pestis at 6C, 10C and 15C were upregulated in Y. pestis (Table 4.5).  
The hydroxyphenylacetate (HPA) transport gene (hpaX) of Y. pestis, was up-regulated at the 
three lower temperatures (6C, 10C and 15C) with concomitant down-regulation of the HPA 
catabolic  genes (hpaBCI) at sub-ambient temperatures when compared to Y. pestis at 23C 
(Table 5.).  Expression of the glucose phosphotransferase system (PTS) genes, manXYZ, was 
significantly increased in Y. pestis grown at the three sub-ambient temperatures relative to Y. 
pestis grown at 23C.  Significant down-regulation of the actP (6C and 10C ), and acs (only at 
6C) genes, representing uptake of acetate and its conversion to acetyl-CoA, respectively, 
suggests that other mechanisms are being utilized at the lower temperatures of 6ºC and 10ºC to 
provide sufficient amounts of acetyl-CoA in order to potentiate the TCA cycle.  The uxaA and 
uxaC genes encoding altronate hydrolase and glucouronate isomerase, respectively, involved in 
pentose and glucuronate interconversion, were up-regulated in Y. pestis grown at 6C, 10C and 
15C when compared to Y. pestis at our control temperature (Table 4.5).  We also found that 
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genes necessary for respiration were significantly up-regulated (hydN and dmsA) in Y. pestis 
grown at 6C, 10C and 15C as were those required for oxidative phosphorylation 
(atpABDFHI) in Y. pestis grown at 6C (Table 4.5).  Other genes that were up-regulated in Y. 
pestis at all three sub-ambient temperatures included lipid metabolism genes, fadB and cdh, 
though accBD and acpD only showed increased expression at 6C (Table 4.5).  Specific fatty 
acid degradation genes (fadHDE), also were up-regulated in Y. pestis at all three lower 
temperatures when compared to 23C (Table 4.5). 
Differential expression of Y. pestis pathogenesis-related genes: 
 Y. pestis contains many temperature-induced virulence factors, such as the iron 
acquisition systems, (ybt,yfe and yfu operons), and the oxidative and nitrosative stress response 
genes (radC,  hmp), all of which contribute plague infection, and in this study, these genes were 
found to be down-regulated or exhibited no change in regulation when Y. pestis was grown at the 
sub-ambient temperatures.  The Y. pestis F1 capsular antigen genes (caf1M, caf1A), were down-
regulated at Y. pestis grown at 6C, 10C and 15C, expected since the F1 antigen is only 
expressed at temperatures >33C as would be encountered within the mammalian host and 
essential for virulence and evasion of the host immune system.  Interestingly, the Y. pestis outer 
surface protein gene yadB, which is required for dissemination of Y. pestis from a subcutaneous 
inoculation site, specifically enhancing bubonic plague pathogenesis (Forman, 2008), was up-
regulated in Y. pestis at 6C (5.1-fold) and 10C (3.5-fold) (Table 4.5).  Other known virulence 
and transmission factors were not found to be differentially regulated in Y. pestis grown at the 
low temperatures when compared to pathogen growth at ambient temperatures, including the 
hms genes, necessary for biofilm formation within the flea, the Y. pestis plasminogen activator 
(pla), critical for dissemination from extravascular tissue at the fleabite site, and ymt, which is 
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necessary for bacterial survival in the flea vector.  Up-regulation of the universal stress response 
gene B (uspB) was found in Y. pestis grown at 10C (9.8-fold) and 15C (6.4-fold), when 
compared to 23C, and the universal stress response gene A (uspA) was up-regulated at 10C 
(2.2-fold) and 15C (2.1-fold), but was down-regulated at 6C (-3-fold) (Table 4.5). 
Validation of NGS sequencing results by qRT-PCR: 
Quantitative reverse transcription-PCR confirmation was performed to further validate 
the NGS RNA-seq results.  Target genes were selected by choosing genes which fell into one of 
the following criteria: most highly-upregulated, highly down-regulated, virulence gene, or 
involved in regulation of virulence genes.  All sample results were normalized against the 
expression level of the proS gene which encodes a proline tRNA ligase.  For the qRT-PCR 
samples, the average Ct values were used to quantify the relative level of expression ratios (fold 
change), and compared to the RNA-seq differentially expressed gene fold changes to test for 
accuracy of the RNA-seq sequencing results.  Genes identified as being up-or down-regulated by 
NGS, were further validated by our qRT-PCR results (Figure 4.2).  For each temperature, the 
Pearson correlation coefficient was used to measure the strength of a linear association between 
the qRT-PCR results and the NGS results.  All temperatures showed a high association between 
the qRT-PCR fold changes, and the fold changes identified by NGS (all r values >0.900).  Y. 
pestis primer sets can be found in Table 4.6. 
 
4.4. Discussion 
Y. pestis is a highly adaptive organism that inhabits different ecological niches as it 
cycles between arthropod vector and mammalian hosts and surviving under different, 
occasionally extreme, environmental conditions.  The pathogenic lifestyle of Y. pestis, requires 
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strict control of virulence and general stress response genes.  In the plague pathogen, the crp 
gene is found to be responsible for regulation of multiple virulence factors, including 
components of the type III secretion system (T3SS) and the plasminogen activator Pla (Lathem, 
Schroeder et al. 2014).  It was previously demonstrated Y. pestis crp is positively regulated at the 
posttranscriptional level by the activity of the small-RNA (sRNA) chaperone, Hfq (Lathem, 
Price et al. 2007).  The posttranscriptional activation of Crp was found to be necessary for 
expression of Pla in Y. pestis, and both Hfq and Crp are known to contribute immensely in the 
virulence of Y. pestis specifically during pneumonic plague infections (Lathem, Price et al. 2007, 
Lathem, Schroeder et al. 2014).  Binding of Hfq to mRNA transcripts, results in either enhanced 
transcript stabilization or promotion of transcript degradation.  In Salmonella Typhimurium, Hfq 
has been found to be responsible for controlling multiple metabolic pathways such as the purine 
and pyrimidine metabolism pathways, glycolysis/gluconeogenesis, pyruvate metabolism, the 
TCA cycle, and amino-acyl tRNA biosynthesis; whether Hfq plays the same role in the 
regulation of these metabolic pathways in Y. pestis is uncertain (Sittka, Pfeiffer et al. 2007, 
Sittka, Lucchini et al. 2008, Ansong, Yoon et al. 2009, Geng, Song et al. 2009, Sittka, Sharma et 
al. 2009, Bai, Golubov et al. 2010, Schiano, Bellows et al. 2010, Ansong, Deatherage et al. 2013, 
Kakoschke, Kakoschke et al. 2014).  It is known however, that Hfq along with sRNAs, 
contribute to heightened virulence in Y. pestis, and have been implicated in the 
posttranscriptional regulation of the T3SS/Yop machinery in Y. pestis and Y. pseudotuberculosis. 
(Geng, Song et al. 2009, Schiano, Bellows et al. 2010, Schiano, Koo et al. 2014).  Studies have 
found that the loss of both Crp and Hfq, resulted in attenuation of Y. pestis, further validating the 
importance of these two genes in virulence as well as the ability to adapt to different nutritional 
conditions (Zhan, Han et al. 2008).  Since the Y. pestis crp gene is responsible for direct 
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transcriptional regulation of pla, loss of the Crp gene leads to reduced virulence of Y. pestis in 
the mammalian host and the inability of the bacterium to disseminate from the flea bite or 
inoculation site (Zhan, Han et al. 2008, Lathem, Schroeder et al. 2014).  In the current study, 
there is ample evidence of Crp’s regulatory function even at sub-ambient temperatures.  Y. pestis 
grown at 6C, resulted in the altered expression of 81 genes, known to be controlled by the Y. 
pestis crp gene product.  In our previous studies, Y. pestis-infected-Oropsylla montana fleas 
maintained at sub-ambient temperatures (6C, 10C and 15C), found that infected fleas 
maintained at 6C, had higher bacterial loads and demonstrated increased transmission to naive 
mice when compared to the Y. pestis-infected O. montana fleas maintained at 23C (Williams et 
al., 2013).  From differential gene expression analysis performed in this study, it would be of 
interest to determine the role of Crp and its influence on the survival of the pathogen in the flea 
gut at 6C and subsequent transmissibility to mammalian hosts.  Other studies have already 
demonstrated that Hfq positively regulates crp in Y. pestis at the posttranscriptional level, and 
both of these genes were found to be up-regulated in this study when Y. p stis was grown at 6C.  
Determining how the altered expression of the Crp-regulated genes at 6C ffects pathogen 
fitness and virulence would be of value.  For example, Y. pestis grown at 6C, resulted in up-
regulation of the crp gene with concomitant up-regulation of the galactose operon (galETKM).  
Previous studies have found that when Y. pestis is grown at temperatures as low at 6C, galactose 
can get incorporated into the LPS core oligosaccharide structure (Knirel and Anisimov 2012).   
Y. pestis galactose-containing LPS potentially could lead to increased virulence by further 
enhancing evasion of host innate immunity.  Further studies could better elucidate the 
importance of the galactose operon at lower growth temperatures, and the significance of 
galactose incorporation into the LPS of Y. pestis at sub-ambient temperatures.  Orthologous gal 
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genes have been identified in Escherichia coli, Neisseria gonorrhoeae, Rhizobium meliloti, 
Erwinia amylovora and other Gram-negative bacteria (Metzger, Sawyer et al. 1993).  In a study 
examining the importance of the galactose operon in E. amylovora, the pathogen responsible for 
the necrotic disease, fire blight, in rosaceous plants, found that the gal operon is constitutively 
expressed independent of galactose concentration in the growth medium or environment.  This 
study found that the galE gene is essential for virulence of E. amylovora pathogen, whereas galT 
and galK were not (Metzger, Sawyer et al. 1993).  In addition, this study looked at the effects of 
a gal operon mutation on the incorporation of LPS O-antigen side chains and determined that 
this mutant elicited O-antigen side chain incorporation effects, but an intact O-antigen was not 
needed for successful virulence of the pathogen (Metzger, Sawyer et al. 1993).  Similarly, 
Metzger et al, also demonstration that disruption of galactose metabolism affected capsule 
synthesis and virulence of E. amylovora, which were restored if galactose was added to the 
growth medium (Metzger, Sawyer et al. 1993).  Galactose in Y. pestis is utilized by the LeLoir 
pathway, and the pathogen encodes the structural genes alK, galT, galE, which are organized in 
an operon induced by galactose.  In Y. pestis, two gal promoters, which are modulated by the 
cyclic AMP (cAMP) receptor protein complex, and one gal repressor are encoded on the operon 
and essential for controlling regulation of the galactose operon (Cornwell, Adhya et al. 1987, 
Majumdar and Adhya 1987, Majumdar, Rudikoff et al. 1987).  A more recent study examining 
the galactose network in Enterobacteria, found that galactose is highly important for survival and 
virulence of Enterobacteriacae (Csiszovszki, Krishna et al. 2011).  This study determined that 
each pathogen has a unique galactose utilization system in order to optimize the system for 
different bacterial environments.  Also of importance, this study found that the galactose 
mutarotase gene (galM) of Y. pestis is inactive due to a single base pair deletion; interestingly, 
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they found the ability of the galM gene to be restored by single base pair insertions.  They 
hypothesized that during the evolution of Y. pestis from Y. pseudotuberculosis, in order to adapt 
to a vector-borne lifestyle, many genes were likely converted to pseudogenes.  These workers 
suggest that Y. pestis pseudogenes are not deleted because meiotrophic reactivation of these 
genes may be necessary for survival in certain environments (Csiszovszki, Krishna et al. 2011).  
In the current study, we found that when Y. pestis was grown at 6C, the galactose operon was 
the most highly up-regulated operon, including significant up-regulation (28.5 fold) of the galM 
pseudogene.  Since galM was found to be significantly up-regulated in at 6C, this could indicate 
possible restoration and reactivation of the gene, which may be necessary for bacterial adaptation 
and survival at colder temperatures.  The incorporation of galactose into Y. pestis LPS at low 
temperatures, further implies that the galactose operon may have an important role in Y. pest s
survival and virulence under these conditions. 
The maltose operon of Y. pestis, which can also be influenced by the crp gene, was up-
regulated when the pathogen was grown at 6C.  The maltose operon is well-characterized in 
other pathogens such as E. coli.  This maltose operon includes malQPT, malEFG, malK lamB 
malM, and malS (Boos, Ferenci et al. 1981, Boos and Shuman 1998). Maltose genes are 
important for the uptake and metabolism of maltose, in addition to the conversion of maltose into 
glucose and glucose α-1- phosphate (Boos, Ferenci et al. 1981, Boos and Shuman 1998).  The 
mal genes are regulated by the transcriptional activator, MalT, and responds to the presence of 
maltose and maltodextrins (Boos, Ferenci et al. 1981, Richet and Raibaud 1987, Richet and 
Raibaud 1989, Boos and Shuman 1998).  It has also been demonstrated that some of the maltose 
operon genes can be controlled by catabolite repression (Chapon 1982, Chapon 1982, Chapon 
and Kolb 1983, Boos and Shuman 1998).  MalT, is a member of the “STAND” (Signal 
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Transduction ATPases with Numerous Domains) family of transcription factors, and can receive 
input from multiple regulatory systems and subsequently transmit a new signal of its own 
(Marquenet and Richet 2007, Danot 2010).  The maltose operon encodes structural genes, malF 
and malG for maltose metabolism, as well as components of an ATP-dependent transport 
complex for the uptake of maltose via the periplasmic space.  In this system, malK hydrolyzes 
ATP to facilitate maltose transport and can also act as a regulatory protein.  Increased levels of 
MalK lead to repression of the mal operon by inhibiting the binding of malT (Boos, Ferenci et al. 
1981, Boos and Shuman 1998)(Reyes and Shuman, 1988; Panagiotidis et al., 1998; Joly et al., 
2004; Richet et al., 2005).  The maltose operon has been found to play a universal role in 
metabolism of maltose, and the genes have also been linked to virulence in Y. p stis, Vibrio 
cholerae and Yersinia enterocolitica (Lange, Kremer et al. 1994, Brzostek and Raczkowska 
2001).  In these studies, the addition of maltose to medium for V. cholera growth, resulted in the 
inhibition of cholera toxin secretion, as well as an increase in the production of the toxin-
coregulated pilus.  By comparison, malF-deficient V. cholera mutants were unable to synthesize 
or secrete the cholera toxin (Lange, Kremer et al. 1994).  It has also been found that in Y. pest s, 
maltose can be utilized as a nutrition source, and the malQ pseudogene, encoding a maltodextrin 
phosphorylase, prevents glucose-1-phosphate from converting back to glucose to complete 
synthesis of the O-antigen unit.  Thus, the synthesized core constituents Y. pestis LPS are devoid 
of extensive O-antigen (Perry and Fetherston 1997).  In this study, at 6C, the (malQPT) and 
(malEFG) genes were found to be up-regulated, but were not up-regulated when Y. pestis was 
grown at 10C and 15C.  This up-regulation could have been related to increased need for 
energy production for bacterial survival at the lower temperature, and the potential effects that it 
plays on the virulence of the organism would need to be further assessed using mal mutant 
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strains of Y. pestis, and performing subsequent transmission studies. 
The furanone-producing autoinducer-2 (AI-2) quorum-sensing system, which is a 
mechanism for interspecies cell-to-cell communication, relies primarily on secretion and 
detection of chemical signals and has been linked to many different bacterial phenotypes and 
regulatory changes in pathogenic bacteria.  In a study by Jing and colleagues, the AI-2 quorum 
system was associated with metabolic activities and oxidative stress genes, which may contribute 
to Y. pestis survival (Dong, Wang et al. 2001, Dong, Gusti et al. 2002).  This was confirmed by 
observing that a luxS mutant was more sensitive to killing by hydrogen peroxide, suggesting a 
potential requirement for AI-2 in evasion of oxidative damage.  In addition, this study found that 
many membrane protein genes are controlled by LuxS, suggesting a role for quorum sensing in 
membrane modeling.  It still remains unclear if LuxS plays a role in pathogenesis.  One study 
using a luxS mutant strain of Y. pestis found that the lethal dose was the same for the mutant and 
wild-type strain of Y. pestis, indicating the luxS was not important for virulence (Bobrov, 
Bearden et al. 2007).  In the current study, luxS was found to be up-regulated in Y. pestis when 
grown at 6C and 10C, and may be necessary for survival in colder temperatures to regulate 
metabolic activities.  The luxS gene was not found to be differentially regulated in Y. pestis when 
grown at 15C, relative to bacterial growth at 23C.  Quorum sensing in Y. pestis has also been 
shown to play a role in regulation of metabolism in the pathogen and altering the maltose and 
galactose operons.  In our study, it is unclear whether quorum sensing, the crp  g ne or other 
factors are  responsible for the increased expression of the galactose and maltose operons in Y. 
pestis at 6C, since previous studies have linked each to successfully altering the operons 
(LaRock, Yu et al. 2013).  In Y. pestis, quorum sensing has also been linked to controlling the 
glyoxylate bypass genes, aceA and aceB, which encode, isocitrate lyase and malate synthase, and 
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work together to bypass the carbon dioxide evolving steps of the TCA cycle.  Metabolic 
variation in the TCA cycle is necessary for altering capability of pathogens to grow on fatty acid 
substrates.  The aceA and aceB genes have been found to be significantly up-regulated by 
quorum sensing signals (LaRock, Yu et al. 2013).  In this study, aceA was up-regulated in Y. 
pestis at all three of the lower growth temperatures, and ceB was up-regulated at 6C and 10C.  
Up-regulation of the glyoxylate bypass pathway would provide a selective advantage by 
allowing growth on the fatty acids of the blood meal inside of the flea vector and providing a 
way to scavenge acetate from the fatty acid breakdown and allowing earlier growth on the 
glucose in the blood.  The glyoxylate bypass pathway has been implicated in the pathogenesis of 
several different bacterial species, Salmonella, Mycobacterium tuberculosis and Pseudomonas 
aeruginosa (McKinney, Honer zu Bentrup et al. 2000, Fang, Libby et al. 2005, Lindsey, Hagins 
et al. 2008).  Quorum sensing mutants in Salmonella were unable to cause persistent infections, 
but had no effect on growth or acute infections (Fang, Libby et al, 2005).  The direct effects of 
luxS up-regulation in this study will need to be further evaluated using luxS knock-outs in order 
to identify the possible role of quorum sensing in Y. pestis at these lower temperatures.  
The LPS of Y. pestis characterized as a rough-type LPS lacking the O-antigenic 
polysaccharide (Chart and Rowe 1995).  The LPS or endotoxin elicits a variety of inflammatory 
responses in mammalian hosts, and the hexa-acylated form of the LPS has been shown to 
efficiently activate the toll like receptor 4 (TLR4) in mammalian hosts, which results in the 
activation of the host innate immune system (Knirel and Anisimov 2012).  A typical LPS 
consists of three main parts: the lipid A, core, and O-antigen.  The lipid A portion is associated 
with toxicity in mammalian hosts, and the immunogenicity is associated with the polysaccharide 
components (Knirel and Anisimov 2012).  In Y. pestis, different LPS types have been discovered, 
214 
 
and the different forms have been associated with differences in growth temperature.  Growth of 
Y. pestis at ambient temperatures results in the synthesis of a hexa-acylated lipid A; whereas 
growth of the pathogen at 37°C results in a tetra-acylated LPS (Kawahara, Tsukano et al. 2002, 
Telepnev, Klimpel et al. 2009).  The tetra-acylated form of the LPS in Y. pestis has been further 
evaluated and determined that the change in structure and number of acylations on the lipid A, 
results in an increased immune response or decrease in recognition in mammalian hosts.  For 
example, the tetra-acylated form of the LPS was less immunogenic and resulted in immune 
evasion in a mouse model when compared to the hexa-acylated form of the LPS in which all 
virulence was ablated (Sun, Koumoutsi et al. 2011).  The differences in LPS structures were 
studied in more detail, and found that Y. pestis growth at 6°C, which mimics burrow and rodent 
hibernation temperatures, resulted in biosynthesis of a completely different LPS type.  Multiple 
differences were found in the core such as: a replacement of the terminal galactose with terminal 
d-glycero-d-manno-heptose; phosphorylation of the terminal oct-2-ulosonic acid with 
phosphoethanolamine, resulting in a lower content of GlcNAc, and; absence of glycine.  Changes 
at this temperature in the lipid A were: a lack of 4-amino-4-deoxyarabinose and partial 
oxygenation of the fatty acids.  This study suggested that cold temperature changes results in an 
alternative mechanism of control and synthesis of the Y. pestis LPS (Kawahara, Tsukano et al. 
2002).  Knirel and colleagues further identified the genes necessary for LPS biosynthesis (Figure 
4).  They found that three main gene clusters were responsible for the LPS core synthesis waaI, 
waaII and wab (Knirel and Anisimov 2012).  Our study found that when Y. pestis was grown at 
6C and 10C, the LPS core biosynthesis protein (CoaD) was up-regulated and genes involved in 
the inner core biosynthesis waaE, waaA and kbl were down-regulated, which are all found on the 
waaI gene cluster.  WaaE and kbl were also down-regulated when Y. pestis was grown at 15C.  
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On the waaII gene cluster, YPO0415 was found to be up-regulated in Y. pestis grown at 6C, 
10C and 15C (Figure 4).  WaaC, part of the waaI gene cluster and waaQ, part of the of waaII 
gene cluster, both encode LPS heptosyltransferase enzymes, and were up-regulated only when Y. 
pestis was grown at 15C.  In the waaI gene cluster, four out of the seven LPS biosynthesis 
genes are down-regulated when Y. pestis is grown at 6C and 10C, which may contribute to the 
partial replacement of the Kdo (3-deoxy-D-manno-oct-2-ulosonic acid), residue in the side chain, 
to the close derivative, Ko (D-glycero-D-mal-oct-2-ulosonic acid) of the LPS core structure.  In 
addition, a galacatose residue can be incorporated into the core, attaching to the heptose residue 
most distal from the lipid A, resulting in D-glycero- D-galactose-heptose at lower temperatures 
(Knirel and Anisimov 2012).  It is unclear whether the highly expressed gal operon that we 
observed in Y. pestis at 6C, could lead to this genotype where galactose residues become 
incorporated in the LPS core structure.  Further studies evaluating the roles that different LPS-
types have on virulence and pathogenesis of Y. pestis would need to be further elucidated.  Next, 
structural variations of the lipid A component of Y. pestis have been found to occur when the 
pathogen is grown at different temperatures (Knirel and Anisimov 2012); (Kawahara, Tsukano et 
al. 2002).  Changes in content and different acylated forms of lipid A have been discovered in Y. 
pestis.  These changes have been observed when cultivation conditions of Y. pesits were altered, 
indicated temperature as a significant role leading to structural variations.  When Y. pestis is 
grown at temperatures ranging from 20-28°C, it resulted in a mixture of tetra-acyl, penta-acyl 
and hexa-acyl forms of lipid A being produced (Knirel and Anisimov 2012)  A rise in 
temperature to 37°C, resulted in a decrease in acylation of lipid A, and further hypothesized as 
playing a role in pathogenesis to better evade the host immune system, by decreased recognition.  
When Y. pestis was grown at 6°C, a mixture of tetra-acyl and hexa-acyl forms of lipid A were 
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discovered (Knirel and Anisimov 2012).  Our study further demonstrated that genes necessary 
for LPS biogenesis were altered, which could explain the change in structure described by Knirel 
and colleagues.  The temperature dependence of the catalytic activity of the enzymes could result 
in a change in the lipid A acylation patterns, which could lead to increased virulence in Y. pestis 
at lower temperatures.  The LPS core is thought to contribute to serum resistance, and mediated 
by the effect of the LPS on the folding correctness and functional activity of the outer membrane 
protein Ail (OmpX), which plays known role in serum resistance (Bartra, Styer et al. 2008), and 
found to be up-regulated in our study when Y. pestis was grown at 6°C (6.7-fold).  The 
temperature-dependent variations of the core and lipid A structures of the Y. pestis LPS may 
facilitate adaption to lower temperatures resulting in increased survival of Y. pestis, as well as, 
potentially making the pathogen more virulent, specifically when tetra-acylated forms of lipid A 
are formed, in addition to potential galactose incorporation into the LPS core. 
In Y. pestis, outer membrane proteins (OMPs) have been linked to virulence and 
pathogenesis.  Some outer membrane proteins (Yersinia outer proteins-Yops), are induced by 
growth in calcium-deficient medium at 37°C and partially secreted, and found to be directly 
involved in pathogenesis in the mammalian host (Bölin and Wolf-Watz 1984, Bölin, Portnoy et 
al. 1985, Bölin, Forsberg et al. 1988, Bölin and Wolf-Watz 1988).  In Y. pestis, outer membrane 
protein R or OmpR, is found to regulate ompCFX, directly through OmpR-promoter DNA 
association, and a component of the OmpR-EnzV two component regulatory system (Reboul, 
Lemaitre et al. 2014).  OmpR is required for both virulence and survival within macrophages.  In 
addition, Y. pestis OmpA has also been found to be necessary for intracellular survival in 
macrophages and virulence in mice (Gao 1986, Bartra, Styer et al. 2008, Gao, Zhang et al. 2011).  
The osmotic regulator OmpR, regulates differentially the expression of major porin proteins 
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OmpF and OmpC.  In Y. enterocolitica and Y. pseudotuberculosis, OmpR also has been found to 
be required for both virulence and survival within host macrophages.  The role ofOmpR in Y. 
pestis is thought to be involved in building resistance against phagocytosis by countering the 
toxic effectors secreted by polymorphonuclear leukocytes in the tissues, in addition to 
controlling adaptation to various stressful environments (Feng, Oropeza et al. 2003, Reboul, 
Lemaitre et al. 2014).  This study found an increase in expression of the transcriptional 
regulators, OmpR and OmpF, in addition to up-regulation of the outer membrane proteins A and 
X, (OmpA and OmpX), as well as up-regulation of the chaperone protein OmpH when grown at 
6C.  At 10C, ompR, ompF and ompH were all up-regulated; whereas the outer membrane 
protein C gene, ompC, was down-regulated at 6C and 10C (Table 4.).  Increased expression of 
ompR, a component of the OmpR-EnvZ two component regulatory system of Y.pestis, at 6C and 
10C, may play a role in bacterial adaption and survival at the lower temperatures.  Y. pe tis 
encodes 24-two component regulatory systems, and only two of the systems (PhoP-PhoQ; 
OmpR-EnvZ) have been found to be important for pathogen virulence and immune evasion 
(Reboul, Lemaitre et al. 2014).  The main role of two component regulatory systems is thought 
to be the enhancement of bacterial adaptation to environmental changes; therefore, the increased 
expression of OmpR at 6C and 10C, may play a role in allowing the pathogen to successfully 
survive at these colder temperatures.  Previous studies have demonstrated that OmpF and OmpC 
are reciprocally regulated by medium osmolarity, and OmpC is predominantly expressed in high 
osmolarity environments, while the OmpF expression is repressed (Kawaji, Mizuno et al. 1979).  
This was demonstrated in this study, when ompF was found to be upregulated at 6C and 10C, 
and ompC was downregulated; further indicating a growth environment in which low osmolarity 
conditions were encountered by Y. pestis.  OmpF is found to be predominantly expressed in 
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aqueous environments as well as adapting to increases in medium osmolarity (Nikaido 2003, 
Ayyadurai, Houhamdi et al. 2008).  Expression of OmpC is increased in the flea midgut, while 
OmpF is predominately expressed in the aqueous habitats (as demonstrated in this study).  The 
pore size of OmpC is smaller and has a slower flux; whereas, OmpF has a larger pore size and 
may play an additional role in scavenging for bacterial nutrients (Nikaido 2003).  Lastly, OmpX 
in Y. pestis is required for efficient bacterial adherence, as well as conferring resistance to human 
serum (Kolodziejek, Schnider et al. 2010, Kolodziejek, Schnider et al. 2010).  Y. pestis ompX 
was up-regulated in our study when grown at 6C, and may play a role in increased virulence in 
mammalian hosts at lower temperatures.  Much is still unknown about the porin regulation in Y. 
pestis and a comparison between porin regulation in Y. pestis and Y. pseudotuberculosis may 
provide new insights into possible evolutionary forces selecting for altered gene regulation. 
Y. pestis is a facultative anaerobe and possesses a constitutive glyoxylate bypass and 
unregulated L-serine deaminase expression, but lacks detectable adenine deaminase, aspartase, 
glucose 6-phosphate dehydrogenase, ornithine decarboxylase, urease, and -ketoglutarate 
dehydrogenase activities (Brubaker 1972, Brubaker 1991, Brubaker 1991, Holt, Krieg et al. 
1994).  At all temperatures, Y. pestis has nutritional requirements for L-isoleucine, L-valine, L-
methionine, L-phenylalanine, and glycine (or L-threonine); these auxotrophies, some of which 
are capable of reversion, are due to cryptic genes.  At 37C, Y. pestis also requires biotin, 
thiamine, pantothenate, and glutamic acid (Perry and Fetherston 1997).  In our study, the 
glyoxylate bypass genes were up-regulated in Y. pestis grown at 6C and 10C, as indicated by 
genes aceA (encoding an isocitrate lyase) and aceB (encoding a malate synthase).  These genes 
permit the synthesis of tricarboxylic acid cycle intermediates from two carbon precursors.  AceA 
catalyzes the reversible aldol cleavage of threo-isocitric acid to succinic and glyoxylic acids; 
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whereas AceB catalyzes the condensation of acetyl-coenzyme A (CoA) with glyoxylic acid to 
form malate.  AceAB are up-regulated during growth in the presence of two carbon compounds 
such as ethanol or acetate (Kornberg 1966, Kornberg and Smith 1966, Hillier and Charnetzky 
1981).  In our study, when Y. pestis is grown at sub-ambient temperatures (6 C, 10C and 15C) 
the largest proportion of the DEGs were those related to metabolism were involved in the uptake 
and catabolism of amino acids and carbohydrates, resulting in up-regulation of the 
phosphotransferase system (anXYZ).  Y. pestis appears to use amino acids, arginine, histidine 
and methionine, as primary carbon, nitrogen, and energy sources, in which the carbon gets 
funneled into the TCA cycle.  Fatty acid degradation (fadHDE) was up-regulated at the sub-
ambient temperatures when compared to 23C, and respiration was highly up-regulated at the 
lower temperatures (hydN and dmsA), while oxidative phosphorylation (atpABDFHI) was highly 
up-regulated only at 6C.   
Gene reduction of Y. pestis has shown that genes are inactivated or deleted under 
selective pressure, and that this process is likely related to the interaction of the bacterium with 
the nutrient rich environments in which the pathogen is primarily inhabiting, such as flea 
midguts or mammalian hosts.  The genome of Y. pestis indicates that the pathogen possesses a 
full complement of the biosynthetic metabolic pathways, yet Y. pestis is dependent on satisfying 
its nutritional requirements by acquiring them from the environment in which it is residing.  
Characteristic of parasitic relationships, Y. pestis metabolism is very inefficient, and more than 
half of the carbon sources that are imported into the cell are excreted as waste material and 
respiratory metabolism is more carbon efficient than anoxic metabolism.  Additionally, oxidative 
metabolism produces lower amounts of the acidic by-products produced by the organism, which 
are known to inhibit cellular growth.  This aversion to acidity, results in Y. pestis using gluconate 
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as a carbon source (Englesberg, Chen et al. 1954, Chain, Carniel et al. 2004).  Y. pestis must 
apply a considerable number of adaptive strategies in order to survive in both the mammalian 
host and the flea.  Previous studies have shown the ability of the pathogen to live successfully in 
a flea gut for over a year, further implicating the flea as a potential long-term reservoir for Y. 
pestis (Gage and Kosoy 2005).  Factors affecting Y. pestis growth and infection efficiency in the 
flea greatly depend on the mammalian host from which the flea obtains its blood meal.  The 
closed environment of the flea gut will eventually lead to nutrient deprivation born out by long 
periods with only sporadic blood feedings; therefore, the metabolic pathways of Y. pestis may 
have adapted in such ways to allow for complete utilization of the blood meal under austere 
conditions.  Future studies evaluating the transcriptome of Y. pestis-infected fleas, would lead to 
even more insight on the pathogen-vector interactions allowing for increased persistence of Y. 
pestis or changes in virulence at these lower temperatures. 
  Y. pestis has many temperature-regulated virulence and pathogenesis factors, facilitating 
immune evasion and dissemination, which are up-regulated upon entry into a mammalian host 
(37C).  At 37C or mammalian temperature, the pathogen encounters low Ca2+ concentrations 
and a nutrient rich environment.  The pCD1 plasmid, encodes the Yop virulon, a T3SS, and Ysc 
(Yersinia SeCretion).   There are 29 different Ysc proteins which all play a role in inhibiting 
phagocytosis, inflammation, and inducing apoptosis of macrophages and other phagocytes.  This 
plasmid also encodes the V antigen (LcrV), which functions in producing the type three secretion 
apparatus, as well as suppression of the host immune response.  The outer membrane protein 
plasminogen activator gene, pla, is found on the pPCP1 plasmid and promulgates dissemination 
of the pathogen by interfering with blood coagulation and host complement activation pathways.  
The pMT1 plasmid of Y. pestis encodes the F1 caspular antigen (F1) expressed at 37C, 
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enhances resistance to phagocytosis.  Also encoded on this plasmid is the Yersinia murine toxin 
(Ymt), which is optimally expressed in the flea at 26C, and encodes a phospholipase D required 
for flea gut colonization.  Y. pestis transmission and infection could not be accomplished without 
the chromosomal pgm locus, which contains the hmsHFRS genes essential for biofilm formation 
within the flea vector; therefore expressed at 26C.  The pgm locus also harbors the Yersinia 
high-pathogenicity island (HPI), which encodes a siderophore-based iron acquisition system 
(Ybt) needed for infection in the mammalian host (Hinnebusch, Perry et al. 1996).  Consistent 
with current knowledge regarding temperature regulation of Y. pestis virulence factors, our study 
found further down-regulation of the Y. pestis F1 capsular antigen at low temperature, in addition 
to down-regulation of pla.  Interestingly, one potential virulence gene, yadB, was found to be up-
regulated at 6C and 10C growth temperatures.  YadB encodes the outer surface protein gene 
yadB, and is required for adhesion and dissemination of Y. pestis after a flea bite and is necessary 
for the progression of bubonic plague (Vadyvaloo, Jarrett et al. 2010).  Thus, yadB up-regulation 
at burrow temperatures ranging between 6-10C, could prepare the pathogen for the host 
environment and is implemented specifically when Y. pestis-infected fleas feed on a hibernating 
rodent host. 
In conclusion, transcriptome studies, as the one described here, demonstrated their value 
by presenting a global view for differential expression of genes from selected environments, 
tissues, or whole animals.  Next generation sequencing has made it possible to examine the 
complex array of genes associated with selected biological functions in a single sample, and is 
extremely beneficial when an existing reference genome is available.  In this novel study, we 
examined Y. pestis gene regulation at burrow temperatures of hibernating rodents, and provided 
new insights on virulence and survival strategies of this pathogen at sub-ambient temperatures.  
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Our study used a powerful approach that integrated gene expression measurements with large-
scale genome-wide association data to identify genes whose expression were altered by changes 
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Figure 4.1.  Overview of the differentially expressed genes (DEGs) of Y. pestis at low growth 
















6 deg 10 deg 15 deg
# Differentially Expressed Genes (DEGs)
656 655
442









Figure 4.1. A. Histogram showing the differentially expressed genes (DEGs) from the NGS-
RNA-seq transcriptome study examing Y. pestis gene expression at 6C, 10C, 15C compared 
to 23C. B. Histogram of the number of total up-regulated genes of Y. pestis at 6C, 10C, 
15C when compared to 23C. C. Histogram of the number of total down-regulated genes of Y. 
pestis at 6C, 10C, 15C when compared to 23C. (Black bar-6C, Grey bar-10C, White bar-































crp cyclic AMP receptor protein Up 3.1 
Amino Acid Transport and Metabolism     
gltJ glutamate/aspartate ABC transporter, permease protein Down -6.6 
serA D-3-phosphoglycerate dehydrogenase Up 10.2 
serC Phosphoserine aminotransferase  Up 3.4 
glnH glutamate and aspartate transporter subunit Down -4.4 
hpaE 4-hydroxyphenylacetate catabolism Down -7.5 
hpaR 4-hydroxyphenylacetate catabolism Down -2.8 
deoC 2-deoxyribose-5-phosphate aldolase Up 2.7 
deoA thymidine phosphorylase Up 3.5 
deoB phosphopentomutase Up 2.5 
deoD purine nucleoside phosphorylase Up 2.8 
tdk Thymidine kinase  Down -3 
Carbohydrate Transport and Metabolism     
manX PTS enzyme IIAB, mannose-specific Up 3.1 
manY PTS system, mannose/fructose/sorbose family, IIC subunit Up 5.3 
manZ PTS enzyme IID, mannose-specific Up 7.5 
nagB Glucosamine-6-phosphate deaminase  Up 3 
nagA N-acetylglucosamine-6-phosphate deacetylase  Up 8.9 
nagC N-acetylglucosamine-6P-responsive transcriptional repressor NagC, ROK family Up 3.4 
nagD Phosphatase NagD predicted to act in N-acetylglucosamine utilization subsystem Down -2.3 
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nagE PTS system, N-acetylglucosamine-specific IIA component Up 15.6 
zwf Glucose-6-phosphate 1-dehydrogenase  Up 8.7 
maeB malic enzyme Up 2.3 
malE maltose ABC transporter periplasmic protein Up 3.5 
malF ABC superfamily (membrane), maltose transport protein Up 3.8 
malP maltodextrin phosphorylase Up 2.8 
malQ 4-alpha-glucanotransferase Up 2.7 
malT transcriptional regulator MalT Up 2.5 
dppA dipeptide ABC transporter, substrate-binding protein Down -2.8 
dppB dipeptide ABC transporter, permease protein Down -5 
dppC dipeptide transporter Down -3.1 
dppD dipeptide transporter ATP-binding subunit Down -4 
dppF dipeptide transporter ATP-binding subunit Down -4.1 
gntT gluconate transporter Up 3.6 
uxaC Uronate isomerase  Up 2.1 
pgk phosphoglycerate kinase Up 2.5 
aroA 5-Enolpyruvylshikimate-3-phosphate synthase  Up 2.1 
argH Argininosuccinate lyase  Up 4.5 
ugpC SN-glycerol-3-phosphate transport ATP-binding protein UgpC  Down -2.7 
mglA Galactose/methyl galactoside ABC transport system, ATP-binding protein MglA  Down -2.9 
mglC Galactose/methyl galactoside ABC transport system, permease protein MglC  Down -3.5 
ugpC SN-glycerol-3-phosphate transport ATP-binding protein UgpC  Down -2.7 
Cell Wall/Membrane Biogenesis     
galE UDP-galactose-4-epimerase Up 179.4 
galT galactose-1-phosphate uridylyltransferase Up 185.3 
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galK galactokinase Up 53.1 
galM aldose 1-epimerase Up 28.5 
Energy Production and Conversion     
aceE Pyruvate dehydrogenase E1 component  Up 4.4 
aceF 
Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase 
complex  Up 6 
atpI ATP synthase subunit I Up 2.1 
adhE Alcohol dehydrogenase/Acetaldehyde dehydrogenase Up 2.5 
epd D-erythrose 4-phosphate dehydrogenase Up 2.7 
focA formate transporter Up 3.6 
pflB formate acetyltransferase Up 7.4 
dcuA anaerobic C-4-dicarboxylate symporter Up 2.5 
lpdA Dihydrolipoamide dehydrogenase of pyruvate dehydrogenase complex Up 3.7 
nirB nitrite reductase (NAD(P)H) subunit Up 3.8 
aceA isocitrate lyase Down -4.4 
sdhC Succinate dehydrogenase cytochrome b-556 subunit Down -2.2 
sdhD Succinate dehydrogenase hydrophobic membrane anchor protein Down -4.1 
sdhA Succinate dehydrogenase flavoprotein subunit  Down -2.4 
sdhB Succinate dehydrogenase iron-sulfur protein  Down -2.5 
glk glucokinase Down -2.3 
glpA sn-glycerol-3-phosphate dehydrogenase subunit A Down -4.4 
glpB Glycerol-3-phosphate dehydrogenase subunit B Down -3.8 
glpC anaerobic glycerol-3-phosphate dehydrogenase subunit C Down -3.3 
glpD glycerol-3-phosphate dehydrogenase Down -6.8 
glpF facilitator for glycerol uptake Down -14.1 
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Lipid Transport and Metabolism     
fadD long-chain-fatty-acid--CoA ligase Down -3 
fadH 2,4-dienoyl-CoA reductase [NADPH] (2,4-dienoyl coenzyme A reductase) Down -2.7 
lipB Octanoate-[acyl-carrier-protein]-protein-N-octanoyltransferase Down -5 
Transcription and signal transduction mechanisms     
hexR Phosphogluconate repressor HexR, RpiR family Up 6 
ctyR transcriptional repressor Down -5.9 
uspA Universal stress protein A Down -3 
pdhR Transcriptional repressor for pyruvate dehydrogenase complex Up 5.4 
fxsA suppressor of F plamsid exlusion of phage T7 Down -4 
Replication, recombination and repair     
deaD ATP-independent RNA helicase Down -2.1 
hupA DNA-binding protein HU-alpha (HU-2) Up 3.2 
iciA chromosome replication initiation inhibitor protein Up 2.1 
Coenzyme transport and metabolism     
cyoE protoheme IX farnesyltransferase Down -2.6 
General function and prediction unknown     
actP acetate permease Down -13.6 
acs acetyl-coenzyme A synthetase Down -5.3 
yohK LrgB family protein Down -2.5 
Translation     







Table 4.2. Table of the galactose operon genes up-regulated in Y. pestis at 6°C 
 
 








galE UDP-galactose-4-epimerase Up 179.4 7.5 
galT galactose-1-phosphate uridylyltransferase Up 185.3 7.5 
galK galactokinase Up 53.1 5.7 
galM aldose 1-epimerase Up 28.5 5.4 
galR galactose operon repressor galR Up 2.6 1.0 






















Table 4.3. Table of the known genes necessary for the biosynthesis of the Y. pestis LPS that are up- or down-regulated ≥2-fold 




Genes Gene Function 
Up/Down Regulation 
6° 10° 15° 
waaI 
coaD (kdtB) Lipopolysaccharide core biosynthesis protein  4.1 3.2 NC * 
waaE (kdtX) Lipopolysaccharide core biosynthesis glycosyl transferase 4.3 3.1 2.6 
waaA (kdtA) 3-deoxy-D-manno-octulosonic-acid transferase 5.2 3.6 NC * 
waaC Lipopolysaccharide heptosyltransferase I NC * NC * 3.3 
waaF  Lipopolysaccharide heptosyltransferase II NC * NC * NC * 
hldD ADP-L-glycero-D-manno-heptose-6-epimerase NC * NC * NC * 
kbl 2-amino-3-ketobutyrate coenzyme A ligase -2.4 -3.6 -5.3 
waaII 
YPO0415 putative carbohydrate kinase 4.5 10.2 3.4 
waaQ LPS inner-core heptosyltransferase III NC * NC * 3.7 
waaL LPS biosynthesis enzyme NC * NC * NC * 
YPO0418   NC * NC * NC * 
 
*Represents genes that were not up- or down-regulate when compared to 23°C
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Table 4.4. Table of the differentially expressed outer membrane protein (OMP) genes up- or down-regulated ≥2-fold of Y. 
pestis at 6°C, 10°C, and 15°C compared to 23°C 
 
Outer membrane protein (OMP) genes Up/Down Regulation 
Gene Gene function 6° 10° 15° 
ompR Transcriptional regulatory protein ompR 3.8 2.3 NC * 
ompF Transcriptional regulatory protein ompF 3.4 2.1 NC * 
ompC Outer membrane protein C, porin -3.4 -5.0 NC * 
ompA Outer membrane protein A 2.4 NC* NC * 
ompH Chaperone protein 2.7 2.0 NC * 
ompX Outer membrane protein X 6.7 NC * NC * 
 
*Represents genes that were not up- or down-regulated when compared to 23°C
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Table 4.5.  Differentially expressed genes (DEGs) up- or down-regulated ≥2-fold of Y. pestis grown at 6°C, 10°C, and 15°C 






Amino Acid Transport and Metabolism 6° 10° 15° 
ureA urease gamma subunit 2.5 4.1 3.1 
ureB urease beta subunit 2 6.9 3.1 
ureC urease alpha subunit 2 7.2 3.5 
ureD urease gamma subunit 2 4.7 3.3 
ureF urease beta subunit 2 4.2 3 
ureG urease subunit alpha 2.5 2.4 2.4 
gltJ aspartate/glutamate ABC transport system 6.6 NC* NC* 
argC   N-acetyl-gamma-glutamyl-phosphate-arginine 4.5 4.7 3.4 
argH Argininosuccinate lyase 4.5 4.9 5.1 
argD Acetylornithine/succinyldiaminopimelate 6.6 10 3.1 
metB O-succinylhomoserine (Thiol)-lyase NC* 2.3 NC* 
metC cystathionine beta-lyase -6.6 -5.6 -3.3 
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metF 5,10-methylenetetrahydrofolate reducatase 3.6 7.9 NC* 
metH 5-Methyltetrahydrofolate--homocysteine methyltransferase NC* NC* -4.9 
metN Methionine import ATP-binding protein MetN 1 8.4 5.6 3.4 
metQ D-methionine-binding lipoprotein MetQ 3.2 NC* NC* 
ilvC ketol-acid reductoisomerase -11.2 5 2.7 
livM leucine/isoleucine/valine transporter permease subunit NC* NC* 3.4 
lysC amino acid metabolism 2.5 2.8 2.1 
nanA acetylneuraminate lyase 42.3 4.3 2.3 
nanT Putative sialic acid transporter 6.2 6.7 NC* 
cysK cysteine synthase A -2.7 -2.3 -4.2 
cysM Cysteine synthase 3.3 2.1 NC* 
cysE Serine acetyltransferase -2.6 -2.4 NC* 
cysB HTH-type transcriptional regulator CysB 2.9 2.5 2.3 
cysJ Sulfite reductase [NADPH] flavoprotein alpha-component -5.8 NC* NC* 
cysQ Inositol monophosphatase family protein NC* 2.7 2.1 
cysS Cysteine--tRNA ligase NC* NC* 2.1 
csyI hypothetical protein -4.7 -3 -4.3 
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ybtS salicyclate synthase Irp9 -6.6 -2.6 -3.1 
hisD histidinol dehydrogenase 2.5 NC* NC* 
hisB imidazole glycerol-phosphate dehydratse/histidinol phosphatase NC* -2.3 -3.1 
aspC aromatic amino acid aminotransferase 2.9 22.8 8.5 
aspA amino acid metabolism 2.9 2.5 2.3 
serA D-3-phophoglycerate dehydrogenase 10.2 6.3 3.4 
serB Phosphoserine phosphatase SerB 4.9 2.2 3.2 
serC Phosphoserine aminotransferase 3.4 NC* NC* 
proC pyrroline-5-carboxylate reducatase 3.2 2.8 NC* 
speC ornithine decarboxylase isozyme NC* NC* 3.4 
leuB 3-isopropylmalate isomerase large subunit 4.1 2.1 NC* 
leuC isopropylmalate isomerase large subunit 8 4.3 NC* 
dapB dihydrodipicolinate reducatase -2.9 3 3.4 
dapX hypothetical protein 2 2.3 2.3 
thrA bifunctional aspartokinase I/homoserine dehydrogenase 2.3 2.5 3.2 
glnH glutamine ABC transporter periplasmic binding protein -5.2 -2.4 NC* 
glnQ glutamine ABC transporter periplasmic binding component -10.7 -10.3 NC* 
246 
 
glnP glutamine ABC transporter periplasmic binding permease -12.2 -2.9 -6 
hutI imidazolonepropionase-histidine 3.1 3 NC* 
hutG histidine degradation 3.3 3 2.3 
hpaC hypothetical protein -2.3 -3.2 NC* 
hpaB component B of 4-hydroxyphenylacetate acid-hydroxylase -4.6 -3.3 -3.9 
hpaX 4-hydroxyphenylacetate permease 5.3 3.9 3.2 
hpaI 2,4-dihydroxyhept-2ene-1,7-dioate hydratase -3.5 -3.9 NC* 
ansB periplasmic L-asparaginase II -9.7 -2.8 -5.4 
artQ arginine 3rd transport system permease -5 -4.2 NC* 
Carbohydrate Transport and Metabolism       
lamB maltoprotein precursor -3 -5.5 NC* 
manX PTS system, mannose, specific IIAB component 8.1 6.4 2.6 
manZ PTS system, mannose specific IID component 7.5 9.1 4.7 
manY PTS enzyme, IIC, mannose-specific 5.3 3.9 2.7 
tpiA triosephosphate isomerase 3.2 2.2 NC* 
eno phosphophyruvate hydratase-glycolysis/gluconeogenesis 2.2 NC* NC* 
sgbU putative L-xylulose 5-phosphate-3-epimerase -2.1 NC* NC* 
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nagA N-acetylglucosamine-6-phosphate deacetylase 8.9 11.6 10.3 




4.2 NC* NC* 
zwf glucose-6-phosphate dehydrogenase 8.7 2.3 2 
malK ATP-binding component of transport system for maltose -6 -5.5 NC* 
malP Maltodextrin phosphorylase 2.8 NC* NC* 
malQ 4-alpha-glucanotransferase 2.7 NC* NC* 
malT MTH-type transcriptional regulator malT 2.5 NC* NC* 
malZ Maltodextrin glucosidase 2.1 -2.2 NC* 
malE Maltose-binding periplasmic protein 3.5 -2.2 NC* 
malS Alpha-amylase 3.3 -3.9 NC* 
fruK 1-phosphofructokinase -5 -5.6 NC* 
bglA 6-phospho-beta-glucosidase A -5 -6.1 -7 
galK galactokinase 53.1 NC* NC* 
malG malG type permease 2 -2.7 -2.1 
malF malF-type permease 3.8 -4 -4.1 
fba fructose-bisphosphate aldolase 2 NC* NC* 
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pgk phosphogluycerate kinase 2.5 2.8 NC* 
tktA transketose-pentose phosphate 2.1 NC* NC* 
uxaA altronate hydrolase 2.4 4.3 4.6 
uxaB altronate oxidoreductase NC* 3 NC* 
uxaC glucouronate isomerase 2.1 3 3.2 
deoB phosphopentomutase 2.5 6.1 2.1 
gntV glucuronate isomerase NC* 2 NC* 
glgX glycogen debranching enzyme NC* 9.7 5 
glgC glucose-1-phosphate adenylytransferase -2.9 4.5 5.1 
glgA glycogen synthase 6 5.3 2.3 
glgP glycogen phosphorylase NC* 2.6 NC* 
csrA carbon storage regulator homolog 2.2 2.6 NC* 
ompA putative outer membrane protein porin A 2.4 NC* NC* 
lpp major outer membrane protein NC* 2 NC* 
ail attachment invasion locus protein -3.4 -2.8 -2.5 
Cell cycle control       
minD cell division inhibitor 3.1 4 3.3 
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Cell motility       
flgK cell distal portion of basal body rod -5 -4.2 3.3 
flgI flaggellar basal body P-ring protein -3.3 -2.8 -2.6 
cheD2 methyl-accepting chemotaxis protein 2.2 5.4 NC* 
Cell Wall/Membrane Biogenesis       
kdtX Lipopolysaccharide core biosynthesis glycosyl transferase -3.1 -4.5 -3.5 
mscL Large-conductance mechanosensitive channel -2.2 -2.4 -2.6 
acrA accridine efflux pump 2.6 2.6 NC* 
tonB transport protein tonB -9.7 NC* NC* 
ompC outer membrane porin protein C -3.4 -5 -4 
galE UDP-galactose-4-epimerase 179.4 3.2 4.5 
galT galactose-1-phosphate uridylytransferase 185.3 2.9 NC* 
alr alanine racemase 9.3 5.7 NC* 
Coenzyme transport and metabolism       
panF sodium/panthothenate symporter NC* 2.1 NC* 
btuB vitamin B12/cobalamin outer membrane transporter 3.4 NC* -2.3 
btuC vitamin B12/cobalamin outer membrane transport protein 2.3 2.3 NC* 
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thiC thiamine biosynthesis protein NC* NC* 2.3 
panC pantoate-beta-alanine ligase NC* NC* -2.5 
metK S-adenosylmetehionine synthetase 4 2.8 NC* 
tbpA thiamine transporter substrate binding subunit 2.1 NC* NC* 
menG ribonuclease activity regulator protein NC* NC* -2 
cyoE protoheme IX farnesyltransferase -2.6 -3.1 -2.6 
Defense Mechanisms       
pcp outer membrane lipoprotein 3.5 5.1 2.9 
Energy Production and Conversion       
ppc phosphenolpyruvate carboxylase 5.5 NC* NC* 
qor quinone oxidoreductase, NADPH-dependent 2.9 NC* NC* 
hydN electron transport protein 6.5 10.4 12 
aceE pyruvatedehydrogenase subunit EI 4.4 NC* NC* 
aceF dihydrolipoamide dehydrogenase 6 2.6 NC* 
lpdA dihydrolipoamide dehydrogenase 3.7 NC* NC* 
hmp flavohemoglobin nitric oxide dioxygenase -5 -4.2 -2.6 
maeB malic enzyme 2.3 8.7 2.6 
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adhE CoA-linked acetaldehyde dehydrogenase 2.3 NC* NC* 
pntA NAD(P) transhydrogenase subunit alpha 3.6 4.3 3.3 
putA trifunctional transcriptional regulator/proline -5.2 -2.8 NC* 
nirB nitrate reductase NAD(P)(H) subunit 3.8 -3.2 3.4 
atpF F0F1 ATP synthase subunit B 2.5 NC* NC* 
sdhC succinate dehydrogenase cytochrome large subunit -2.2 NC* NC* 
sdhD succinate dehydrogenase cytochrome small subunit -4.1 -2.2 -2.6 
sdhB succinate dehydrogenase catalytic subunit -2.5 NC* NC* 
atpB ATP synthase subunit A 3.4 NC* NC* 
atpI ATP synthase subunit I 2.6 NC* NC* 
frdD fumarate reductase subunit NC* 3 NC* 
nqrE Na+-translocating NADH_quinone -2.7 -4.2 -3.6 
uxaC pentose and glucuronate interconversions 2.1 3 NC* 
aceA Isocitrate lyase 5.2 4.4 2.3 
aceB Malate synthase A 4.1 2.1 NC* 
dmsA respiration 5.1 4.3 2.9 
ccmA cytochrome c-type biogenesis 2.6 2.5 2.1 
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hcp hydroxylamine reductase NC* NC* 2.3 
Oxidative Phosphorylation       
atpD  ATP synthase subunit beta  3.7 NC* NC* 
atpA ATP synthase subunit alpha 3.4 NC* NC* 
atpH ATP synthase subunit delta 4.5 2.1 NC* 
atpF ATP synthase subunit b 2.5 NC* NC* 
Fatty Acid Degradation       
fadH fatty acid oxidation complex subunit alpha 2.5 2.8 2.1 
fadD long-chain-fatty-acid--CoA ligase 6.8 4.2 2.1 
fadE acyl-CoA dehydrogenase  3 3 2 
fadL long-chain fatty acid transport protein NC* 10.5 2.7 
Inorganic Ion Transport and Metabolism       
sbp1 exported sulfate-binding protein -2.6 -3 -2.6 
zntA zinc, lead, cadmium, and mercury transporting ATPase -3.5 NC* NC* 
pstB putative phosphate transport ATP-binding protein 6.2 5.7 4.5 
cysP thiosulfate-biding protein -2.5 NC* NC* 
cysA sulfate transport ATP-binding protein -2.9 -4.5 -2.5 
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dps DNA protection during starvation conditions -3.2 4.4 4.6 
wrbA TrpR binding protein NC* 2.1 2.3 
bfr bacterioferritin 8.3 6.2 2.2 
hmuT periplasmic heme binding protein -5.9 -3.4 NC* 
hmuS heme uptake system component -15 -5.1 -3.4 
hmuR TonB-dependent outer membrane receptor -3.3 -3.5 NC* 
terB tellurium resistance protein 10.8 10.9 4.6 
katY catalse; hydroperoxidase HPI(I) -36.4 -26.3 -41.1 
kdpA potassium-transporting ATPase subunit A NC* 2.7 NC* 
yfeB ATP-binding protein for iron and manganese ABC transporter -2.2 -2.6 -3.1 
yfeA periplasmic binding protein for iron and manganese ABC transporter -2.4 NC* NC* 
metN DL-methionine transporter ATP-binding subunit 8.4 5.6 3.3 
metQ DL-methionine transporter substrate binding subunit 3.2 NC* NC* 
nirC nitrite reductase small subunit NC* 2.1 NC* 
secY preprotein translocase 3.2 NC* NC* 
hmuU hemin ABC transporter permease -12.6 -9.9 -2.8 
modB molybdate transporter permease protein NC* 3.6 NC* 
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Lipid Transport and Metabolism       
accB acetyl-CoA carboxylase biotin carboxylase subunit 2.1 NC* NC* 
accC acetyl-CoA carboxylase biotin carboxylase subunit 2.7 NC* NC* 
fadB multifunctional fatty acid oxidation subunit complex 6.2 4.2 2.1 
acpD acyl carrier protein phosphodiesterase 2.2 2 NC* 
cdh CDP-diacylglycerol pyrophosphatase 6.8 4.3 3.5 
acpP acyl carrier protein NC* -2.4 NC* 
lipB lipoyltransferase -5 -4.6 -4.7 
Intracellular Trafficking and Secretion       
ftsY cell division protein 3.1 3 2.4 
cysQ inositol monophosphatase family protein NC* 2.7 NC* 
tatE twin arginate translocase system permease -4.8 NC* NC* 
Nucleotide Transport and Metabolism       
amn purine metabolism 2.5 NC* NC* 
pyrB aspartate carbamoyltransferase catalytic subunit NC* 2.1 NC* 
udp uridine phosphorylase 5.4 5.1 2.5 
purH bifunctional phosphoribosylaminoimidazolecarboxamide -3.9 -3.1 NC* 
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cpdB bifunctional 2',3'-cyclic nucleotide 2'-phosphodiesterase NC* 2.9 NC* 
nrdF ribonucleotiode-diphosphate reductase subunit beta -6.4 -5.4 -3.4 
nrdE ribonucleotiode-diphosphate reductase subunit alpha -5 -4.2 -3 
nrdH glutaredoxin-like protein -4.8 -4.1 -3.1 
purL phosphoribosylformylglycinamidine synthase -3.6 -3.3 -2.1 
upp uracil phosphoribosyltransferase -2.4 -2.1 NC* 
deoC cytosine deaminase 2.8 6 NC* 
Posttranlational  modification, protein turnover, chaperones       
bcp bacterioferritin comigratory protein 4.3 2.3 4.2 
hslJ putative heat shock protein -2.1 -2 -2.2 
grxA glutaredoxin 1 2.1 NC* NC* 
hslU ATP-dependent protease ATP-binding subunit -2.1 -2.2 -3.8 
clpB protein disaggregation chaperone -2.9 -2.4 -3.4 
tig peroxidase 2.2 NC* NC* 
htpG heat shock protein 90 -2.6 -2.6 -4 
gst glutathionine S-transferase NC* 2.5 NC* 
hfq RNA-binding protein 2.6 NC* NC* 
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ibpB heat shock protein -90.4 -19.8 -10.9 
Insertion Elements       
YPO4050 transposase -2.2 NC* NC* 
Replication, recombination and repair       
priC primosomal replication protein n -2.7 NC* NC* 
mutM formamidopyrimidine-DNA glycosylase NC* -2.3 -5.4 
dnaB replicative DNA helicase 2.2 NC* NC* 
deaD ATP-dependent RNA helicase DeaD -2.1 -2.9 -2.3 
xthA exonuclease III 3 NC* NC* 
mutY adenine DNA glycosylase 3.3 2.4 NC* 
ihfB integration host factor beta subunit 2.7 NC* NC* 
hupA DNA-binding protein HU-alpha 3.2 NC* NC* 
tnp transposase for the IS1541 insertion element 16.3 NC* -2.8 
Secondary metabolite biosynthesis, transport and catabolism       
trxC thioredoxin 2 7.4 9.9 2.3 
irp2 HMWP2 nonribosomal peptide  synthetase (yersinabactin) -4.4 -3.3 -3.1 
irp1 HMWP1 nonribosomal  peptide/polyketide synthase -11 -4 -9.3 
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fabG 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase 2.1 NC* NC* 
Transcription and signal transduction mechanisms       
slyA transscriptional regulator SlyA -2.7 NC* NC* 
slyD transscriptional regulator SlyD 2.3 NC* NC* 
psaE putative regulatory protein -3.9 -4 -2.5 
treR trehalose repressor -5.6 -7.8 -12.9 
cytR DNA-binding transcriptional regulator -5.9 NC* NC* 
hexR DNA-binding transcriptional regulator 6 4 3.1 
ybtA AraC-type transcriptional regulator for yersiniabactin uptake -5.7 -4.8 -3 
flgM anti-sigma28 factor FlgM 2.4 NC* NC* 
hepA ATP-dependent helicase HepA 2.8 2.4 2.1 
cspE cold shock protein E -19.8 NC* NC* 
cspa1 major cold shock protein -3 -7.2 -4 
cspa2 major cold shock protein  -7.2 -6.8 -3.3 
rpoS RNA polymerase sigma factor NC* 2.2 NC* 
rseA  sigma E factor negative regulatory protein NC* 2.2 NC* 
rseB periplamsic negative regulator of sigmaE -2.2 NC* NC* 
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uspA universal stress protein A -3 2.2 2.1 
csrA carbon storage regulator 2.2 2.6 NC* 
uspB universal stress protein B NC* 9.8 6.4 
slmA nucloetide occulusion protein 2.3 3.4 4.1 
pspA phase shock protein A NC* 2.2 3 
gcvA positive regulator of gcv operon  NC* NC* -3.1 
Translation       
infA translation initiator facor IF-1 2.5 NC* NC* 
infB translation initiator facor  2 NC* NC* 
rplA 50S subunit ribosomal protein 2.9 NC* NC* 
rplB 50S subunit ribosomal protein 3.8 NC* NC* 
rplD 50S subunit ribosomal protein 4 NC* NC* 
rplE 50S subunit ribosomal protein 3.3 NC* NC* 
rplF 50S subunit ribosomal protein 2.4 NC* NC* 
rplI 50S subunit ribosomal protein 3.9 NC* NC* 
rplJ 50S subunit ribosomal protein 2.3 NC* NC* 
rplK 50S subunit ribosomal protein 4.1 NC* NC* 
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rplN 50S subunit ribosomal protein 5.4 NC* NC* 
rplO 50S subunit ribosomal protein 4.2 NC* NC* 
rplP 50S subunit ribosomal protein 4.3 NC* NC* 
rplQ 50S subunit ribosomal protein 2.3 NC* NC* 
rplT 50S subunit ribosomal protein 2.6 NC* NC* 
rplV 50S subunit ribosomal protein 5 NC* NC* 
rplW 50S subunit ribosomal protein 2.8 NC* NC* 
rplX 50S subunit ribosomal protein 3 NC* NC* 
rpmA 50S subunit ribosomal protein 2.2 -2.1 NC* 
rpmD 50S subunit ribosomal protein 4.7 NC* NC* 
rpmF 50S subunit ribosomal protein 2.9 NC* NC* 
rpmG 50S subunit ribosomal protein 4 NC* NC* 
rpmH 50S subunit ribosomal protein 2 NC* NC* 
rpmI 50S subunit ribosomal protein 3.7 NC* NC* 
rpmJ 50S subunit ribosomal protein 3.6 NC* NC* 
rpsA 30S subunit ribosomal protein 2.7 NC* NC* 
rpsC 30S subunit ribosomal protein 4.3 NC* NC* 
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rpsD 30S subunit ribosomal protein 6.7 NC* NC* 
rpsE 30S subunit ribosomal protein 3.6 NC* NC* 
rpsF 30S subunit ribosomal protein 2.2 NC* NC* 
rpsH 30S subunit ribosomal protein 2.6 NC* NC* 
rpsJ 30S subunit ribosomal protein 2.1 NC* NC* 
rpsK 30S subunit ribosomal protein 4.4 NC* NC* 
rpsL 30S subunit ribosomal protein 2.3 NC* NC* 
rpsM 30S subunit ribosomal protein 5 NC* NC* 
rpsN 30S subunit ribosomal protein 3.5 NC* NC* 
rpsQ 30S subunit ribosomal protein 4.3 NC* NC* 
rpsR 30S subunit ribosomal protein 2.1 NC* NC* 
rpsS 30S subunit ribosomal protein 3.1 NC* -2.8 
rpsT 30S subunit ribosomal protein 2.4 NC* NC* 
pheS phenylalanine-tRNA synethase subunit alpha 2.4 NC* NC* 
infC translation initiator facor IF-3 2.8 NC* NC* 
General function and prediction unknown       
hns global DNA-binding transcriptional regulator NC* -2 NC* 
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dkgB 2,5-diketo-D-glyconate reducatase B -3.1 -2.6 NC* 
trmE tRNA modification GTPase TrmE -2.5 -2.3 -9.5 
asr acid shock protein -6.4 -2.8 -3.4 
tus DNA replication terminus site-binding protein NC* -2.8 NC* 
ilvB ilvB operon leader peptide NC* 2.9 NC* 
actP acetate permease -13.6 -5.6 -2.9 
acs acetyl coenzyme A synthethase -5.5 NC* NC* 
yddG drug efflux pump -2.8 NC* NC* 
Plasmid Genes       
caf1M putative F1 chaperone protein -3.3 -2.6 NC* 
caf1A F1 capsule antigen -15.6 -10.9 -8.3 
rop putative replication regulatory protein -10.1 -6.3 -2.6 
pla coagulase/fibrinolysin precursor -12.7 -3.6 -2.3 
parA partitioning protein 3.3 -2.1 NC* 
parB partitioning protein 6.4 NC* NC* 
mgtC modulator of P-type ATPase -5.5 -9.4 -4.9 
pspG phage shock protein G -3.6 NC* NC* 
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yadB putative outer membrane virulence factor 5.1 3.5 NC* 
Quorum Sensing       
luxS S-ribosylhomocysteine lyase, synthesis of autoinducer AI-2 2.6 5.4 NC* 
 
 





Table 4.6.  Differentially expressed genes (DEGs) up- or down-regulated ≥2-fold of Y. pestis secretome and outer surface 




System Up/Down Regulation 
Protein Secretion Systems 6° 10° 15° 
Type 1 secretion 
secA NC* NC* NC* 
secE NC* NC* NC* 
Twin arginine translocation 
tatE -4.8 NC* NC* 
Two-partner secretion 
YPO0600 NC* NC* NC* 
YPO0599 NC* 3.2 2.7 
YPO3721 NC* NC* NC* 
Type 2 secretion 
yacC NC* NC* NC* 
YPO0033 2.7 2.4 2.1 
Type 3 secretion 
yopB -4.1 -3.8 -2.4 
yopD -3.6 -3.2 -2.8 
yopE -2.3 -3.3 -3.1 
yopR -2.1 -2.2 -2.6 
yopT -3.6 -5.0 -5.1 
Type 5 secretion 
yapA 12.7 4.1 2.6 
yapC -4.1 -2.2 -2.1 
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yapH -2.0 2.5 -2.1 
Type 6 secretion 
YPO3704 3.2 2.3 NC* 
YPO3705 NC* NC* NC* 
YPO3706 NC* -3.6 -2.6 
YPO3707 -2.0 -2.5 -3.8 
YPO2727 -2.3 NC* NC* 
YPO0506 NC* NC* NC* 
YPO0514 -2.3 -3.6 -4.1 
YPO0516 3.1 NC* NC* 
Putative secretome components 
Chaperone/Usher transport systems 
caf1R NC* NC* NC* 
caf1M -3.6 -3.2 -2.8 
caf1A -2.3 -3.3 -3.1 
caf1 NC* NC* NC* 
psaA NC* NC* NC* 
psaE -2.0 -2.5 -3.8 
papD NC* NC* NC* 
Secreted/exported protein genes 
YPO1698 NC* NC* NC* 
YPO1699 NC* NC* NC* 
YPO1700 -2.4 -2.3 NC* 
YPO3675 NC* NC* NC* 
yeiB NC* NC* NC* 
sanA NC* NC* NC* 
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YPO0337 NC* NC* NC* 
YPO3699 -2.4 NC* NC* 
YPO4064 NC* NC* NC* 
YPO0033 6.2 4.2 2.6 
YPO1858 2.3 3.0 3.1 
YPO0800 NC* NC* Up 
YPO2857 NC* NC* NC* 
YPO3069 NC* NC* NC* 
yiaF NC* NC* NC* 
ybgF NC* NC* NC* 
Insecticidal-like toxin genes 
yitR NC* NC* NC* 
yitA NC* NC* NC* 
yitC NC* NC* NC* 
yipB NC* NC* NC* 
YPO2312 -3.2 NC* NC* 
Haemolysin-heamagglutinin-like genes 
YPO0900 -2.8 NC* NC* 
YPO3721 NC* NC* NC* 
YPO0599 NC* 5.2 3.7 
YPO4005 NC* NC* NC* 
Outer membrane components 
Outer membrane protein genes 
ompH 2.7 2.0 NC* 
ompA 2.4 NC* NC* 
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ompC -2.2 -2.6 NC* 
tolC NC* NC* NC* 
hmsH NC* NC* NC* 
hmsF NC* -3.1 NC* 
yaeT NC* NC* NC* 
btuB 4.3 NC* -2.3 
ail -3.2 -2.6 -2.1 
YPO1011 -2.1 -3.1 -5.3 
YPO1313 -4.3 -3.3 NC* 
Lipoprotein genes 
spr NC* NC* NC* 
lgt NC* NC* NC* 
ybaY -3.6 NC* NC* 
yiaD NC* NC* NC* 
YPO0420 NC* NC* NC* 
YPO1635 NC* NC* NC* 
YPO2202 NC* NC* NC* 
YPO2292 4.8 3.4 2.3 
pal 3.2 NC* NC* 
lolD NC* -3.6 -5.2 
slyB NC* NC* NC* 
lpp 2.3 3.0 NC* 
rlpA -3.9 -3.6 NC* 
dapX 5.8 3.9 2.6 
yfiO NC* NC* NC* 
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YMPT1.32 -2.4 -3.6 -5.2 
YPO1354 NC* NC* NC* 
YPO2073 2.3 3.0 3.1 
LPS modification genes 
pmrL NC* NC* NC* 
pmrM NC* NC* NC* 
msbB -3.2 -2.6 -2.1 
eptB NC* NC* NC* 
wzxE NC* NC* NC* 
wecC NC* NC* NC* 
*Represents genes that were not up- or down-regulated when compared to 23C.
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Figure 4.2. Histogram showing the quantitative reverse transcription (QRT) PCR confirmation 
results compared to the NGS results.  The quantity of each mRNA was determined relative to 
that of the reference gene proS.  Fold-differences in transcript levels of the Y. pestis genes at 
each growth temperature (6C, 10C, 15C compared to 23C) were compared to the NGS 
transcriptome fold changes (dark grey bars) and qRT-PCR (light grey bars). Figure A. 
Validation of the Y. pestis grown at 6C, comparing qRT-PCR results compared to the 6C 
NGS fold change results.  Figure B. Validation of the Y. pestis grown at 10C, comparing qRT-
PCR results compared to the 10C NGS fold change results.  Figure C. Validation of the Y. 
pestis grown at 15C, comparing qRT-PCR results compared to the 15C NGS fold change 
results.  For each temperature, the Pearson correlation coefficient was used to measure the 
strength of a linear association between the qRT-PCR results and the NGS results.
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Figure 4.3. Schematic overview of the differentially expressed genes (DEGs) up- or down-regulated ≥2-fold of Y. pestis grown 















Figure 4.3. Figure of the known genes necessary for the biosynthesis of the Y. pestis LPS.  The genes in the clusters waaI contain 
most of the genes necessary for the synthesis of the inner core, which comprises the genes of Kdo transferase waaA; 
heptosyltransferases, waaC and waaF to transfer LD-HepI and LD-HepII, and glucosyltransferase waaE.  In addition, it includes the 
gene of heptose 6-epimerase HldD catalyzing the synthesis of ADP-LD-Hep from its biosynthetic precursor ADP-DD-Hep.  WaaQ, 
located in the waaII cluster, encodes a heptosyltransferase gene.  The enzyme encoded by this gene transfers LD-HepIII to LD-HepII; 
glucose must be present on LD-HepI in order to accomplish the transfer.  Gene cluster waaII is a homologue of the gene of ligase 
waaL, which attaches the O-antigen to the core; however, with the absence of O-antigen in Y. pestis, waaL attaches the GlcNAc 








    
 
      CoaD waaE waaC waaF hldD kbl waaA 
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